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III. Summary 
The Metabotropic glutamate receptor 2 (mGluR2) belongs to the family of G-protein coupled 
receptors, a specific class of transmembrane proteins involved in cellular signaling. The 
functionality of such transmembrane proteins has been identified to largely depend on their 
microenvironment, namely the lipid bilayer surrounding them. However, the regulation of the 
receptors by their lipid microenvironment remains poorly understood. In particular, it remains 
unclear how specific protein-lipid interactions may modulate the function of mGluR2. 
In the last years, general motifs for non-covalent cholesterol and sphingolipid interaction 
within helical domains of transmembrane proteins have been described. In these motifs, both 
tryptophan and tyrosine residues have been found to play a decisive role. For that reason, an 
alanine mutagenesis screening, targeting tryptophan and tyrosine residues at the 
transmembrane surface, was carried out in the search of specific sphingolipid or cholesterol 
interaction sites for mGluR2. For the different Y→A and W→A variants, surface 
biotinylation and co-immunoprecipitation showed that neither trafficking nor dimerization 
were disturbed by substitution of these aromatic residues. In contrast, cellular photo-
crosslinking assays demonstrated that cholesterol binding was compromised if one tyrosine 
residue located at the helix five or another at the helix six was replaced. 
Thus, these experiments suggested these two helices to contain specific cholesterol binding 
sites. To get a better molecular insight into these specific protein-lipid interactions, lipid 
binding to the transmembrane domain of mGluR2 was investigated in molecular dynamics 
(MD) simulation. The molecular dynamics simulations in GROMACS were performed in 
collaboration with the Max Planck tandem group of Dr. Camilo Aponte-Santamaría. All-atom 
and coarse-grained MD simulations of the mGluR2 transmembrane domain confirmed the 
experimental observation, by revealing a highly-localized density of cholesterol near these 
residues in helices five and six, which smeared out when they were changed to alanine in 
silico. The simulations also revealed flexibility of the protein structure at the exoplasmic end 
of helix six which changed upon introduction of point mutations. Overall, the work combining 
functional assays and MD simulations demonstrated the existence of specific cholesterol 
binding sites in mGluR2. It will be highly interesting to investigate the functional implications 
of this newly-found specific protein–cholesterol interaction on the activity and conformation 
of the receptor. 
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IV. Zusammenfassung 
Der metabotrope Glutamatrezeptoren 2 (mGluR2) gehört zu der Familie der G-Protein-
gekoppelten Rezeptoren (GPCRs). GPCRs sind Transmembranproteine, die an der zellulären 
Signaltransduktion beteiligt sind. Die Funktionalität dieser Transmembranproteine wird 
wesentlich von den zellulären Membranen und deren Lipidzusammensetzung beeinflusst. Die 
genaue Interaktion der Membranlipide mit den Transmembranproteinen ist jedoch oft nur 
unvollständig verstanden. Im Besonderen ist für den Rezeptor mGluR2 der Einfluss solcher 
Protein-Lipid-Interaktionen noch nicht vollständig begriffen. 
In den letzten Jahren wurden Motive für die Interaktion von Cholesterin und Sphingolipiden 
mit α-helikalen Transmembranproteinen beschrieben. Die aromatischen Aminosäuren 
Tryptophan (W) und Tyrosin (Y) waren häufig Teil dieser Interaktionsmotive. Aus diesem 
Grund wurden diese beiden aromatischen Aminosäurereste in einem Alanin-Screening der 
Transmembrandomäne des mGluR2 Rezeptors einzeln ausgetauscht. Die acht Y→A oder 
W→A mGluR2 Varianten zeigten im zellulären Transport keine Auffälligkeiten; alle acht 
schienen korrekt durch den anterograden Transportweg zur Plasmamembran zu gelangen. 
Überdies hatte der Austausch der aromatischen Aminosäurereste gegen Alanin keinen 
entscheidenden Einfluss auf die Homodimerisierung des Rezeptors zu haben. Im Gegensatz 
dazu zeigte sich in zellulären Kreuzvernetzungsansätzen mit bifunktionalen Lipiden, dass die 
Cholesterininteraktion bei den Varianten Y745A und Y781A, lokalisiert in den 
Transmembranhelices fünf und sechs, im unter steady state-Bedingungen reduziert war. 
Um den molekularen Mechanismus der reduzierten Cholesterininteraktion an den Helices fünf 
und sechs zu entschlüsseln, wurde die Transmembrandomäne des mGluR2 Rezeptors in einer 
computergestützten Molekulardynamik (MD)-Simulation näher untersucht. Die MD-
Simulationen wurden mit dem Programm GROMACS in Zusammenarbeit mit Dr. Camilo 
Aponte-Santamaría (Max Planck-Tandem Gruppe Computational Biophysics, Universität Los 
Andes, Bogotá) durchgeführt. Die atomistischen und coarse-grained Simulationen in 
Phospholipid-Membranen zeigten unter anderem an den Helices fünf und sechs signifikant 
erhöhte Affinität zu Cholesterin. Diese Cholesterininteraktion wurde durch die Einführung der 
Y745A- und Y781A-Variante auch in silico gestört. Zusammengefasst legen die Daten eine 
spezifische Interaktion zwischen dem mGluR2 Rezeptor und Cholesterin nahe, die unter 
Umständen auch Einfluss auf die Konformation der Transmembrandomäne haben könnte, wie 
erste Untersuchungen zur Root mean square fluctuation (RMSF) der Aminosäurereste 
angedeutet haben.  
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1 Introduction 
The eukaryotic cell is separated into different compartments which are enclosed by biological 
membranes. The membranes are self-assembling and conformationally flexible lipid bilayers 
of about 5 nm. Depending on the cellular compartment they have changing lipid compositions 
(1). The lipid bilayers of the secretory pathway exhibit an increasing complexity from the 
endoplasmic reticulum (ER), to the Golgi apparatus and the plasma membrane. The early 
secretory pathway of the ER and cis-Golgi apparatus is distinguished by a low charge density 
and loose packing (2). From the trans-Golgi to the plasma membrane, the bilayer sees an 
increasing cholesterol content and saturation of fatty acids which pack more tightly in the 
membrane (2). In addition, the membrane composition becomes more complex with a lateral 
asymmetry existing between the leaflets of the plasma membrane (reviewed by van Meer, 
Voelker (3)) (Figure 1.1). 
 
Figure 1.1 | Lipid metabolism and transport in mammalian cells. The graphics represents an overview of 
the lipid metabolism and transport from the endoplasmic reticulum (ER) to the plasma membrane. The glycero-
lipids phosphatidylcholin (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol 
(PI), and triayclglycerol (TAG) are synthesized in the ER along with the sphingolipids ceramide (Cer), 
galactoyslcermide (GalCer), as well as cholesterol (Chol). The lipids shuttle through the secretory pathway via 
vesicular transport or transfer proteins, such as the PC carrier StarD7. In the Golgi appartus sphingomyelin 
(SM), glucosylcermide and complex gangliosides (GSL) are synthesized. Some lipids, like phosphorylated PI 
species, are specifically localized to distinct membranes, like PI(4,5)P2 to the plasma membrane. In the plasma 
membrane signal induced hydrolysis of sphingolipids to sphingosine-1-phosphate (S1P) and sphingosine (Sph) 
takes places. From the ER to the plasma membrane the cholesterol content increases (Chol/Phospholipids(PL)) 
and the membrane becomes increasingly packed and with a lateral asymmetry between the leaflets. Drafted in 
ChemDraw (Ver. 16.0.1.4, PerkinElmer Informatics, Waltham, USA) with modifications from van Meer, 
Voelker (3) and Holthuis and Levine (2). 
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The resulting properties of these mixtures of lipids are often broken down to the parameter of 
liquid (dis-)order: the disordered phase shows a higher content of low melting lipids 
((poly-)unsaturated fatty acyl chains, low cholesterol content) whereas the ordered phase is 
rich in high melting lipids (saturated fatty acyl chains, high cholesterol content) (4). In 
complex lipid mixtures phases may coexist within one membrane structure. The resulting 
alternating biophysical properties between and within the membrane structures contribute to 
the function of the peripheral or integral membrane proteins. The function of the lipid bilayer 
as microenvironment of membrane proteins is not well understood and is the subject of this 
thesis. 
1.1 Protein-lipid interactions 
Both peripheral and integral membrane proteins shape the curvature, thickness and 
composition of membranes and are themselves attracted by certain biophysical or biochemical 
properties of membranes (2, 5). The binding of peripheral proteins can for example dependent 
on the packing of the membrane. One example is the ArfGAP1 protein involved in COPI 
trafficking within the early secretory pathway. ArfGAP1 binds via its ALPS motif to highly 
curved membranes, which are characterized by packing defects in the lipid bilayer (6). Others 
proteins depend on the presence of specific lipid headgroups at the surface of the lipid bilayer, 
such as phosphoinositide-binding proteins. Different phosphorylation states of the 
phosphatidylinositol (PI) headgroup were found as organelle marker and recruit proteins with 
different Pleckstrin homology domains (7). An example is PI(4,5)P2, which is a plasma 
membrane marker and is involved in transient recruitment of soluble proteins to the 
membrane (8). Some lipid transport proteins not only recognize specific lipid classes but also 
have binding pockets that can accommodate specific lipid species. Examples are START-
domain proteins that have a ~210 amino acid domain which forms a binding pocket for the 
cytosolic transport of lipids (9). One of these proteins, Star-D7, was found to have a specific 
function in phosphatidylcholine (PC) transport (10). 
For the presented examples in lipid transport and signaling, distinct consensus motifs within 
the peripheral proteins have evolved. These consensus motifs allowed uncovering additional 
family members once the functional motif had been identified. This was for example done for 
the START-domain lipid transporters or the signaling proteins with a Pleckstrin homology 
domain (7, 11, 12). Compared to that, so far a few conserved amino acid sequences or 
structural domains within integral membrane proteins have been described to participate in 
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covalent lipid modifications or non-covalent interactions with lipids. This is due to their often 
transient nature and the low conservation of modification and interaction sites. Here we 
further go into detail as the lipid interaction of integral membrane proteins is the central 
subject of this thesis. 
G-protein coupled receptor (GPCR) signaling complexes are often used as model to study 
both covalent lipid modification and non-covalent interactions (reviewed by Escriba, 
Wedegaertner (13)). This is because they are a highly relevant drug targets and at the same 
time are influenced by a nearly all known lipid modification and interactions events. The 
GPCRs make up a total of about 800 genes in the human genome which have been mostly 
characterized by the hepta-α-helical transmembrane domain (14). The seven α-helices are 
connected by three intra- and three extracellular loops with the N- and C-termini being extra- 
and intracellular, respectively (14, 15). While the fold of the transmembrane domain is 
conserved, the N- and C-terminal end showed greater variation in length and structure (16). 
The C-terminal end is usually unstructured but is often associated with regulatory post-
translational modifications (see Section 1.2.4). The N-terminal end can greatly vary in length 
and structure. While for family A usually is very short N-termini, the other families possess 
large extracellular ligand binding sites (16). Other features, like G-protein coupling, the ligand 
and its binding site, have not been uncovered for all receptors (17). According to the 
International Union of Basic and Clinical Pharmacology, the human GPCRs are classified into 
four classes: Rhodopsin receptors (Family A), Secretin receptors (Family B), Metabotropic 
glutamate receptor (mGluR) family (Family C) and Frizzled receptors (Family F) (18). 
1.1.1 Covalent lipid modifications of proteins 
Both peripheral and integral membrane proteins can be covalently modified with lipids. 
Especially for GPCR complexes a diverse set of lipid modifications is found both on the 
(integral) membrane receptors, on which this work is focused, as well as on the downstream 
located (peripheral) trimeric G-proteins (see Figure 1.2). 
1 Introduction 
26 
 
 
Figure 1.2 | β2-adrenergic receptor coupled to heterotrimeric GαS/βγ. The graphic shows an approximated 
binding site of the heterotrimeric G-protein complex (G-alphaS, G-beta, G-gamma) to the β2-adrenergic 
receptor (beta2AR) coupled on the cytoplasmic side (19, 20). The beta2AR structure was crystallized with the 
S-palmitoylation (purple spheres) at C341 and one adjacent cholesterol molecule (orange spheres). Two more 
cholesterols are bound at a cleft between helix I and IV (indicated above the transmembrane helices). Drafted in 
ChemDraw with modifications from Liang, Khoshouei (19) and Cherezov, Rosenbaum (20). The relative 
position of the G-protein to the receptor and the membrane are approxiamated and do not depict a physiological 
assembly. 
1.1.1.1 Modification of GPCRs by S-palmitoylation 
All GPCRs are integral membrane proteins with a hepta-α-helical transmembrane domain. 
Therefore they require the hydrophobic core of the membrane as solvent but do not depend on 
covalent lipid modification to ensure membrane localization (13). However, the receptors are 
subject to regulatory post-translational lipid modifications of which S-fatty acylation is the 
most prominent one (13). S-palmitoylation via a thioester to cysteine residues usually occurs 
in the cytoplasmically localized C-terminal domain of the receptors and is catalyzed by 
DHHC-family palmitoyltransferases (21, 22). With a total of 23 enzymes, the members of the 
DHHC-family are located in the early and late secretory pathway (23). This goes along with 
the finding that S-fatty acylation of GPCRs was found in some cases to be required for correct 
trafficking, for example for the Chemokine receptor 5 (24). For other GPCRs, such as the 
beta2-Adrenergic receptor (β2AR), S-palmitoylation was suggested to be involved in 
modulating receptor activity or, like for the 5-Hydroxytryptamine 1A Receptor (5-HT-1A), in 
association with specific membrane domains (25, 26) (see also Figure 1.2). As opposed by 
other types of protein acylation, palmitoylation can be reversed by the action of acylprotein 
thioesterases. Thus, S-palmitoylation is considered a flexible post-translational modification 
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(27). However, both for S-palmitoylation and depalmitoylation only a few enzyme-receptor 
pairs have been assigned so far (28, 29). A fact that hampers the identification of new 
palmitoylation sites is that even though predictive algorithms are available no definite 
consensus sequence has been established so far (30). Web-based programs like CSS-Palm 
were trained with a data set of experimentally determined palmitoylation sites (31). 
1.1.1.2 Covalent lipid modifications of G-proteins 
G-proteins are the downstream effectors of GPCRs usually coupled to the receptors at the 
cytoplasmic side of the plasma membrane. In contrast to the receptor, both α- and βγ-subunit 
of the trimeric G-protein complex are peripheral and thus rely on lipidation for membrane 
association. To shuttle through the secretory pathway to the plasma membrane, the 
isoprenylated βγ-subunit of the heterotrimeric G-proteins needs to pair with the fatty acylated 
α-subunit in the ER or Golgi apparatus (32, 33). 
For the G-protein α-subunit both S-palmitoylation and N-myristoylation sites were identified 
(reviewed by Escriba, Wedegaertner (13)). N-myristoylation is a co-translational and 
irreversible modification catalyzed by the N-myristoyltransferase at the N-terminal glycine of 
target proteins after the start methionine residue has been removed (34). While the N-
myristoylation is static, the more flexible S-palmitoylation sites appeared for some α-subunits, 
as for example GαS or Gα0, to be connected to dynamic shuttling between plasma and Golgi 
membrane or endocytic vesicles (35-37). For the βγ-subunit of the heterotrimeric G-protein, 
isoprenylation sites on the consensus motif CaaX have been identified. The cysteine residue is 
irreversibly linked to a either a farnesyl or a geranylgeranyl moiety by either a farnesyl or a 
geranylgeranyl transferase. The cysteine residue is followed by two aliphatic amino acid 
residues and an amino acid X that determines the nature of the modification (13, 38). 
1.1.2 Non-covalent lipid interactions of integral membrane proteins 
In contrast to covalent lipid modifications of proteins, non-covalent protein-lipid interactions 
within the membrane are often more difficult to study because of their transient nature. 
Another layer of complexity is also the presence of annular and non-annular membrane lipids 
surrounding transmembrane proteins (39). The former one describes the first lipid shell at the 
surface of the transmembrane protein. At the roughened surface the fatty acyl chains of the 
annular lipids usually get distorted when they adapt to the more solid protein structure (40). 
This process is mainly driven by unspecific forces, such as hydrophobic interactions of the 
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acyl chains or electrostatic interactions of the head groups. Non-annular lipids display a 
different kind of interaction in binding with a low koff rate distinct spots or pockets on the 
protein surface (5). This first lipid shell of lipids is also influenced by the overall thickness of 
the bilayer and the structure of the protein’s transmembrane domain. To avoid hydrophobic 
mismatches either the lipid bilayer, the protein or both have to adapt (41).  
1.1.2.1 Modulation of GPCR activity by interactions with cholesterol and glycerolipids 
For the GPCR rhodopsin it has been shown that protein function depends on the presence of 
unsaturated PE, but also PC and PS, species in the rod membranes. Low-melting docosa-
hexaenoic and oleic acid glycerolipids adapt to the α-helical surface structure and are thought 
to facilitate allosteric changes in the receptor structure towards an active state (42, 43). An 
increasing cholesterol content makes the membrane more rigid and shifted the equilibrium of 
rhodopsin towards the inactive state (44). For β2AR, cholesterol was co-crystallized with the 
receptor (45).Here, two cholesterol molecules were bound in a groove between the helices I, 
II, III and IV (see Figure 1.3 A). From the structure a cholesterol consensus motif (CCM) for 
GPCRs was determined: [4.39-4.43(R,K)]—[4.50(W,Y)]—[4.46(I,V,L)]—[2.41(F,Y)] 
according to the helix numbering by Ballesteros and Weinstein (46). The site distinguished 
itself by similarities with cholesterol binding motifs identified earlier and the spatial 
distribution of the conserved residues in family A receptors (45). The experimental findings 
were later confirmed by molecular dynamics simulations (47). These in silico studies showed 
that the CCM groove between helices I and IV on the intracellular site occupied by 
cholesterol in the crystal structure 3D4S was also occupied in atomistic molecular dynamics 
simulation (47). Notably the simulations, which were performed in a DOPC bilayer with up to 
40mol% cholesterol, showed two more specific cholesterol binding sites within the dimer: one 
in an intracellular cleft between helices V and VI, and another one between helices VI and VII 
on the extracellular leaflet. Also coarse-grained molecular dynamic simulations – simulation 
conducted at a lower resolution – of β2AR dimers in a POPC bilayer system with 9-50mol% 
cholesterol showed a cholesterol density for the CCM motif (48). Further experiments found 
that the cholesterol binding had thermostabilizing activity (45). A similar effect was found for 
the Oxytocin receptor (49). Concerning the physiological meaning, further experimental data 
have suggested that while β2AR resided in disordered phase its interaction partners were 
found in raft-like regions (50, 51). Subsequently the depletion of cholesterol led to an 
increased basal activity. 
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Figure 1.3 | Non-covalent cholesterol interaction sites. (A) A cholesterol consensus motif (CCM) in the beta2-
Adrenergic receptor (45). The four amino acid residues assigned to the 3-dimernsional motif are localized in 
helices II and IV (indicated above): [4.39-4.43(R,K)]—[4.50(W,Y)]—[4.46(I,V,L)]—[2.41(F,Y)] (depicted in 
orange spheres). Notably there were also further residues involved in binding a second cholesterol with a 
reduced number and less conserved interaction sites (depicted in yellow spheres). The graphic was generated 
with Pymol (Ver. 1.7.0.3, Schrödinger, New York, USA) and ChemDraw. (B) The cholesterol 
recognition/interaction amino acid consensus (CRAC) with the consensus motif N-(L/V)X1-5YX1-5(R/K)-C and 
its inverted counter part CARC with the sequence N-(K/R)X1-5(Y/F)X1-5(L/V)-C bind cholesterol to α-helical 
structures (52, 53). By bioinformatics more sites were found in different GPCRs and other integral membrane 
proteins. Graphic retrieved with permission (License Number 4498110779910) from Fantini, Di Scala (54). 
A direct role of cholesterol in modulating receptor activity was described for the 5-
hydroxytryptamine receptor 1A (5-HT-1A) and the Metabotropic glutamate receptor 2 
(mGluR2) (26, 55). 5-HT-1A was suggested to reside in raft-like membrane domains. Both 
partitioning to these domains and coupling to Gαi protein was reported to be dependent on 
palmitoylation of the GPCR (26). mGluR2 was reported to partion into liquid-ordered 
membrane regions upon activation and to alter its affinity toward an agonist upon cholesterol 
depletion (55). The mGluR2 homologue mGluR1 showed a similar behavior as ectopic 
expressed protein in human cells: Upon activation the protein shifted cholesterol-dependent 
into liquid-ordered phase (56). In the liquid-ordered phase, the cholesterol interaction with the 
receptor appeared to be at least partly dependent on another cholesterol binding motif, the 
cholesterol recognition/interaction amino acid consensus (CRAC) motif (see Figure 1.3 B). A 
N-(L/V)X1-5YX1-5(R/K)-C motif is present in the 5
th
 helix of the heptahelical domain and is 
conserved throughout the whole mGluR family. Disruption of the motif by point mutations 
led to a decrease in coupling to downstream effectors (56). Notably also the 5-HT-1A and the 
Oxytocin receptor contain a CRAC motif within the transmembrane helix V (57). 
The original CRAC motif was discovered in the cytosolic portion of a cholesterol transport 
protein, the Peripheral-type benzodiazepine receptor (52). A CRAC inverted motif 
N-(K/R)X1-5(Y/F)X1-5(L/V)-C, defined as CARC motif, was studied in the integral membrane 
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protein human Nicotinic acetylcholine receptor by molecular docking experiments after the 
cholesterol interaction to single helices in the receptor had been tested earlier (53, 58) (see 
Figure 1.3 B). Both the CRAC and the CARC motif are defined by a triad of basic (R/K), 
aromatic (F/Y) and aliphatic (L/V) amino acid residue (54). The basic residues are thought to 
interact with the 3’OH group of cholesterol that orients towards the surface of the membrane 
bilayer. The aromatic residue residing in the hydrophobic phase of the membrane bilayer was 
suggested to stack on the aliphatic ring system of cholesterol (59). Finally the aliphatic amino 
acid residue is thought to interact with the branched hydrocarbon chain attached to the C-17 
atom of the cyclopentane ring (59). Both motifs are found in a variety of transmembrane 
domains even though only few of them have been confirmed experimentally or by in silico 
studies (reviewed by Fantini, Di Scala (54)). 
Interaction of GPCRs with sphingolipids 
In contrast to cholesterol, sphingolipids have gained less attention in protein-lipid interaction 
studies with GPCRs. This is remarkable because of the well-studied co-partitioning of 
cholesterol and sphingolipids into membrane domains. The findings published concerning 
GPCRs dealt mostly with effects of inhibition of the sphingolipid metabolism (60-62). Only 
few studies focused so far on specific interactions of GPCRs with sphingolipids. One example 
is a coarse-grained simulation study of the human 5-hydroxytryptamine (serotonin) receptor 
1A (5-HT-1A) which showed binding of the sphingolipid monosialotetrahexosylganglioside 
(GM1) to the first extracellular loop of the protein (63). The motif was suggested to be 
homologues to a sphingolipid binding domain (SBD) identified as V3(-like) domain in HIV 
protein gp120, Prion protein and Alzheimer β-amyloid (64). As in these different proteins, the 
helix-loop-helix structure in 5-HT-1A showed a combination of aromatic, basic and turn-
inducing amino acid residues (63) (Figure 1.4 A). The actual contact with the sugar tree of 
GM1 was established by an aromatic tryptophan residue in the loop. However, the SBD was 
more of a structural motif which had been established by homology (64). 
Apart from the SDB, only one other sphingolipid interaction domain in proteins has been 
identified so far. In the COPI machinery protein p24 a specific sphingomyelin binding motif 
had been identified by means of cellular, in vitro and in silico experiments (65). The single-
spanning integral p24 protein is the membrane resident anchor for the COPI vesicle budding 
machinery (66). The sphingomyelin interaction motif N-VX2-TL-X2IY-C, sensitive to 
perturbations by point mutations, was found opposite to the designated dimerization interface 
(65) (Figure 1.4 B). The simulation studies suggested an interaction of the tyrosine residue 
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with the choline moiety of sphingomyelin while the beta-branched residues and leucine 
interacted with sphingosine and fatty acid chain. 
A 
 
B 
 
Figure 1.4 | Sphingolipid interaction motifs. (A) The V3(-like) domain in HIV protein gp120 was identified as 
structural sphingolipid binding domain (SBD). Presumably, the aromatic amino acid tyrosine in the loop (Carbon 
atoms highlighted as orange spheres) plays a role in the binding of the sugar tree of GM1 (64, 67). The graphic 
was generated in Pymol. (B) The sphingolipid interaction site in the transmembrane domain of the COPI 
machinery protein p24 (dimer, depicted in light and dark blue) is thought to have a sphingomyeline (cholin 
headgroup: yellow, acyl chains: green) interaction site (highlighted in red) opposite to the p24 dimerization 
interface. Graphic retrieved with permission (License Number 4498091273490) from Contreras, Ernst (65). 
1.1.3 Methods to study protein-lipid interactions 
The methods mentioned in the previous chapters can be divided into experimental and 
computational methods. The former ones were especially useful in identifying novel covalent 
lipid modification sites. The identified modification sites were then used to search for 
homologous motifs by means of bioinformatics. For some modifications, like isoprenylation, 
consensus motifs have been identified while for others, like S-palmitoylation, trained 
algorithms are available (31, 38). Such trained algorithms have also been used for non-
covalent interaction sites, like the CCM or sphingolipid interaction motif (45, 68). As 
methods to define non-covalent lipid interaction sites in proteins are especially laborious, also 
molecular dynamics simulation have got more and more attention to confirm or also predict 
novel sites (69). 
1.1.3.1 Experimental methods to identify and characterize protein-lipid interactions 
The most powerful methods to date are X-ray crystallography, cryo-electron microscopy and 
native mass spectrometry. The CCM has been identified by co-crystallization and X-ray 
crystallography of the β2AR with cholesterol (45). Further interaction sites of GPCRs with 
cholesterol have been identified for example in the Serotonin receptor 5-HT-2B, of which two 
homologues are used in the thesis, and also mGluR1 was co-crystallized with cholesterol at 
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the dimer interface (70, 71). In the context of crystallization cholesterol could be both a non-
annular lipid and/or a stabilizing agent. Close to that approaches was the electron 2D-
crystallization performed by the group of Thomas Walz (72): the structure of the Aquaporin 
was resolved along with the annular glycerolipids bound to the surface. As for the X-ray 
crystallography, specific lipid types added to the stability of the crystal (73). Another way to 
resolve the lipid shell is mass spectrometry. One example is the identification of lipids driving 
the oligomerization integral membrane proteins by native mass spectrometry (74). Notably, 
the study identified the lipid set bound at the protein-protein interface but would not resolve 
the whole lipid shell (74). Another mass spectrometry-based approach was chosen to resolve 
the sphingolipid binding to the COPI protein p24 (75) (see also Section 0). A sphingomyelin 
lipid with diazirine group was incorporated into proteoliposomes with the p24 transmembrane 
domain which was then UV-crosslinked to the molecules. Prerequisite for this kind of 
experiments is knowledge of the binding preferences for the protein in vivo. 
A technique to identify protein-lipid interaction in vivo is metabolic labeling of cells with 
functionalized lipid precursors that carry either a radioactive isotope or a terminal alkyne 
group amenable to click-chemistry (see Figure 1.5 A). Radioactive groups have proven 
powerful tools for the identification of covalent lipid modifications, such as palmitoylation 
(76). For non-covalent lipid interactions, reporter lipids are used that contain a diazirine group 
to allow for UV-crosslinking to proteins in closest proximity (77, 78) (see also Figure 1.5 B). 
Alternative introduction of alkyne groups in these photoactivatable lipids then also allowed 
identifying lipid interactomes (79, 80). Here the alkyne group is ‘clicked’ to biotin which is 
then used to pull-down all proteins interacting with the bifunctional lipid. Data from these 
experiments can again be used to enhance in vitro experiments or in silico approaches. 
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C Figure 1.5 | Cellular distribution and metabolism of 
sphingolipid and cholesterol analogues. (A) The 
simplified depiction shows that the uptake of precursor 
lipid analogues, like photoactivatable and click-
able(PAC)-sphingosine, via the endocytotic pathway 
(80). From there on the lipid probes are distributed and 
metabolized by different enzymes in the endoplasmic 
reticulum (Ceramide (Cer), Galactosylceramide 
(GalCer), Cholesterol (Chol)). Further metabolism 
happens in the Golgi (Sphingomyelin (SM), 
Glucosylceramide (GlcCer), Gangliosides (GSL)). At 
the plasma membrane functionalized lipids can be 
broken down again (Sphingosine-1-phosphate (S1P), 
Sphingosine (Sph)). (B) Different functionalized lipids 
carry groups for detection (Tritium or alkyne, labeled 
in yellow and orange), as well as for crosslinking 
(diazirine, violet). (C) A simplified scheme of the 
sphingolipid metabolism shows that the sphingosine 
analogues enter the metabolism via a degradation 
pathway (deep purple) while the de novo synthesis 
happens inside the ER (light purple). Graphic retrieved 
with permission (Account #3001385975) from 
Haberkant, Stein (80). Copyright (2018) American 
Chemical Society. 
 
1.1.3.2 Molecular dynamics simulations to study protein-lipid interactions 
It is often difficult for experimental methods, like crystallography, to capture the molecular 
picture of (non-)annular lipid binding to proteins. Molecular dynamics (MD) simulation is a 
well-established technique that in the recent years has proven successful to address this issue 
(69). MD simulations monitors the spatio-temporal evolution of biomolecular systems at 
atomistic or quasi-atomistic (coarse-grained) level, to thereby reveal functionally relevant 
structural, (thermo-)dynamic, and energetic information, that complements and guides 
experimental methodologies. MD has been exhaustively used to understand the interplay 
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between lipids and proteins in biological membranes (69, 81, 82). The simulations revealed 
key details on how proteins alter the conformational architecture of their surrounding lipids, 
how in turn lipids modulate the activity of membrane proteins, and how complex 
compositions of lipids and proteins coexist to give raise to diverse functionalities of biological 
membranes. 
As mentioned above, there are two important kinds of MD simulations for protein-lipid 
interaction: atomistic and coarse-grained. While the former one assigns position, velocity, 
long- and short-range interactions for explicitly each atom, the latter one merges several 
atoms into one bead for which the physical properties are calculated (69). To conduct the 
simulation, one needs a force-field to parameterize the physical properties and a program in 
which to calculate. For membrane system the CHARMM36 (83) and for the coarse-grained 
simulations the Martini force field (84) were used in the thesis. Both have been designed for 
proteins and were extended to lipids later on. CHARMM36 is especially convenient because 
of the online program CHARMM-GUI which allows step-by-step assembly of the system 
with all data generated for the energy minimization and production run of the system 
generated automatically (85, 86). Likewise, for MARTINI the program Insane allows to 
assemble solvated bilayer system with a simple command line and obtain preset parameters 
for the production run (87). 
For GPCRs, especially cholesterol binding has been extensively investigated by MD 
simulations (69). Combinations of both atomistic and coarse-grained simulations have been 
used to reveal distinct binding modes of cholesterol to this family of proteins. One example is 
the Chemokine receptor 4, whose function has been linked to cholesterol (88). Coarse-grained 
MD simulations in this case revealed how cholesterol binds to certain regions of the receptor 
and thereby alters its dimerization (89). Snap-shots from the coarse-grained simulation were 
then ‘backmapped’ to the atomistic level to identify cholesterol interaction sites on the amino 
acid residue level. 
1.1.3.3 Combining experimental and molecular dynamic approaches to study protein-
lipid interactions of COPI protein p24 
To study sphingolipid binding to the COPI protein p24 a combined approach was chosen (65): 
The lipid binding was evaluated by in vitro and in vivo experiments on p24 with 
functionalized sphingolipids. The data were then used as input of subsequent MD simulations. 
In this case, the simulations, along with a point mutation screening of the p24 transmembrane 
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helix, revealed the putative sphingolipid interaction motif N-V-(X)2-TL-(X)2IY-C. In a 
subsequent screening for similar (linear) interaction motifs a number of GPCRs were found 
(68). Among the found GPCRs, there were also members of the mGluR family, which had 
been associated with specific cholesterol binding earlier by structural and biochemical means 
(55, 56, 71). For that reason, one family member, namely human mGluR2 contained the 
N-T-(X)2-TT-(X)2IW-C motif, was chosen as model for most of the later experiments in this 
thesis. The putative sphingolipid interaction motif N-T-(X)2-TT-(X)2IW-C was located in 
transmembrane helix VI of mGluR2. Helix VI has been associated with receptor activation in 
other GPCRs (90). Therefore, it was regarded as an interesting target to study the influence of 
cholesterol and sphingolipid binding to GPCRs. 
1.2 Metabotropic glutamate receptors 
The previous chapter has shown multiple examples how GPCRs and their downstream 
effectors, namely the heterotrimeric G-protein, are affected by covalent lipid modifications 
and non-covalent protein-lipid interactions. However, the life of a GPCR protein in the 
eukaryotic cell has also other aspects, such as the control of the expression and translation, the 
trafficking and activity control. 
1.2.1 GPCRs: Structures and common features 
Between the different families only few residues in the amino acid sequence were found to be 
conserved in the transmembrane domain (14). In contrast to that, advancements in the 
crystallization of the receptors have shown that the fold of the transmembrane domain is 
conserved between the families: The crystal structure of the mGluR1 and mGluR5 
transmembrane domains were well aligned to family A, B and F receptors with their 
transmembrane helices I-IV and VI (71, 91). Greater variation was seen for the helices V and 
VII which were shifted inwards as compared to the other structures. The more compact 
packing of the helix bundle in family C receptors was associated with the fact that they bind 
their natural ligand in the extracellular domain (71); other than the family A receptors which 
bind their ligand usually in the transmembrane bundle. Two other important structural 
features which have been uncovered in the different structures were the E(D)RY-motif and 
the cysteine bond in the extracellular loops. The E(D)RY motif is an ionic lock between helix 
VI and helix III that is thought to control receptor activation by controlling the movement of 
helix VI. It was found with slightly different characteristic in family A and C, but not B and F 
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(71, 91-95). In the same structures, the second extracellular loop tied to the transmembrane 
core by a disulfide bridge to helix III. 
The family C receptors distinguish themselves structurally by large N-terminal extracellular 
ligand binding sites (16). For mGluRs the ligand binding cleft is found between two lopes and 
therefore nicknamed Venus flytrap domain. Between the eight different receptors the binding 
affinity of the Venus flytrap domain for their ligand varies (see Table 1.1). The domain is 
connected to the helix bundle by a cysteine-rich linker. The linker is found throughout the 
family C expect for the Gamma-aminobutyric acid (GABA) receptors and found to be 
involved in allosteric signal transduction to the transmembrane domain (96, 97). 
Within the family C of GPCRs, the phylogenetic subgroup of the Metabotropic glutamate 
receptors (mGluRs) is subdivided by sequence and pharmacology into Group I, II and III (15) 
(see also Table 1.1). All mGluRs share a high sequence similarity (~70% identity within and 
~45% between groups (98)) and glutamic acid as common ligand. The three different groups 
couple to distinct sets of G-proteins (see Table 1.1). The physiology and function of mGluRs 
is well understood in the neuronal context (reviewed by Nicoletti, Bruno (99) and Benarroch 
(100)), but less is known about functions of mGluRs, which are expressed in non-neuronal 
tissues (101). 
Table 1.1 | Phylogenetic subgroup of the Metabotropic glutamate receptors. The table lists the principle 
characteristics of the eight known Metabotropic glutamate receptors (mGluRs). The values were retrieved from 
Pin, De Colle (102), IUPHAR/BPS Guide to PHARMACOLOGY (103) and UniProt (104). EC50 = effect 
concentration 50, GO Term = gene ontology term. 
Group Members  
(UniProt ID) 
Ligand affinity 
Glutamic acid (EC50) 
Principal 
transduction 
GO term ‘Plasma membrane’ 
I 
mGluR1 (Q13255) 
mGluR5 (P41594) 
9-13 µM 
3-10 µM 
Gαq/11 
Gαq/11 
Postsynaptic membrane 
Postsynaptic membrane 
II 
mGluR2 (Q14416) 
mGluR3 (Q14832) 
4-20 µM 
4-5 µM 
Gαi/o 
Gαi/o 
Presynaptic membrane 
Pre-/Postsynaptic membrane 
III 
mGluR4 (Q14833) 
mGluR6 (O15303) 
mGluR7 (Q14831) 
mGluR8 (O00222) 
3-20 µM 
16 µM 
1000 µM 
2.5-11 µM 
Gαi/o 
Gαi/o 
Gαi/o 
Gαi/o 
Presynaptic membrane 
Presynaptic membrane 
Pre-/Postsynaptic membrane 
Presynaptic membrane 
1.2.2 Transcription and translation of Metabotropic glutamate receptors 
The different homologues encoded one GPCR receptor type are just one layer of complexity. 
According to bioinformatical analysis, about 50% of the human GPCR genes are intronless, 
while the other 50% contain at least one intron and may have splice variants (105). Many of 
these splice variants have not received much attention and for most it is not known if they 
result in a functional isoform of the receptor. However, some studies have investigated the 
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impact of alternative splicing on GPCRs. Receptor isoforms resulting from alternative 
splicing can impact ligand binding, G-protein coupling or post-translational modifications 
(reviewed by Markovic and Challiss (105)). 
For the phylogenetic group of Metabotropic glutamate receptors, there are there are several 
splice variants described, such as for mGluR1, mGluR3, mGluR5, mGluR6, mGluR7 and 
mGluR8 (106). Notably for mGluR2 no isoforms were reported for the UniProt entry Q14416 
(104). In contrast to that, the closest ‘relative’ of mGluR2, mGluR3, a truncation isoform was 
described lacking the whole transmembrane domain. It was shown that this truncated isoform 
was expressed at the cell surface of human neurons (107). Recent studies have shown that the 
isoform acts via dominant-negative inhibition of ligand binding in heterodimers formed with a 
full length version of mGluR3 (108). Another example of splicing variants within the mGluR 
family is the alpha and beta isoform of mGluR1. As for most isoforms of mGluRs, alternative 
splicing targets the C-terminal tail of the receptor. The alpha-form has a longer C-terminal 
end as compared to the truncated mGluR1β isoform. Several studies investigated how the 
interaction with tail-binding proteins and the trafficking was affected by the different termini 
of mGluR1 (109-111). One important different between the isoforms was the RRKK signal 
peptide in the C-terminal tail which appeared to be sterically blocked in the alpha-isoform 
while it caused ER retention in the beta-isoform when expressed in Hek293 cells. This was 
the reasons mGluR1α was used as representative for group I mGluRs in the thesis. 
The next step after transcription is the translation of GPCRs into the ER. The vast majority of 
family C GPCRs carries a signal peptide at the N-terminal end which is necessary for the 
correct translation of the nascent chain into the ER (112). Translation of membrane proteins 
into the ER is aided by the low cholesterol content and the presence of glycerophospholipids 
with unsaturated fatty acyl moieties (3). The resulting biophysical properties make the ER 
membrane more adaptable to protein structures that are ‘designed’ to reside in the plasma 
membrane (113, 114). However, it should be noted that overall few GPCRs carry a cleavable 
N-terminal signal peptide (112). Kochl, Alken (115) proposed that it is only necessary for big 
and/or stably folded N-terminal peptide chains. In the case that there is no signal peptide the 
first transmembrane domain serves as signal anchor sequence, which is the case for most 
family A and B GPCRs (112).  
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1.2.3 Trafficking and dimerization 
During the insertion of the nascent polypeptide of mGluRs into the ER, the receptors are co-
translationally modified by glycosylation. N-glycosylation is one of the most common 
co-/post-translational modification of family C receptors and has been described mostly by 
means of bioinformatic analysis of the consensus sequence N-N-X-(S/T)-C where amino acid 
X is any amino acid except proline (116). Experimental data on Metabotropic glutamate 
receptors glycosylation are available for mGluR1α, mGluR3 and mGluR5 (117-119). 
Interestingly, for mGluR3 and mGluR5 it was shown that many of putative N-glycosylation 
sites seem not to be modified (118, 119). However, only for mGluR1α the physiological 
implication was investigated and suggested that while surface expression was not affected 
agonist response was reduced (117). 
The other important modification in maturation of mGluRs is the formation of disulfide 
bridges. For mGluRs, the disulfide bonds are found at three distinct sites within the protein 
(see also Figure 1.6). The first site is the disulfide tether between transmembrane helix III and 
the second extracellular loop; the connection is thought to be a structural hallmark of GPCRs 
(71, 91). The second one is in the cysteine-rich linker connecting transmembrane and Venus 
flytrap domain (96). Here, several beta-sheets and loops are linked to one another by cystine 
bonds (120). Finally, the mGluR protomers are covalently connected with a disulfide bridge 
between the Venus flytrap domains mediated by C121 in the mGluR2 homodimer (96, 121). 
Several studies suggested that mGluR (homo-)dimers are the physiological active forms 
(reviewed by Pin and Bettler (122)). 
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Figure 1.6 | Schematic overview of the 
post-translational modifications on 
Metabotropic glutamate receptors. The 
graphic shows the crystal structure of 
mGluR3 complexed with glutamic acid 
(orange spheres) (96). The transmembrane 
domains are models of the mGluR2 
transmembrane domain in SwissModel (71, 
123). The exact arrangement between the 
domains is not know as no structure for the 
full length receptor has been determined 
(border indicated by red bars). The 
disulfide bonds and N-glycans are found on 
the extracellular side, including a cystine 
bond between transmembrane helix III and 
the 2
nd
 extracellular loop (ECL). S-
palmitoylation, ubiquitination and 
sumoylation are suggested to occure at the 
C-terminal tail (unstructured, no model 
available), while phosphorylation might 
also occur in the intracellular loops 
(discussed in Section 1.2.3). 
Lipidation can also occur as early as in the ER and has been shown for some GPCRs to be 
important for trafficking (24, 124) (see Section 1.1.1.1). However, little information on 
lipidation of mGluRs is available (116). Among the mGluRs, only mGluR4 was reported with 
a S-palmitoylation site but neither the position nor the physiological relevance have been 
further investigated (125). This is why mGluR4 was included as representative for group III 
mGluRs in the palmitate labeling of the thesis. 
For the COPII mediated ER export of the family C receptors ER retention signals have been 
identified in some family C receptors (126): In mGluR1 the signal the RRKK signal is found 
in the C-terminal tail (111). The signal is thought to be sterically shielded in alpha-isoform 
while the beta-isoform required heterodimerization to be trafficked further through the 
secretory pathway (127). Dimerization is also a prerequisite for GABA receptor trafficking 
(128, 129). A RXR-based ER retention signal was found in the C-terminal tail of the isoform 
B1 that is shielded upon dimerization with isoform B2. The tails form a coil-coiled structure 
which buries the signal. For other family C receptors, such as mGluR2 or mGluR4, no such 
ER retention signals have been identified to date. 
1.2.4 Physiological activity and post-translational modifications of mGluRs 
Metabotropic glutamate receptors usually reside at the plasma membrane and are only 
functional as dimers (130, 131). Notably the disulfide bond between the protomers was 
neither a prerequisite for dimerization nor for signaling (120, 121, 132, 133). In the dimer 
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both or just one of the Venus flytrap domains can be in the open or closed state, that is the 
inactive or active state, respectively (134, 135). In the open state the agonist is bound and the 
hinge relocated the lopes by 70°. One agonist is sufficient to activate the receptor but both 
binding sites needed to be occupied for full activity (136). Upon activation by the agonist, the 
signal is transferred from the extracellular Venus flytrap domain in an allosteric fashion via 
the cysteine-rich linker and the transmembrane domain to the cytoplasmic effectors (97, 137). 
The receptor forms a ternary complex with the cytoplasmic effector that then triggers the 
(intra-)cellular response (see Figure 1.7). 
 
Figure 1.7 | Signaling pathways of Metabotropic glutamate receptors. Metabotropic glutamate receptors 
signal either via Gαi (Group II and III receptors) or Gαq (Group I receptors). The activation of the receptor by 
gluatmic acid leads to a closing of the lopes. Full activation requires the binding of orthosteric agonists to both 
protomers. The trimeric G-protein is activated by exchange of guanosine diphosphate (GDP) to guanosine 
triphosphate (GTP). The Gαi pathway downregulates the activity of the membrane resident enzyme 
adenylylcyclase. The Gαq pathway signal via hydrolysis of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) 
into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). The later opens calcium channels in the 
endoplasmic reticulum (ER) that in concert with DAG activate the protein kinase C. Drafted in ChemDraw with 
modifications from Conn and Pin (98) and Alberts, Johnson (138). 
Like for other GPCRs, the intracellular effector for mGluRs is a trimeric G-protein. The 
trimeric G-protein consist of a α- and a βγ-subunit, which are both anchored to the membrane 
via covalent lipid modifications (Section 1.1.1.2), couples to the receptor via helices II and IV 
and the second intracellular loop (137, 139). The second intracellular loop seems to determine 
the specificity of G-protein coupling. There are mainly two main pathways described: One via 
Gαi which inhibits adenylyl cyclase and another one via Gαq that activates phospholipase C 
and releases calcium ions from the ER. The former one is the principal transduction way of 
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group II and III mGluRs while the later seems to be important for group I mGluRs (reviewed 
by Conn and Pin (98)) (Figure 1.7). 
Apart from the previously mentioned modifications related to folding and trafficking, namely 
glycosylation, disulfide bonding and lipidation (Section 1.2.3), other post-translational 
modifications were found to be more related to the regulation the receptor activity (116). The 
most commonly described modification is phosphorylation. For the group I receptors 
mGluR1α and mGluR5 it was shown that phosphorylation in the C-terminal tail and 
intracellular loops by protein kinase C led to desensitization after agonist stimulation (140, 
141). Group II and III receptors were found to be phosphorylated at distinct sites in the C-
terminal tail by Protein kinase A, which had an inhibitory effect on signaling as well (142, 
143). For mGluR2, phosphorylation was reported to occur at position S843 in the C-terminal 
tail (143). In addition, for mGluR1 ubiquitination was reported and was suggested to be 
linked to endocytosis and degradation (144, 145). Sumoylation-dependent trafficking and 
surface expression was reported for mGluR7 (146). Notably none of the later modifications 
has been identified in mGluR2. 
1.3 Aim of the thesis 
In a collaborative work with the group of Prof. Irmgard Sinning, mGluR2 has been found to 
be regulated by the cholesterol content in the membrane and might also harbor a sphingolipid 
binding site (55, 68). The goal of my PhD thesis was to identify specific lipid binding sites in 
mGluR2 which may modulate its function. By applying biochemical and molecular biological 
methods, I aimed identified a potential binding site for cholesterol and sphingolipids at the 
hydrophobic surface of the mGluR2 transmembrane domain. The goal was to map single 
amino acid residues which stabilize lipid interaction at a particular position. To verify the 
experimental data, I started collaboration with the Max Planck tandem group of Dr. Camilo 
Aponte-Santamaría at the University of Los Andes in Bogotá (Colombia). In this project of 
the projected we aimed to study the binding of lipids at the molecular level and describe the 
functional consequences of this process using computer simulations. 
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2 Results 
2.1 Design of constructs for expression of tagged proteins in 
mammalian cells 
The constructs used for the expression of mGluR2 and other proteins were based on the 
pCMV6-Entry vector which is commercially available at OriGene (Rockville, USA) as 
pCMV6-Entry Tagged Cloning Vector (Section 4.2.5). 
The two tags encoded in the vector are a c-Myc or Myc-tag, and a Flag-tag, also called in 
resemblance of the single-letter amino acid code DDK-tag. The cloning of the expression 
constructs was conducted with a pCMV6 construct that already contained the open reading 
frame (ORF) for GRM2 (NM_000839.4, NP_000830.2): pCMV6_GRM2_MycFlag (Origene, 
RC218103). The tags were encoded downstream (3’ end) of the GRM2 ORF (Figure 2.1), and 
thus were positioned at the C-terminal end of the protein. C-terminal tagging was preferred at 
this stage, because it would not interfere with the N-terminally localized signal peptide and in 
addition would only be detectable in fully translated proteins. 
 
Figure 2.1 | Vector map of the 
pCMV6_GRM2_MycFlag vector. For 
protein expression in mammalian cells, 
the GRM2 ORF (red) was under the 
control of a constitutive active CMV 
enhancer/promotor (orange). Both a c-
Myc and a Flag-tag were available for C-
terminal tagging (light blue). The helices 
I-VII of the transmembrane domain are 
indicated in dark blue. For propagation in 
a bacterial context, the plasmid contained 
a ColE1 origin (of replication), as well as 
an kanamycin resistance gene for 
selection. Graphic built in SnapGene 
Viewer. 
In these constructs, the ORF was under the control of an upstream (5’ end) CMV 
enhancer/promotor that shows constitutive activity without tissue or mammalian species 
selectivity (147, 148) (Figure 2.1). A neomycin resistance gene under the control of the 
constitutive SV40 promotor allows for selection of plasmid-harboring cells. 
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The pCMV6_GRM2_MycFlag vector was used to generate the pCMV6 vector control, as 
well as the single-tag constructs of GRM2 and other GPCRs (Sections 4.2.6 and 4.2.10). To 
generate the pCMV6 vector control, the pCMV6_GRM2_MycFlag vector was digested to 
excise the ORF of GRM2 and the filled up sticky ends were blunt ligated (Section 4.2.5). The 
product was a vector similar to the pCMV6-Entry vector sold by OriGene (PS100001). The 
overlap with OriGenes’ pCMV6-Entry vector was 98.6%. The difference resulted from a loss 
of 63 bp at the ligation site in the self-made pCMV6 vector control (Figure 2.2 B). This would 
have been disadvantageous if the pCMV6 vector had served as acceptor for insert fragments, 
as the deletion site had contained multiple cloning site features. However, pCMV6 vector 
control was used solely to mock transfect mammalian cells. 
A 
 
 
 
B 
 
 
 
Figure 2.2 | Cloning work with pCMV6 vector. (A) The commerically available vector 
pCMV6_GRM2_MycFlag (OriGene, RC218103) inherently contained a deletion of 6 bp downstream of the 
GRM2 ORF (red), within the linker regions to the Myc-tag (blue). The deletion was silent and did not cause any 
frameshift in the downstream encoded regions. (B) The pCMV6 vector control was generated by excision of the 
GRM2 ORF from the pCMV6_GRM2_MycFlag vector and subsequent blunt ligation of the Klenow DNA 
Polymerase I fragment-treated loose ends (details see Section 4.2.5). Shown is the sequence alignment between 
pCMV6 vector control (Vec_1) and OriGene pCMV6-Entry (Vec_2). The self-made vector control showed a 
loss of 63 bp at the multiple cloning site downstream of the T7 primer binding site (green) and upstream of the 
Tag-coding regions (blue). The alignment was mapped with SerialCloner. 
2.1.1 eGFPA207K-tagged GRM2 constructs 
In order to monitor the expression of GRM2 constructs in Hek293 cells, the GRM2 ORF was 
tagged C-terminally with eGFP. eGFP is an enhanced version of the wild type GFP (149). In 
addition to the enhancement in the fluorophore, a mutation (A207K) was introduced to 
prevent clustering of eGFP or eGFP-tagged proteins (150). The eGFP
A207K
 was attached at the 
C-terminal end of mGluR2. Two constructs were cloned: one without and one with a Gly4Ser-
linker between GRM2 and eGFP
A207K
 ORF (Figure 2.3). The Gly4Ser-linker is a commonly 
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used linker that was introduced in the construct in case that without linker the eGFP
A207K
 
protein would not fold – or would not exhibit a fluorescent signal (151). However, the C-
terminal tail is usually considered to be unstructured and can as such be described as linker on 
the structural level (71, 91). 
A 
 
 
B 
 
 
Figure 2.3 | eGFP
A207K
_Flag-tagged GRM2 constructs. Two different constructs were cloned into the 
pCMV6 expression vector: (A) GRM2- eGFP
A207K
-Flag and (B) GRM2- G4S-eGFP
A207K
-Flag. The ORF was 
under the control of a CMV promotor and expressed as fusion protein. The start codon from the eGFP
A207K
 had 
been removed (details see Section 4.2.8). The possible restriction sites are printed bold with the nucleotide 
number on the plasmid in brackets. Genetical features are mapped coloured. The map was drawn with 
SnapGene Viewer. 
2.1.2 Generation of Myc- and Flag-tagged GPCR constructs and 
corresponding point mutants 
Different metabotropic glutamate, adrenergic and serotonin receptors were cloned for 
expression into the pCMV6 vector. Only C-terminally tagged GPCR variants were used 
because it would only detect fully translated proteins and not interfere with the N-terminal 
translocation signal. The only exception here was the Beta-2 adrenergic receptor (ADRB2). 
While the original pCMV6_GRM2_MycFlag vector had been delivered as C-terminally 
tagged construct by OriGene, the ADRB2 construct had been obtained as N-terminally tagged 
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construct from Addgene (Watertown, USA). The ADRB2 construct had been deposited by the 
lab of Robert Lefkowitz (152). The deposited construct had an additional signal peptide 
sequence (N-MKTIIALSYIFCLVFA-C) just before the Flag-coding region, upstream of the 
ADRB2 ORF, to enhance expression (152, 153) (Figure 2.4 A). Notably, no such signal 
peptide sequence was found in the original ADRB2 mRNA sequence (NM_000024.5, 
NP_000015.1). In addition to the original construct, a C-terminally tagged ADRB2 version 
was cloned with the Flag-tag connected by a short linker to the ORF, just as for the other 
constructs (Figure 2.4 B). The constructs would be later compared in the [
3
H]-photo-
cholesterol labeling assay. 
A 
 
B 
 
 
Figure 2.4 | N- and C-terminally Flag-tagged pCMV6_ADRB2 constructs. The ADRB2 ORF 
(NM_000024.5, NP_000015.1, clone obtained from Lefkowitz lab (152)) was cloned into the pCMV6 vector as 
(A) N-terminally or (B) C-terminally Flag-tagged construct (details see Section 4.2.10.1). The former one 
contained an additional signal peptide sequence (N-MKTIIALSYIFCLVFA-C) upstream of the ADRB2 ORF 
absent in the N-terminally tagged version. The map was drawn with SnapGene Viewer. 
The other GPCR ORFs, namely GRM1 (NM_001278064.1, NP_001264993.1), GRM4 
(NM_000841.3, NP_000832.1), ADRA2 (NM_000681.3, NP_000672.3), Htr1a 
(NM_008308.4, NP_032334.2) and HTR2A (NM_000621.4, NP_000612.1) were all tagged 
with a C-terminal Flag and /or Myc-tag. The Flag-tag (N-DYKDDDDK-C) was linked to the 
protein with a N-TRAANDIL-C peptide linker, while the Myc-tag (N-EQKLISEEDL-C) was 
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joined by a short N-(TR)TRPL-C peptide linker. Both the tags and the linker sequences were 
adapted from the original pCMV6_GRM2_MycFlag plasmid. 
2.1.2.1 Loss-of-function at S-fatty acylation sites 
S-fatty acylation, or also called S-palmitoylation referring to the common fatty acid found 
attached to the cysteine residue, for mGluRs has been poorly investigated so far (116). Only 
one receptor has been identified to date: Alaluf, Mulvihill (125) reported a S-palmitoylation 
site in mGluR4, but did not assign it to any amino acid residue or domain for the 
modification. To investigate if mGluR2 or other mGluRs were S-palmitoylated, also with 
regard to a possible implication to cholesterol binding as shown for the mouse 5-
hydroxytryptamine receptor 1A (5-HT-1A), different Flag-tagged mGluR constructs were 
tested for S-acylation in a [
3
H]-palmitic acid labeling (26). In order to have positive and 
negative controls at hand, known S-palmitoylated cysteine residues in other GPCRs were 
subjected to C→A point mutations (Figure 2.5). The alanine variants served as controls to 
exclude the possibility of false positive signals due to incorporation of radioactive metabolites 
into amino acids or post-translational modifications (76). 
Two serotonin receptors were included in the S- fatty acylation assay (Figure 2.5): the above 
mentioned 5-HT-1A from mouse is also a Gαi-coupled receptor, just as mGluR2. It has been 
shown that Gαi-coupling to the receptor is dependent on S-palmitoylation in its C-terminal tail 
(26). Thus a similar effect could govern G-protein coupling –and eventually also cholesterol 
binding – in mGluR2. Moreover, an interaction partner of mGluR2, human 5-
hydroxytryptamine receptor 2A (5-HT-2A), was considered as well because the receptors 
might share a similar membrane environment and also a 5-HT-2A homologue in mouse had 
been found in a S-fatty acylation screening (154, 155). In addition to that, two human 
adrenergic receptors were included in the palmitate labeling (Figure 2.5). As mGluR2, the 
Alpha-2A adrenergic receptor (α-2AAR) is coupled to Gαi, and had been reported with a S-
palmitoylation site in the C-terminal tail (156). Furthermore, the Beta-2 adrenergic receptor 
(β2AR) was used in the assay, as it had both a defined cholesterol interaction site and C-
terminal palmitate modification (45, 76). 
For the C→A mutants, ADRB2 and 5-HT-1A were chosen as the S-fatty acylation mutants 
because they were relatively well described with no reported trafficking defects upon loss of 
S-palmitoylation site in the respective cell lines used (26, 157). The mutants were generated 
by mutating the reported cysteine residues in the C-terminal tail to alanine by mutagenesis 
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PCR (mPCR) (Section 4.2.11). The target sites were C341 in ADRB2, and C417 and C420 in 
5-HT-1A (Figure 2.5). Notably, another designated S-palmitoylation site in the ADRA2A 
ORF could not be mutated by mPCR despite efforts to adjust the reaction conditions. 
A 
 
B 
 
 
Figure 2.5 | Palmitoylation sites in GPCRs. Two different serotonin receptors with known palmitoylation sites, 
namely (A) 5-hydroxytryptamine receptor 1A (5-HT-1A) from mouse and human 5-hydroxytryptamine receptor 
2A (5-HT-2A), and two human adrenergic receptors, (B) the Alpha-2A adrenergic receptor (α-2AAR) and Beta-
2 adrenergic receptor (β2AR), were chosen as controls for the [3H]-palmitic acid labeling (26, 76, 155, 156). The 
graphic indicates the approximated position of the fatty acid modification at the C-terminal tail of the GPCRs. 
The position C397* for 5-HT-2A was approximated from the mouse analog. All constructs were Flag-tagged, 
here written as peptide (N-DYDDDDK-C). The graphics were designed with ChemDraw. 
On the site of the metabotropic glutamate receptors, the above mentioned mGluR4 was 
chosen as representative for the Group III mGluRs, while mGluR1α was picked as 
representative for the group I mGluRs. The later one was reported negative for palmitoylation 
in the study published by Alaluf, Mulvihill (125). The protein of interest, mGluR2 belonged 
to the group II of the mGluR family. 
2.1.2.2 Cholesterol and sphingolipid interaction: W→A and Y→A variants of GRM2 
In the case of the non-covalent cholesterol and sphingolipid interaction sites, assumptions on 
putative interaction motifs in the transmembrane domain of mGluR2 were made based on the 
published linear and three-dimensional motifs (45, 52, 53, 65). However, the selection of the 
target sites was complex as general several residues would presumably be involved in the 
interaction with the non-annular lipids at one particular spot. 
For cholesterol interaction, there are two published linear motifs: The “Cholesterol 
Recognition/interaction Amino acid Consensus sequence” (CRAC) motifs was originally 
identified as N-L/V-(X)1–5-Y-(X)1–5-R/K-C in the mitochondrial cholesterol transport protein 
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Peripheral-type benzodiazepine receptor (52). An inverted motif, termed “CARC”, was 
described in the α-helical transmembrane domain of the human nicotinic acetylcholine 
receptor (53). The motif was later also identified in helix V of the transmembrane domain of 
the mGluR family (56). The first experimentally determined three dimensional motif in a 
GPCR was the four component cholesterol interaction site in a crystal structure of β2AR (45). 
Considering the specific interaction of cholesterol with a set of amino acid residues conserved 
in family A receptors, the cholesterol consensus motif (CCM) motif was reported as N-[4.39-
4.43(R,K)]-[4.50(W,Y)]-[4.46(I,V,L)]-[2.41(F,Y)]-C sequence based on the Ballesteros-
Weinstein numbering system for family A GPCRs (45, 46). For sphingolipids, there was one 
published linear motif in a α-helical transmembrane domain (65). The sequence in the single-
spanning Transmembrane emp24 domain-containing protein 2 (p24) was identified as e 
N-V-(X)2-TL-(X)2IY-C. Subsequently, a similar motif was identified in the transmembrane 
helix VI of mGluR2, 7 and 8 (68). Notably, there is also another published structural motif for 
sphingolipid binding to V3-like domains (helix-turn-helix motif) (64). However, apart from 
the involvement of aromatic amino acids in the turn, no sequence specificity was reported. 
For the linear CRAC and CARC, the tyrosine residue was considered a crucial part of the 
interaction motif, however, not necessarily for intramembrane interactions sites where it 
might be replaced by phenylalanine (53, 54). For the three dimensional CCM, aromatic amino 
acid residues were identified at the interaction sites with the CHπ-hydrogen bonding system 
of cholesterols’ sterol rings as well as with its 3β hydroxyl group (45). Aromatic tyrosine and 
tryptophan residues were also found in the p24 sphingolipid interaction motif and the V3-like 
sphingolipid binding domain (65). For this reasons the tyrosine and the tryptophan residues in 
the transmembrane domain of mGluR2 were targeted in an alanine screening. The 
phenylalanine residues were left aside to reduce the complexity of the screening. 
The tryptophan and tyrosine residues were selected on the basis of a homology model of the 
mGluR2 transmembrane domain. The amino acid sequence of the domain was used to build 
the homology model with SWISS-MODEL (158-161). To build the homology model with 
SWISS-MODEL, effectively two crystal structures were available: the transmembrane 
domain of mGluR5 co-crystallized as T4-lysozyme fusion construct, and mGluR1 with an N-
terminal fusion to thermostabilized apocytochrome b562RIL (71, 91). Other suggested GPCRs, 
namely Rhodopsin and the Chemokine receptor type 4 showed only a poor sequence identity 
(Table 2.1). 
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Table 2.1 | SWISS-MODEL template library for mGluR2 transmembrane domain. The table returned the 
description of the different templates (RCSB access number) and their sequence identity (Seq Identity) with the 
mGluR2 transmembrane domain (incl. loops) as calculated in SWISS-MODEL. BLAST and HHblits are two 
different sequence alignment algorithms used to search for matching amino acid sequences (162, 163). The table 
also shows the oligostate as well as the resolution of the template and its coverage of the target sequence. The 
Quaternary structure quality estimate (QSQE) reflects the expected accuracy of the interchain contacts for a 
model based on a given alignment and template (0-1). 
Template 
(RCSB) 
Seq 
Identity 
Oligostate QSQE 
Found 
by 
Resolution Coverage Description 
4or2.1.A 53.53 
homo-
dimer 
0.10 BLAST 2.80Å 0.96 
Soluble cytochrome 
b562, Metabotropic 
glutamate receptor 1 
4or2.1.A 51.02 
homo-
dimer 
0.11 HHblits 2.80Å 0.97 
Soluble cytochrome 
b562, Metabotropic 
glutamate receptor 1 
5cgd.1.A 51.22 monomer  HHblits 2.60Å 0.98 
Metabotropic 
glutamate receptor 
5,Endolysin,Metabo-
tropic glutamate 
receptor 5 
5cgd.1.A 53.16 monomer  BLAST 2.60Å 0.63 
Metabotropic 
glutamate receptor 
5,Endolysin,Metabo-
tropic glutamate 
receptor 5 
5cgd.1.A 51.52 monomer  BLAST 2.60Å 0.39 
Metabotropic 
glutamate receptor 
5,Endolysin, Metabo-
tropic glutamate 
receptor 5 
5dys.1.A 9.10 monomer  HHblits 2.30Å 0.33 Rhodopsin 
3oe6.1.A 9.57 monomer  HHblits 3.20Å 0.37 
C-X-C chemokine 
receptor type 4, 
Lysozyme Chimera 
A sequence identity of >50% in the primary structure was obtained for the X-ray structures of 
mGluR1 and mGluR5 (Table 2.1). The mGluR1 template 4or2.1.A was used to build the 
homology model of the mGluR2 transmembrane domain, because it had the highest sequence 
identity as calculated with BLAST (71).  
The model was reported with the QMEAN4 score, a quality estimate for the overall model of 
the protein, which compared the model with experimental available structures and thus 
estimates its ‘nativeness’ (160). The QMEAN4 consisted of four statistical scores (Figure 
2.6): The All atom and CBeta factors described the long-range interactions on the atom and 
the residue level, respectively. The Solvation factor described how well the residues were 
buried in the structure. The backbone geometry of the model was calculated with the Torsion. 
The Torsion described the torsion angels over three consecutive amino acid residues of the 
amino acid backbone. The modelled structure of the mGluR2 transmembrane domain showed 
overall a low QMEAN4 (Table 2.1 A). A QMEAN4 score of <-4.0 is considered of low 
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quality, while better scores would have shown a tendency to positive values (123). While the 
overall QMEAN4 was not satisfactory, the local scores for the transmembrane domains with 
values above 0.6 were considered reasonable (Table 2.1 B). While the α-helical regions of the 
transmembrane domain were resembled with an acceptable quality, the intra- and extracellular 
loops were only poorly described (Table 2.1 C). Here, the amino acid sequence showed a 
lower conservation between mGluR1 and mGluR2 and for that reason was more difficult to fit 
into the X-ray structure of the former one, which served as template. The α-helical regions on 
the other side were well enough resembled to make assumption on the surface exposure of 
single residues. 
A 
 
B 
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Figure 2.6 | Model of mGluR2 transmembrane domain using SWISS-MODEL. The model of the mGluR2 
transmembrane domain was built based in the mGluR1 (RCSB 4or1) crystal structure (71) (details see Section 
4.13.1). (A) The QMEAN4 score consisted of a linear combination of four structural descriptors: All atom and 
CBeta described distance dependent interactions, Solvation described the solvent accessibility of the residues, 
and Torsion was a measure for the torsion angel over three consecutive residues. (B) The Local quality estimate 
showed the expected similarity to the X-ray structure for each amino acid residue. (C) The alignment showed the 
QMEAN score per residue between the input sequence (Model_01, mGluR2 transmembrane domain) and the 
template (4or2.1.A, mGluR1 template). The boxes around the template sequence indicate the α-helical regions 
while the arrows show beta-sheets. In between are the unstructures regions of the intra- and extracellular loops. 
The quality of the model was also validated by visual comparison to the experimentally 
determined X-ray structures: the mGluR2 transmembrane model was aligned to the mGluR1 
(RCSB 4OR1), as well as to the mGluR5 (RCSB 4OO9) crystal structure (71, 91) (Figure 
2.7). In both cases the mGluR2 transmembrane model was fitted to the X-ray structures with 
the ‘align’ tool in Pymol (Schrödinger, New York) which also returned root mean square 
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deviation (RMSD) between the mGluR2 model and the experimental structures. Whereas in 
both cases the α-helical regions were well aligned, the loops were often not well reproduced 
in the mGluR2 model (Figure 2.7). In the mGluR1 X-ray structure for example, data for the 
second intracellular loop were missing which were modelled as unstructured region for 
mGluR2 (Figure 2.7 A, bottom left). On the other side, the beta-sheet of the second 
extracellular loop was well resembled in the mGluR2 model (Figure 2.7 A, top). 
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Figure 2.7 | Alignment of mGluR2 transmembrane model with mGluR1 and mGluR5 X-ray structures in 
Pymol. The transmembrane model of mGluR2 (Helix:Sheet:Loop colour mode, Cyan:Purple:Rosé) was aligned 
in Pymol with the experimental crystal structures of (A) mGluR1 (4OR2; protein: red; allosteric ligand FITM: 
yellow) and (B) mGluR5 (4OO9; protein: green; allosteric ligand M-MPEP: red) (71, 91). The RMSD between 
the mGluR2 model and the experimentally determined structures was 0.152 Å (1223 to 1223 atoms) for mGluR1 
and 0.696 Å (1266 to 1266 atoms) for mGluR5. 
 
90° 
90° 
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The mGluR2 model showed a low RMSD of 0.152 Å from the mGluR1 X-ray structure it was 
modelled from (Figure 2.7). In contrast to that, the deviation from the mGluR5 structure was 
about fourfold higher: 0.696 Å. For mGluR5, the extracellular loops had adopted an α-helical 
structure in the crystal whereas it was a beta-sheet for the second extracellular loop in case of 
the model or unstructured for the other loops (Figure 2.7 B). 
The transmembrane model allowed to investigate the sites of the CRAC and the sphingolipid 
interaction motifs which had been previously identified by sequence homology (56, 68). The 
former one appeared to be completely accessible on the protein surface, including the central 
tyrosine residue Y745 (Figure 2.8). For the sphingolipid interaction domain, not all residues 
appeared to face the surface of the transmembrane domain (Figure 2.8). However, the 
aromatic residue W773 was at least partly tilted towards the protein-lipid interface. 
 
Figure 2.8 | CRAC and sphingolipid interaction 
motifs in the transmembrane model of mGluR2. 
The cholesterol interaction motif CRAC was 
identified as N-LCTLY745AFKTR-C sequence at 
the cytosolic end of transmembrane helix V (56). 
The residues of CRAC motif are highlighted as 
spheres with green carbon atoms. The sphingolipid 
interaction site was identified as putative p24-like 
motif in a bioinformatic screening as 
N-TMYTTCIIW773-C sequence in transmembrane 
helix VI (68). The residues of sphingolipid 
interaction motif are highlighted as spheres with 
orange carbon atoms. The figure was assembled 
with Pymol and ChemDraw. The numbering of the 
transmembrane helices are indicated in roman 
letters. 
From the model of the mGluR2 transmembrane domain, eight point mutation sites were 
chosen by visual inspection of the amino acid residues (Figure 2.9 A). The position for the 
alanine exchange was estimated from the exposure of the side chains to the protein surface: 
W567, Y607, W697, Y734, Y745, Y767, W773 and Y781 (Figure 2.9 B-I). The position 
included also the residues Y745 and W773 which were part of putative cholesterol and 
sphingolipid interactions sites, respectively (Figure 2.8). The tyrosine and tryptophan residues 
were mutated as single point mutants to alanine by mutagenesis PCR (Section 4.2.9). Like 
that, four sets of W/Y→A variants were established. The first set consisted of eight C-
terminally Flag-tagged point mutants of mGluR2, while the second set were double mutants 
that contained also a C121A mutation in the extracellular domain. The third and fourth set 
were cloned accordingly but with a C-terminal Myc-tag. The double mutants were used to 
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find out if the lack of the covalent linkage between the protomers would allow observing 
stronger phenotypes in the bioassays, especially the cellular photocrosslinking with 
bifunctional lipids. The majority of bioassays was conducted with the Flag-tagged variants. 
The Myc-tagged versions were solely used for the co-immunoprecipitation experiments. 
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 Figure 2.9 | mGluR2 mutation sites for W→A 
and Y→A variants. (A) Schematic depiction of 
the mGluR2 homodimer with the covalent 
disulfide linkage between the C121 residues. The 
mutation sites of the variants are indicated in 
orange. The mutations sites (B) W567, (C) Y607, 
(D) W697, (E) Y734, (F) Y745, (G) Y767, (H) 
W773, and (I) Y781 were highlighted in the 
atomistic mGluR2 transmembrane model 
(Helix:Sheet:Loop colour mode, 
Cyan:Purple:Rosé) as sticks (carbon atom: 
orange; oxygen atom: red; nitrogen: blue). The 
number of the transmembrane helices are 
indicated in roman numbers. The view is always 
from top (exoplasmic) to bottom (cytosolic). 
2.1.3 The plasmid DNA concentration determines the transfection efficiency 
To study the transfection efficiency of the pCMV6 vectors, Hek293 cells were transfected 
with eGFP constructs described in Section 2.1.1. The constructs were transiently transfected 
into the cells with FuGENE HD – a commercially available transfection agent – and the 
expression quantified by flow cytometry (details see Section 4.4). 
To test how the amount of plasmid DNA would influence the transfection efficiency, different 
amounts of eGFP constructs were transfected into Hek293 cells along with pCMV6 vector as 
negative control. After 48 h transfection, the cells were harvested and the eGFP fluorescence 
quantified by flow cytometry at 530 nm. It appeared that the transfection efficiency measured 
as eGFP fluorescence in the flow cytometer declined with the amount of plasmid DNA used 
for the transfection (Figure 2.10). The trend appeared to be independent of the construct used 
for the ectopic expression. A drop of >50% transfection efficiency was observed from the 
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highest to the lowest DNA concentration in the experiments: the transfection was >80% at 
1000 ng per well while it dropped to about 30% at 250 ng (Figure 2.10). 
 
 
Figure 2.10 | Transfection efficiency with the FuGENE HD protocol in Hek293 cells. To quantify the 
transfection efficiency, Hek293 cells were transiently transfected in a 6-well cell culture plate format using 
either pCMV6 vector control or different eGFP constructs as indicated. The expression of the constructs was 
quantified 48 h post-transfection by measuring the fluorescence of eGFP at 530 nm in the flow cytometer 
(details see Section 4.4). The grouped bar plot represents n=2 independent experiments plotted as mean+SEM 
in GraphPad Prism. 
The different eGFP constructs showed a dependency of the transfection efficiency on the 
amount of plasmid but no difference was observed between the different eGFP constructs 
(Figure 2.10). In the next experiment, a similar setup was used to test a wider range of 
plasmid DNA concentrations. Here, just eGFP
A207K
-tagged mGluR2 fusion proteins were 
considered. 
The measurement in the flow cytometer showed that there was a consistent dependency 
between the amounts of transiently transfected plasmid DNA and the transfection efficiency 
(Figure 2.11). Also in the second experiment the overall trend remained: the transfection 
efficiency declined with the DNA level. Notably the absolute values were lower as compared 
to the initial experiment (compare Figure 2.10 and Figure 2.11): while at 1000 ng per well an 
efficiency or more than 85% had been measured in the first experiment for mGluR2-
eGFP
A207K
 fusion proteins, the value dropped to 71% and 76% for the fusion proteins without 
and with glycine-serine linker, respectively. Also at 500 ng and 250 ng DNA per well, slightly 
lower values were measured for the two mGluR2 fusion proteins as compared to the first 
experiment. At the lower concentrations of 125 ng and 50 ng per well, which had not been 
included in the previous assay, the average transfection efficiency dropped to 10% and 3%, 
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respectively (Figure 2.11). The smaller eGFP
A207K
 protein was with 83% at 1000 ng per well 
still expressed at the same level as observed beforehand. 
The differences in the transfection efficiency between the first and the second assay were 
eventually connected to the different passage number of the Hek293 cells. While in the first 
experiments a low passage number was used, the second one was conducted at a higher 
passage number. To avoid larger differences in future experiments, cells were used for the 
experiments just between passage three and 20. 
 
 
Figure 2.11 | Transfection efficiency of GRM2 constructs at different plasmid DNA levels. To quantify the 
transfection efficiency, Hek293 cells were transiently transfected in a 6-well cell culture plate format using 
either eGFP
A207K
 control or tagged GRM2 constructs as indicated. The expression of the constructs was 
quantified 48 h post-transfection by measuring the fluorescence of eGFP at 530 nm in the flow cytometer 
(details see Section 4.4). The grouped bar plot represents n=5 independent experiments plotted as mean+SEM 
in GraphPad Prism. 
From the experiments was concluded that the transfection efficiency played a decisive role in 
the context of transient transfection experiments in Hek293 cells. For the further experiments 
this effect would need to be considered to avoid artifacts. 
2.2 Biochemical characterization of mGluR2 and its variants 
Before starting the actual labeling experiments with the tritiated lipids, the Flag-tagged W→A 
and Y→A variants of mGluR2 were tested in transient expression experiments for their basic 
biochemical properties in comparison to the wild type. The two main properties the 
experiments were focused on were the (intra-)cellular trafficking on the one hand, and the 
dimerization on the other. With the testing this biochemical properties it was to be assured 
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that the effect later quantified in the cellular lipid photocrosslinking experiments would not 
result from secondary effects, such as an impaired trafficking. 
2.2.1 Trafficking and cell surface arrival of mGluR2 
2.2.1.1 Cell surface arrival of Flag-tagged W/Y→A mGluR2 variants measured in a 
biotinylation assay 
The cell surface arrival of mGluR2-Flag was considered a central quality measure for the 
receptor and its variants. It allowed making conclusion on the cellular distribution of the 
receptors and indirectly the lipid environment that they faced. The question in the next 
experiment was if that distribution would change at different plasmid concentration used for 
the transient transfection. While intuitively a high amount of DNA for the experiments 
appeared to be desirable, this would have eventually been connected to an overexpression of 
the protein to the manifold and severe stress for single cells. In order to get reliable results for 
the follow-up experiments and at the same time limiting the overexpression, the aim of the 
experiment was to limit the transfection level while at the same time allow a stable 
trafficking. The issue was met with a quantification of the cell surface arrival of the receptors 
at different transfection levels. The starting point for the experiment was the range of transient 
transfection levels which had been established in the initial experiments with the mGluR2-
eGFP
A207K
 fusion proteins (Figure 2.11). Now, the mGluR2-Flag and mGluR2
C121A
-Flag 
proteins were transiently expressed in He293 cells transfected with increasing levels of 
plasmid DNA (Figure 2.12). To capture proteins residing at the plasma membrane, the cells 
were treated with non-membrane permeable Sulfo-NHS-SS-Biotin which would form 
covalent bonds with primary amines (164) (details see Section 4.8). 
For mGluR2-Flag, the efficiency of cell surface arrival was found to be independent of the 
DNA concentration used for transfection in a range between 125 ng and 1000 ng plasmid 
DNA per well (Figure 2.12 C). At the different DNA concentrations, the averaged results for 
Flag-tagged wild type varied between 46-55%. Similar quantification results were seen for 
mGluR2
C121A
-Flag, but here the variation between the DNA levels was higher at lower DNA 
concentrations (Figure 2.12 D). In the range between 125 ng and 1000 ng the averaged cell 
surface arrival varied between 45-69%. In both cases a DNA concentration of less than 
125 ng per well used for transfection lead to increasing variations in the cell surface delivery. 
For example, a cell surface arrival of 110% was measured for mGluR2
C121A
-Flag at 50 ng, the 
lowest DNA concentration in the experiment. This result suggested a quantification artifact. 
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Figure 2.12 | Cell surface biotinylation of mGluR2 at different transfection and expression levels. The 
relative surface arrival of transiently expressed mGluR2-Flag protein was measured following transfection with 
different DNA concentration in a 6-well plate format (details see Section 4.8). (A) Schematic depiction of the 
assay principle. Deprotonated primary amines of cell surface proteins (‘P’) react with the NHS ester of Sulfo-
NHS-SS-Biotin in a one-step reaction. The protein P is biotinylated (‘B’) and N-hydroxysulfosuccinimide 
(Sulfo-NHS) released as byproduct. The proteins are captured by the interaction with neutravidin (avidin 
preparation) on agarose beads. The disulfide bond in the spacer arm is cleaved during sample preparation by a 
reductive agent and the protein is released again (164). The picture was realized with ChemDraw. (B) Input (In) 
and affinity purification (AP) samples were separated by SDS-PAGE. On the immunoblot the αFlag signal of 
monomer and oligomers was quantified as indicated (black arrow heads). The αGAPDH signal was used as 
negative and ASGPR1-MycFlag signal as postive control. The blot is representative for n=3 independent 
experiments with mGluR2-Flag. The blots for mGluR2
C121A
-Flag are not shown. (C) The relative surface arrival 
for mGluR2-Flag was quantified as ratio of the affinity purified αFlag signal versus the total input signal. The 
dot plot in GraphPad Prism shows the values for the three replicates as mean±SEM. (D) The relative surface 
arrival for mGluR2
C121A
-Flag was analyzed as described for mGluR2-Flag. 
From the experiments was concluded that transient transfections with a different DNA 
concentration would result in a stable cell surface expression of the receptors, but below a 
certain DNA concentration artifacts would be more likely to occur. A reproducible cell 
surface arrival for mGluR2-Flag was observed at a transfection level between 125 ng and 
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1000 ng plasmid DNA per well (Figure 2.12). For mGluR2
C121A
-Flag proteins, a stable 
surface expression was measured in a range from 250 ng to 1000 ng plasmid DNA per well. 
Here, the loss of the disulfide bridge did not seem to block surface trafficking. Thus, the cell 
surface arrival was only assayed for the different mGluR2-Flag W→A and Y→A variants. 
The variants’ cell surface arrival was compared to the mGluR2-Flag wild type (Figure 2.13). 
The transfection levels were adjusted to either 125 ng or 250 ng. Variants with a strong 
expression were adjusted to 125 ng and those that were weakly expressed to 250 ng. This was 
done to avoid quantification artifacts on the immunoblot. 
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Figure 2.13 | Cell surface arrival of 
transiently expressed W→A and Y→A 
mGluR2-Flag variants in Hek293 cells. 
The relative cell surface arrival of 
transiently expressed mGluR2-Flag 
variants was measured at a DNA 
concentration of 125 ng or 250 ng in a 6-
well plate format (details see Section 4.8). 
(A) The input (In) and affinity purification 
(AP) samples were separated by SDS-
PAGE. On the immunoblot the αFlag 
signal of monomer and oligomers was 
quantified as indicated (black arrow 
heads). The αGAPDH signal was used as 
negative and ASGPR1-MycFlag signal as 
postive control. The blot is representative 
for n=3 independent experiments. (B) The 
relative surface arrival was quantified as 
ratio of the affinity purified αFlag signal 
versus the total input signal. The dot plot 
in GraphPad Prism shows the values for 
the three replicates as mean±SEM. 
 
2 Results 
61 
 
The surface arrival of the different W→A and Y→A mGluR2 variants did not show 
significant differences as compared to the wildtype in a statistical test with a 1way ANOVA 
(Dunnetts’ post test in GraphPad Prism versus wild type, α=0.05) (Figure 2.13 B).For most of 
the variants 50-70% of total protein had reached the cell surface; an averaged value of 64% 
was measured for the wild type mGluR2-Flag. In summary, none of the Flag-tagged mGluR2 
variants tested showed critical folding defects leading to retention in the endoplasmic 
reticulum (ER). A similar experiment with mGluR2
C121A
-Flag double mutants showed larger 
variations within the measurements but no major difference between the variants (data not 
shown). 
2.2.1.2 Estimation of intracellular trafficking of mGluR2 variants by enzymatic 
deglycosylation with EndoH and PNGaseF 
The quantification of the surface arrival showed that proteins had successfully passed the 
secretory pathway. As a complementing approach to study intracellular transport of mGluR2-
Flag variants, the glycosylation state was investigated using endoglycosidase treatment. 
mGluR2 contains five potential glycosylation sites (UniProt entry Q14416 
(GRM2_HUMAN). Proteins that are retained in the ER show a different N-glycosylation 
pattern than the ones shuttling through the Golgi (109, 165). Due to a different glycolyation 
pattern, ER resident proteins are sensitive to deglycosylation with endoglycosidase H 
(EndoH) which cleaves only N-linked high mannose and some hybrid oligosaccharides within 
the chitobiose core (166). In contrast, the enzyme Glycopeptide N-glycosidase (PNGaseF) 
hydrolyses both high mannose and complex N-linked oligosaccharids by attacking the N4-
(acetyl-beta-D-glucosaminyl)asparagine residue of glycoproteins (167, 168). 
The different W→A and Y→A mGluR2-Flag variants were deglycosylated with either 
EndoH or PNGaseF after transient expression in Hek293 cells to find out whether there would 
be any difference in the sensitivity towards one of the enzymes (Figure 2.14 B) (details see 
Section 4.9). The experiments showed that all receptors treated with PNGaseF migrated 
further on separation by SDS-PAGE (Figure 2.14 B, +P). Both for the mGluR2 monomer and 
dimer, PNGaseF treatment led to a shift towards lower apparent molecular weights. This 
indicated that the proteins had carried one or more N-glycan. 
In contrast to PNGaseF, Endo H cleavage led to a partial shift of the proteins to a lower 
molecular weight band, suggesting that a fraction of the proteins was still Endo H-sensitive 
(Figure 2.14 B, +E, monomer). The shifted fraction was migrating approximately at the same 
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height as the PNGaseF treated samples. Taken together, these data suggest that a significant 
amount of the W→A and Y→A mGluR2-Flag variants had passed the secretory pathway and 
localized to the plasma membrane (109, 165). 
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Figure 2.14 | Deglycosylation of mGluR2 W→A and Y→A variants with EndoH and PNGaseF. mGluR2-
Flag W→A and Y→A variants were transiently expressed in Hek293 cells. After 48 h, the cells were harvested 
and the total protein fraction was subjected to enzymatic deglycolysation using EndoH (+E) or PNGaseF (+P). 
The controls (C) were mock treated in reaction buffer which had been provided with the enzymes (details see 
Section 4.9). (A) Schematic depiction of the assay principle. Proteins of the secretory pathway are modified at 
the consesus site N-x-S/T (x any amino acid but proline) in the lumen of the ER. In several steps, the N-glycan 
modification becomes increasing complex as the protein shuttles through the secretory pathway (138). While 
PNGaseF can cleave any N-linked glycan, EndoH can only cleave high mannose and some hybrid N-glycans 
(169). The picture was realized with ChemDraw. (B) The deglycosylated samples were separated by SDS-
PAGE. On the immunoblot the αFlag signal of fully glycosylated monomer and dimer was indicated with black 
arrow heads. The shifted bands after deglyocylation was indicated with gray arrow heads. The blot is 
representative for n=3 independent experiments. The αFlag signal on the immunoblot was adjusted to optimal 
contrast for each variant. 
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2.2.2 Dimerization of mGluR2 W/Y→A variants 
Dimerization is considered a hallmark of mGluR2 function, as shown both by structural and 
biochemical data (131, 170). For that reason, the oligomeric state of mGluR2 variants was 
tested using cysteine crosslinking, non-reducing SDS-PAGE and co-immunoprecipitation 
(Co-IP) experiments. 
2.2.2.1 Transmembrane cysteine crosslinking assay with N-Ethylmaleimide 
Biochemical data published by the group of Jean-Philipp Pin suggested an activity dependent 
dimerization interface between transmembrane helices IV, V and VI of mGluR2 (121) (see 
also Section 4.7). In this study, the dimerization interfaces of mGluR2 were probed by 
introducing cysteine residues at distinct sites within the transmembrane domain of the protein. 
Adjacent cysteine residues in the transmembrane domain were oxidized to cystine in the 
presence of Dichloro(1,10-phenanthroline)copper(II) (CuP) to determine interactions of the 
individual transmembrane helices. Free sulfhydryl groups were blocked by N-ethylmaleimide 
(NEM) (Figure 2.15 A). 
To test the dimer interface of mGluR2 using this crosslinking approach, cysteine residues 
were introduced by mutagenesis PCR on the background of a C121A mutation in the 
extracellular domain of mGluR2 (Section 4.2.7). This C121 residue was shown to mediate 
covalent crosslinking of the mGluR2 homodimer and thus, had to be removed to allow for 
probing of TMD-TMD interactions (96, 121). By site-directed mutagenesis, the residues L698 
in transmembrane helix IV, Y734 in helix V or V782 in helix VI were changed to cysteine 
residues on the mGluR2
C121A
-MycFlag background. 
Cysteine-mediated crosslinking was measured by the increase in the dimerization ratio. For all 
mGluR2 cysteine variants tested, the dimerization ratio increased in the CuP crosslink as 
compared to the control without CuP and the C121A single mutant (Figure 2.15 C). For the 
mGluR2
C121A/L698C
-MycFlag and mGluR2
C121A/Y734C
-MycFlag variants, the ratio increased 
from 54% and 54% to 99% and 96%, respectively. With 70% the ‘basal’ crosslinking was 
highest for mGluR2
C121A/V782C
-MycFlag in helix VI. The dimerization increased to 96% in the 
presence of CuP. This might be attributed to a better accessibility of the residues towards one 
another which would allow formation of disulfide bridges also in the absence of CuP, or a 
preference for the interface in the current setup. Notably, the dimerization rate was 99% for 
the wild type and ~60% for C121A both in the presence and absence of CuP. 
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Figure 2.15 | Cysteine crosslinking of transmembrane helices using Dichloro(1,10-phenanthroline)-
copper(II). The MycFlag-tagged mGluR2 wild type and the derived C121A single and double mutants were 
transiently expressed in Hek293 cells. The crosslinking procedure was applied to intact cells as described in 
Section 4.7. The negative control (-CuP) was conducted without Dichloro(1,10-phenan¬throline)¬copper(II) 
(CuP) in the corresponding buffer. (A) Schematic depiction of the assay principle. The cysteines are crosslinked 
in the presence of CuP with adjacent cysteine residues to disulfide bridges. N-ethylmaleimide then blocks all 
free thiol groups (121). The picture was realized with ChemDraw. (B) The blot (scanned at an intensity of 3-4) 
is representative blot for n=3 independent experiments. Quantified dimer bands are indicated with a black arrow 
head, the monomer bands with a grey arrow head. (C) The bar plot in GraphPad Prism shows the values for the 
three replicates as mean+SEM. 
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However, the assay confirmed the published data and that a dimerization interface was 
present also within the transmembrane domain (121). Furthermore, it indicated that the 
mGluR2 protein had been expressed correctly in the current setup. 
2.2.2.2 Non-reducing PAGE showed the importance of C121 disulfide bridges in mGluR2 
Disulfide bridge-mediated dimerization of mGluRs can also be analyzed by non-reducing 
SDS-PAGE (132): under non-reducing conditions disulfide bonds stay intact and monomer 
and dimer receptor protein can be separated from each other. To avoid unspecific formation of 
disulfide bridges by unpaired cysteine residues during sample preparation, the sulfhydryl 
groups were alkylated with NEM as described for the previous experiment (details see 
Section 4.10). Metabotropic glutamate receptors are especially prone to the formation of such 
unspecific disulfide bonds as they contain a cysteine-rich linker region between the 
extracellular domain and the transmembrane domain (170). For that reason higher oligomers 
(trimers, tetramers or more) are often visible on the western blot, but are not considered 
physiologically relevant (131). 
The non-reducing SDS-PAGE was performed with all Flag-tagged W→A and Y→A variants 
which had been cloned as single mutants in the background of a wild type mGluR2 or as 
double mutants with an additional C121A modification in the extracellular domain (Figure 
2.16 A). The immunoblot for the single mutants showed a broad signal at an apparent size of 
200-250 kDa which corresponds to the predicted size for the dimer of ~190 kDa. The band 
corresponding to the monomer at an apparent molecular weight of 100 kDa (predicted 
~95 kDa) was by far weaker. Here, the dimerization ratio for the Flag-tagged wild type and 
the corresponding variants averaged between 96-99%. In contrast to that, mGluR2
C121A
-Flag 
and the corresponding W→A and Y→A double mutants showed a stronger signal for the 
monomer band. Subsequently, the dimerization ratio was reduced by 40-50% as compared to 
the single mutants (Figure 2.16 B). The dimerization ratio for the double mutants averaged 
between 38-50%. No significant difference within the single or double mutant set was 
observed (1Way ANOVA with Dunnetts’ post test in GraphPad, W→A and Y→A variants 
versus mGluR2-Flag or mGluR2
C121A
-Flag, α=0.05). The only significant difference 
(P < 0.05) was found between mGluR2-Flag and mGluR2
C121A
-Flag. 
Thus in the current experiment, the non-reducing conditions allowed the C121-C121 disulfide 
bridge in the mGluR2-Flag homodimer to stay intact. The disulfide bridge appeared to be still 
intact also for the different variants of mGluR2-Flag, which suggested that the receptor had 
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been expressed correctly – as already seen in the trafficking assays (Section 2.2.1). Notably, 
the interaction in the homodimer of the mGluR2
C121A
-Flag variants could not be broken 
completely even the disulfide bridge was absent. This argued for strong non-covalent 
interactions between the protomers (Figure 2.16). 
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Figure 2.16 | W→A and Y→A single and double mutants were alkylated with NEM and subjected to non-
reducing SDS-PAGE. For the experiment, mGluR2-(Myc)Flag or mGluR2
C121A
-Flag constructs were 
transiently expressed in Hek293 cells (details see Section 4.10). (A) The protein samples were separated by 
non-reducing SDS-PAGE. On the immunoblot the αFlag (Mouse, F1804) signals of monomer (grey arrow 
heads) and dimer (black arrow heads) were quantified as indicated. The αGAPDH signal was used as loading 
control. For each set of variants, the blots are representative for n=4 independent experiments scanned at 
intensity of 2.5. (B) The dot plot in GraphPad Prism shows the values for the four experiments as mean±SEM. 
Statistics with 1way ANOVA versus mGluR2-Flag or mGluR2
C121A
-Flag (*=P<0.05). 
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2.2.2.3 Co-immunoprecipitation as measure for dimerization of mGluR2 wild type and 
variants 
As a complementing approach to the cysteine crosslinking experiments and the SDS-PAGE 
under non-reducing conditions, Co-IP experiments were performed to find whether the W→A 
and Y→A variants of mGluR2 would still heterodimerize with the wild type receptor. In two 
steps the Co-IP conditions were optimized for specificity and sensitivity. 
In the first step, the detergent composition was adjusted. Six different detergent compositions 
were tested: Triton X-100 (TX100) combined with only sodium deoxycholate (Dx), or with 
Dx and sodium dodecylsulfate (SDS). Likewise, NonIdet-P40 (NP-40) was combined with the 
two ionic detergents (Figure 2.17 A). For the experiments, the cells were lysed with the 
respective buffers and subsequently subjected to Co-IP using the Flag-tagged mGluR2 or 
mGluR2
C121A
 variant as bait and the respective Myc-tagged variant as prey. For the relative 
abundance of the Myc-bait after Co-IP, a value of at most 50% was expected. The value can 
be explained by looking at the binomial (a+b)
2
. The term is solved as a
2
+ab+ba+b
2
 where a 
and b represent the Flag- and Myc-tagged proteins, respectively. That is to say when co-
expressed the Flag+Flag- and Myc+Myc-tagged ‘homodimers’ compete with the Flag+Myc-
tagged ‘heterodimers’. In case that there would be no influence of the tag on dimerization, 
around 50% recovery of the Myc prey was to be expected. 
αFlag signal was enriched under all detergent compositions tested, which showed that the bait 
protein had bound to the αFlag beads (Figure 2.17 B). Thus none of the detergent 
compositions hampered the binding of the Flag-tagged epitope to the antibody. Moreover, the 
αGAPDH loading control showed that no soluble protein had been retained in the IP-fraction. 
Finally, a αMyc signal was observed on the blot in all setups (Figure 2.17 A). The 
quantification of the αMyc signal in the mGluR2-Flag Co-IP showed that the relative 
abundance of the prey protein after Co-IP was rather insensitive to the detergent composition 
(Figure 2.17 C). For the NP-40 based buffers a recovery of 48% was measured which did 
hardly change in the presence of the Dx and SDS. For the TX100 buffers, there was a slight 
increase observable when applying more stringent conditions: for TX100 the averaged 
recovery was 35% while in the presence of all three detergents the value increased to 43%. 
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Figure 2.17 | Co-immunoprecipitation with different combinations of non-ionic and ionic detergents. 
mGluR2-Flag or mGluR2
C121A
-Flag were co-expressed in Hek293 cells with their corresponding Myc-tagged 
variant. The lysis and co-immunoprecipitation was carried out with the indicated buffer (details see Section 
4.11.1). (A+B) The input (In) and immunoprecipitated (IP) protein samples were separated by SDS-PAGE. On 
the immunoblot, αMyc (Rabbit, NB600-336) signals were quantified as indicated (mGluR2: black arrow heads, 
β2AR: grey arrow head). αFlag (Mouse, F1804) signals were used as pull-down and αGAPDH signals as loading 
control. The blots are representative for n=3 experiments scanned at an intensity of 2.5. (C) The bar plot in 
GraphPad Prism shows the relative abundance of the prey protein for the three experiments as mean±SEM. 
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In contrast to that, the mGluR2
C121A
-Flag variants appeared to be sensitive to the presence of 
ionic detergents (Figure 2.17 C). While for TX100 and NP-40 34% and 43% of the Myc-
tagged prey protein were recovered after the Co-IP, the averaged values dropped to 10% and 
15% in the presence of both Dx and SDS. Moreover, NP-40 appeared to be less disruptive 
than TX100. The Co-IP performance of the buffer with 1% NP-40 came closest to the 
theoretical value of 50% recovery and was subsequently chosen as basis for the further 
experiments. 
From the comparison of the different detergent combinations it could be concluded that the 
missing disulfide bond in the extracellular domain of the mGluR2
C121A
-Flag made the system 
more sensitive towards changes in the detergent composition. Overall the gedanken-
experiment concerning the bionomical was in accordance with the obtained result: on average 
no more than 50% prey protein was recovered (Figure 2.17 C). This also suggested that the N-
terminal tags did not alter the dimerization preference. 
In a second step, the experimental conditions were further adjusted and more controls were 
included to get a better insight into the specificity of the system. The mGluR2
C121A
-Flag 
protein was used as bait protein for the corresponding Myc-tagged construct. As controls, the 
C-terminally Myc-tagged mGluR2 wild type or Beta-2 adrenergic receptor (β2AR) were co-
expressed as prey proteins. The experimental conditions were adjusted following the 
protocols described by Milligan and Bouvier (171). As suggested, an alkylating substance was 
included following the already established protocol with NEM described for the cysteine-
crosslinking (Section 2.2.2.1). Second, an ultracentrifugation step was included after lysis to 
remove non-solubilized proteins. Third, to avoid unspecific binding of the Myc-tagged prey 
proteins and thus an increase in the relative abundance after Co-IP, the salt conditions of the 
wash buffer were tested using low versus high salt conditions (Figure 2.18 A) (details see 
Section 4.11.2). 
As in the first Co-IP experiment, the αFlag signal showed that the bait protein was binding to 
the αFlag beads under all given conditions (Figure 2.18 B), also including the more stringent 
conditions with the NEM alkylation step. The quantification of the immunoblot showed that 
the Co-IP of the mGluR2
C121A
- mGluR2
C121A
 homodimer was by magnitudes more efficient 
than for the mGluR2
C121A
- mGluR2 wild type heterodimer (Figure 2.18 C). For the 
homodimer, the relative abundance of the bait after Co-IP in all experimental conditions 
tested was quantified with 29-31% while for the heterodimer the averaged values varied 
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between 3-6%. This observation showed that the dimerization interface was sensitive also to 
subtle changes. For the homodimer, it appeared not to make a major difference whether the 
alkylation step with NEM or more stringent washing conditions were applied; the recovery 
remained largely unchanged. However, with the adjusted Co-IP conditions the relative signal 
for the C121A-C121A homodimer dropped from 43% to about 30% (compare Figure 2.17 
and Figure 2.18).  
To date, no interactions between mGluR2 and β2AR have been reported. For that reason 
β2AR was chosen as negative control. It became evident that – at least by means of 
quantification – the most stringent conditions including alkylation with NEM and high salt 
washing conditions were necessary to suppress unspecific binding of the family A GPCR. To 
wash the loaded αFlag beads with high salt wash buffer was sufficient to reduce 27% binding 
of β2AR-Myc measured at low salt conditions by about 60% (Figure 2.18 C). By applying 
also NEM alkylation, this value was again reduced by ~50% to an averaged recovery of only 
4%. This suggested that both unspecific non-covalent interaction as well as spontaneous 
formation of unspecific disulfide bonds were involved in mGluR2-β2AR heteroreceptor 
formation. However, the immunoblot signals obtained for the β2AR were weak, raising the 
possibility of quantification artifacts (Figure 2.18 A). Nevertheless, based on these 
quantification results the most stringent conditions, including the NEM alkylation step and 
high salt washing, were chosen for further experiments. 
2 Results 
71 
 
A 
 
B 
 
 
C 
 
 
 
Figure 2.18 | Optimization of co-immunoprecipitation using different salt and alkylation conditions. 
mGluR2
C121A
-Flag proteins were co-expressed in Hek293 cells with the indicated Myc-tagged preys. The 
lysis and co-immunoprecipitation was carried out with or without NEM-alkylation and with high or low salt 
washing buffer (details see Section 4.11.2). (A+B) The input (In), flow through (Fl) and immunoprecipitated (IP) 
protein samples were separated by SDS-PAGE. On the immunoblot, αMyc (Rabbit, NB600-336) signals were 
quantified as indicated (mGluR2
(C121A)
-Myc: black arrow heads, β2AR-Myc: grey arrow head). αFlag (Mouse, 
F1804) signals were used as pull-down and αGAPDH signals as loading control. The blots are representative for 
n=3 experiments scanned at an intensity of 1.5. (C) The bar plot in GraphPad Prism shows the relative 
abundance of the prey protein after Co-IP for the three experiments as mean±SEM. 
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With the adjusted conditions, Co-IP experiments with various W→A and Y→A mGluR2 
variants were performed. Either mGluR2-Flag or mGluR2
C121A
-Flag were used as bait protein 
and they were co-expressed with the corresponding Myc-tagged variants (for mGluR2-Flag 
see Figure 2.19 A, mGluR2
C121A
-Flag blots not shown). In addition to the co-expressed 
mGluR2-variant pairs, β2AR-Myc was included as negative control. The ‘Myc vs Myc’ and 
‘Flag vs Flag’ controls were Co-IPs with only the Myc-tagged or only the Flag-tagged bait or 
prey, respectively. Finally, for the lysate control mGluR2 bait and prey proteins that had not 
been co-expressed were co-incubated during the IP (154). The aim of the lysate control was to 
check if the dimerization would also happen post-lysis. 
For the Co-IP of the mGluR2-Flag protein and the corresponding W→A or Y→A variants no 
significant difference was observed (1way ANOVA Dunnetts’ post test in GraphPad Prism 
versus mGluR2-Flag, α=0.05) (Figure 2.19). The average values were in a range of around 
30-40% recovery of Myc-tagged prey after Co-IP (Figure 2.19 C). The controls showed that 
the experimental setup for the Co-IP worked as expected: i) the recovery for β2AR-Myc was 
around 2%, which suggested that binding by random protein-protein interactions was 
neglectable, ii) the mGluR2 ‘Myc vs Myc’ and ‘Flag vs Flag’ signals indicated that there was 
no unspecific binding of Myc epitope to the αFlag beads during the Co-IP and, vice versa, no 
cross-signaling of the αMyc antibody with the Flag epitope on the immunoblot, and iii) the 
‘lysate control’ showed that there was no dimerization occurring during cell lysis or IP. 
Together these data suggested that the W→A and Y→A substitutions in the Flag-tagged 
mGluR2 variants had no effect on ‘heterodimerization’ with the wild type receptor. 
The controls in the mGluR2
C121A
-Flag Co-IP experiment did not show any deviations from the 
controls in the previous experiment (Figure 2.19 C). However, the Co-IP of mGluR2
C121A
-
Flag with the corresponding Myc-tagged W→A or Y→A variants showed a higher variation. 
While for some, like mGluR2
C121A/Y734A
-Myc, rather reproducible results were obtained, 
others showed strong deviations between experiments. Nevertheless, the mean values did not 
show any effects of the point mutations on mGluR2
C121A
-variant dimer formation (1way 
ANOVA Dunnetts’ post test in GraphPad Prism versus mGluR2C121A-Flag, α=0.05). 
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Figure 2.19 | Co-immunoprecipitation of Myc-tagged proteins with a Flag-tagged bait. mGluR2-Flag 
proteins were co-expressed in Hek293 cells with the indicated Myc-tagged preys. Cell lysis and co-
immunoprecipitation was carried out including an NEM-alkylation step and high salt conditions (details see 
Section 4.11.3). (A+B) Input (In), pellet (P), flow through (Fl) and immunoprecipitated (IP) protein samples 
were separated by SDS-PAGE. On the immunoblot, αMyc (Rabbit, NB600-336) signals were quantified as 
indicated (mGluR2-Myc: black arrow heads, β2AR-Myc: grey arrow head). αFlag (Mouse, F1804) signals were 
used as pull-down and αGAPDH signals as loading control. Controls are indicated in cursive letters: ‘Myc vs 
Mys’ represents co-expression of Myc-tagged mGluR2, ‘Lysate control’ shows a lysate mix of Flag- and Myc-
tagged mGluR2, and ‘Flag vs Flag’ is a co-expression of Flag-tagged wild type mGluR2. The blot is 
representative blot for n=3 independent experiments scanned at an intensity of 1.5. (C) The bar plot in GraphPad 
Prism shows the relative abundance of the prey protein after Co-IP for the three experiments as mean±SEM. The 
experiments with mGluR2
C121A
-Flag double mutants were conducted and analysed likewise. 
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The more stable results in the first experiment can be explained by the presence of the 
covalent linker between the two protomers (Figure 2.19). Without the disulfide bond in the 
homodimer, the assay appeared to be more prone to experimental variation. In summary, both 
Co-IP experiments showed that the tested Flag-tagged mGluR2 W→A and Y→A variants had 
retained the ability to dimerize with the corresponding wild type or the C121A mutant. 
2.3 Biochemical characterization of other GPCRs 
Three different metabotropic glutamate receptors were used to assess the S-palmitoylation of 
the family C receptors. Apart from mGluR2, the receptors mGluR1α and mGluR4 were tested 
in the assay. Along with this three receptors, two adrenergic and two serotonin receptors and 
two of their respective S-palmitoylation mutants were tested. This was done to validate the 
assay and minimized the risk of false negative finding because of the lack of specific 
palmitoyltransferases in Hek293 (reviewed by Fukata and Fukata (172)), as well as the risk of 
false positive due to incorporation of tritium into other biomolecules such as amino acids (76). 
2.3.1 Cell surface arrival of transiently expressed GPCRs in Hek293 cells 
The GPCRS, which were used for the S-palmitoylation assay, were subjected to cell surface 
biotinylation to test if their surface arrival was comparable to the one of mGluR2. As 
described in Section 4.8, the receptors were transiently expressed in Hek293 cells and then 
biotinylated with Sulfo-NHS-SS-Biotin. In comparison to the experiments with mGluR2 
(compare Section 2.2.1.1), a higher plasmid DNA concentration was used to account for the 
weaker expression of the Serotonin receptors (Figure 2.20). 
Flag-tagged mGluR1α and mGluR4 were detected with an averaged surface arrival of 
approximately 27% and 30%, respectively (Figure 2.20 B). For mGluR2 the quantified value 
of 46% was higher and thus in the same range as previously observed for the mGluR2 
variants (compare Figure 2.13 and Figure 2.20). In contrast to that, the family A GPCRs and 
also the positive control ASPRGI were only weakly detected at the cell surface (Figure 
2.20 B). For the serotonin receptors, the average cell surface arrival for the Flag-tagged 
constructs was 4% for 5-HT-1A and 5% for 5-HT-2B. Here, the quantification of the signals 
on the immunoblot was hampered by the poor signal-to-noise ratio of the receptors, for 
example of 5-HT-1A from mouse (Figure 2.20 A). For adrenergic receptors, like β2AR-Flag, 
the input sample was clearly visible while only a minor fraction of the receptor appeared to be 
biotinylated: only 5% were detected in the affinity purification. A similar picture appeared for 
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the Alpha-2A adrenergic receptor (α-2AAR). For α-2AAR-Flag, a relative cell surface arrival 
of 6% was detected. For the respective C→A variants, the quantified values were in the same 
range. For the adrenergic receptors, it might also have been a problem, that both receptors 
carried only 2 lysine residue in their extracellular domain which might have lowered the 
possibility to carry biotinylated primary amines. In comparison, the mGluRs have between 37 
and 50 lysine residues in the extracellular domain. 
A 
 
 
B 
 
Figure 2.20 | Cell surface arrival of 
mGluRs, ARs and 5-HT-Rs and loss-of-
function mutants. The relative surface 
arrival of transiently expressed Flag-
tagged GPCRs in Hek293 cells was 
probed in a 6-well plate format (details see 
Section 4.8). (A) The input, flow through 
(Fl) and affinity purification (AP) samples 
were separated by SDS-PAGE. On the 
immunoblot the αFlag signal of monomer 
and oligomers was quantified as indicated 
(black arrow heads: mGluRs, grey arrow 
heads: ARs, white arrow heads: 5-HT-Rs). 
The αGAPDH signal was used as loading 
control and ASGPR1-MycFlag signal as 
postive control. The blot is representative 
for n=3 independent experiments. (B) The 
dot plot in GraphPad Prism shows relative 
surface arrival as ratio of the affinity 
purified αFlag signal versus the total input 
signal for the three experiments as 
mean±SEM. 
 
2 Results 
76 
 
The surface biotinylation assay showed that not all receptors were equally well expressed and 
detected on the immunoblot. For some like 5-HT-1A the detection was generally low, while 
for β2AR for example the number of available primary amines might had hampered a more 
efficient cell surface biotinylation. 
2.3.2 Intracellular trafficking of GPCRs monitored by enzymatic 
deglycosylation 
In addition to the cell surface arrival of the different wild type and version of the GPCRs, an 
enzymatic deglycosylation assay was performed for the mGluRs and the ARs (details see 
Section 4.9). 5-HTs were not included into the analysis because of their poor detection on the 
immunoblot (Figure 2.20). The assay was performed with EndoH and PNGaseF as previously 
described for the mGluR2 variants (Section 2.2.1.2).  
 
 
Figure 2.21 | Enzymatic deglycosylation of GPCRS with EndoH and PNGaseF. Flag-tagged GPCRs were 
transiently expressed in Hek293 cells. After 48 h, the cells were harvested and the total protein fraction 
subjected to enzymatic deglycolysation using EndoH (+E) or PNGaseF (+P). The controls (-E/-P) were mock 
treated in in Glycoprotein denaturating buffer and Glycobuffer which had been provided with the enzymes 
(details see Section 4.9). The deglycosylated samples were separated by SDS-PAGE. On the immunoblot the 
αFlag signal of fully glycosylated monomer and dimer was indicated with black arrow heads both for the 
mGluRs and the ARs. The shifted bands after deglyocylation was indicated with gray arrow heads. The 
αGAPDH signal was used as loading control. The blot is representative for n=3 independent experiments. 
For the different mGluRs, a similar pattern was visible as seen in the deglycosylation of the 
mGluR2 variants (Section 2.2.1.2): The enzymatic deglycosylation with EndoH showed an 
additional faster migrating band both for the monomer and the dimer as compared to the mock 
treated samples (Figure 2.21 +/-E). However, this faster migrating band represented a fraction 
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of the total signal and thus not all proteins were deglycosylated. Upon treatment with 
PNGaseF the whole fraction migrated faster on the immunoblot (Figure 2.21 +/-P). For the α-
2AAR the pattern was similar to the mGluRs: Upon treatment with EndoH a fraction of the 
proteins was deglycosylated and PNGaseF shifted the whole banding pattern into a faster 
migrating band. In contrast to that, all detectable bands of the β2AR shifted already upon 
treatment with EndoH. About four different bands were observed running at the height of the 
monomer which shifted into one upon enzymatic deglycosylation. 
From the experiments was concluded that the mGluRs had successfully trafficked through the 
secretory pathway to the surface of the Hek293 cells. For the α-2AAR at least a fraction 
appeared to have passed the Golgi. For the β2AR, the results indicate that the receptor 
‘smeared’ through the secretory pathway. The previous experiment had shown that a fraction 
had arrived at the surface of the cell (Figure 2.20). Notably, it was suggested in the literature 
that even incorrectly glycosylated β2AR can be trafficked to the surface of the cell (173). 
2.4 S-palmitoylation of GPCRs 
It has been shown that S-palmitoylation in the C-terminal domain can alter the membrane 
localization of GPCRs, such as for the 5-HT-1A in mouse (26). For that reason the mGluRs 
were probed for a potential S-fatty acylation site. 
Palmitoyl residues are often added to the C-terminal tail of GPCRs and can be either more 
static or, despite their covalent linkage to cysteine residues, subject to continues enzymatic 
acylation and deacylation (25, 124, 174, 175). The transient nature of the S-palmitoylation 
allowed to add the [9,10-
3
H(N)]- palmitic acid only after the transient expression of the 
constructs. The cells expressing the Flag-tagged GPCRs were incubated for 3 h with the 
tritiated palmitic acid before harvesting the cells. The proteins were isolated by 
immunoprecipitation with αFlag beads and subsequently separated by SDS-PAGE and blotted 
on PVDF membrane (details see Section 4.12.5). The PVDF membrane was subjected to 
digital autoradiography to detect the incorporation of radioactivity into the protein samples 
(Figure 2.22 A). The tritium signals were then compared to the αFlag immunoblot (Figure 
2.22 B). 
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Figure 2.22 | Labeling of Flag-tagged GPCRs with [
3
H]-palmitic acid. Flag-tagged GPCRs were transiently 
expressed in Hek293 cells for 48 h. The cells were labeled with tritiated palmitic acid 3 h before harvest. Cells 
were lysed and Flag-tagged proteins immunoprecipitated (details see Section 4.12.5). (A) The input (In), flow 
through (Fl), and immunoprecipitated (IP) protein samples were separated under non-reducing conditions by 
SDS-PAGE and blotted on a PVDF membrane. The radioactive signals on the membranes were measured for 
24 h by digital autoradiography. (B) Subsequently Flag-tagged proteins were visualized by immunostaining 
with αFlag. The αGAPDH signal was used as loading control. The blots are representative for n=3 independent 
experiments. 
The autoradiography of the protein samples showed a homogenous staining pattern for in the 
input lanes (Figure 2.22 A). Thus the tritiated palmitic acid had been taken up by the Hek293 
cells and was incorporated into the proteins. In the immunoprecipitated samples, a positive 
signal was obtained for 5-HT-1A and -2A and the adrenergic receptors β2AR and α-2AAR 
suggesting S-palmitoylation of these proteins. The corresponding (double) C→A mutants of 
5-HT-1A and β2AR did not show any signal in the autoradiography; 5-HT-1AC417A/C420A and 
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β2ARC341A appeared not to carry a S-fatty acyl modification. Compared to the immunoblot, 
the autoradiography showed a more pronounced signal for both the serotonin and adrenergic 
receptors (Figure 2.22 B). This indicated that these proteins were equally well expressed but 
not well recognized by the αFlag antibody. Among the metabotropic glutamate receptors, only 
one candidate showed a signal in the autoradiography after immunoprecipitation: mGluR1α. 
The signal corresponded to the dimer band of the receptor on the immunoblot. If there had 
been a signal for the monomer band, it would have superimposed with the background band 
visible in all labelings including the vector control. In contrast to that, no signal was seen for 
mGluR2 or mGluR4. 
The non-reducing separation of the proteins allowed the detection of the radioactive palmitate 
labeling of the different GPCRs (Figure 2.22). To challenge the results of [
3
H]-palmitic acid 
labeling, the protein samples were treated with the reductive agent β-mercaptoethanol. The 
reductive agent should cleave the thioester bond between the acyl chain and the cysteine 
residue of the GPCR (176). Both the input samples as wells as the immunoprecipitated 
samples were separated under reducing conditions. False positive were expected to retain their 
signal under these conditions. The results were visualized again by digital autoradiography 
and αFlag immunostaining (Figure 2.23). 
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Figure 2.23 | Separation of [
3
H]-palmitic acid-labeled samples under reducing conditions. Flag-tagged 
GPCRs were transiently expressed in Hek293 cells for 48 h. The cells were labeled with tritiated palmitic acid 
3 h before harvest. Cells were lysed and Flag-tagged proteins immunoprecipitated (details see Section 4.12.5). 
(A) The input (In), flow through (Fl), and immunoprecipitated (IP) protein samples were separated under 
reducing conditions (15%(V/V) β-mercaptoethanol) by SDS-PAGE and blotted on a PVDF membrane. The 
radioactive signals on the membranes were measured for 24 h by digital autoradiography. (B) Subsequently 
Flag-tagged proteins were visualized by immunostaining with αFlag. The αGAPDH signal was used as loading 
control. The blots are representative for n=3 independent experiments. 
The reducing SDS-PAGE delivered inconclusive results as the blot showed a hemicycle that 
divided the running pattern in upper and lower half (Figure 2.23). This pattern was observed 
in all SDS-PAGEs conducted with β-mercaptoethanol as reductive agent (Figure 2.24). For 
the input and flow through samples, a loss of the signal in the autoradiography was observed 
even though not to completion and a shadow remained in the lower half of the blot. The 
immunoprecipitated samples appeared to be largely deacylated. Probably the total amount of 
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protein in the IP samples was lower and thus the ratio between reductive agent and protein 
higher. Concerning the running pattern in both gels, the artifacts can be probably attributed to 
the presence of β-mercaptoethanol as in no other SDS-PAGE a similar pattern had been 
observed (for example see Figure 2.22). Here, the optimal pH for the reduction of the protein 
samples with β-mercaptoethanol would have been 6.8 and not 8.3, as in the gel system and 
sample buffer which had been optimized for DTT (177) (Section 4.5). Thus, it also cannot be 
excluded that unspecific formation of thioester bonds to unbound [
3
H]-palmitic acid and 
change of pH during the SDS-PAGE had cause the hemicycle visible on the western blot. 
With the exception of mGluR1α, all IP samples were successfully reduced (Figure 2.23, 
Figure 2.24). This confirmed the nature of the S-palmitoylation for the GPCRs and indicated 
that the signal had not been measured due to an incorporation of tritium into amino acids or 
other post-translational modifications. On the other side, the results concerning a potential S-
acylation site in mGluR1α were inconclusive. In the 2nd replicate, the signal on the 
autoradiography was gone and in the 3
rd
 replicate the signal was partly removed. This left 
either the possibilities that the fatty acid was linked with an O- or N-linkage even though this 
has been poorly investigated for GPCRs (13). The other possibility would have been another 
modification of unknown nature that was at least partly sensitive to β-mercaptoethanol. 
 
 
Figure 2.24 | Separation of [
3
H]-palmitic acid-labeled samples under reducing conditions. Flag-tagged 
GPCRs were transiently expressed in Hek293 cells for 48 h. The cells were labeled with tritiated palmitic acid 
3 h before harvest. Following, the cells were lysed and Flag-tagged proteins immunoprecipitated (details see 
Section 4.12.5). The immunoprecipitated (IP) protein samples were separated under reducing conditions 
(15%(V/V) β-mercaptoethanol) by SDS-PAGE and blotted on a PVDF membrane. The radioactive signals on the 
membranes were measured for 24 h by autoradiography The blots represent the 2
nd
 and 3
rd
 experiment (first 
experiment see Figure 2.23). 
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2.5 Non-covalent lipid interaction of GPCRs probed by 
metabolic labeling with tritiated lipids 
To investigate non-covalent interactions of GPCRs with sphingolipids and cholesterol, the 
different W→A and Y→A variants of mGluR2 were subjected to metabolic labeling with 
either [
3
H]-photo-sphingosine or [
3
H]-photo-cholesterol. This photo-lipids carried a diazirine 
group which would allow to covalently UV-crosslink the photo-lipid to proteins in closest 
proximity (78). To screen for loss of lipid interaction sites, the different mGluR2 variants 
were transiently expressed in Hek293 cells which were incubated with the corresponding 
photo-lipid and subsequently crosslinked with UV-light. 
2.5.1 [3H]-(photo-)sphingolipid binding to mGluR2 variants 
The [
3
H]-sphingosine is subject to metabolisation within labeled cells and thus can end up in 
different metabolic products of the sphingolipid pathway (78) (Figure 1.5). The products of 
the labeling with [
3
H]-sphingosine in pCMV6 vector control or pCMV6_GRM2_MycFlag 
transfected cells were compared to the reported lipid pattern (78). To estimate if there were 
any measureable differences in the (sphingo-)lipid metabolism caused by the transfection, 
[
3
H]-sphingosine metabolism was compared for different transfection agents. The transfection 
agents can be grouped into cationic (polymers) and lipid-based agents. The former agents rely 
mostly on the endocytosis of the DNA complex. Some, like Calcium-phosphate (CaP) or poly 
Polyethylenimine (PEI), were prepared based on open-source protocols, while others, like 
Turbofect (ThermoScientific, USA), were commercially available (details see Section 4.3.7). 
Lipid-based agents were only purchased from commercial sources, but here the composition 
stayed unknown. The lipid blend in FuGENE (Promega, Germany), Lipofectamine2000 
(ThermoScientific, USA), and X-tremeGene (Roche, Switzerland) raised the concern that 
some compounds in the lipid mix could affect the (sphingo-)lipid metabolism in the cells. 
After transfection, labeling of cells and extraction of labeled lipids, the metabolism of [
3
H]-
sphingosine was compared by thin layer chromatography (TLC) (Figure 2.25 A). The 
dominant species in the labeling with approximately 60% was ceramide, followed by 
sphingomyelin and sphingosine with around 13%. Smaller fractions were the 
hexosylceramides with 6-9% and gangliosides with 3-6% (Figure 2.25 B). Here, the results 
did not show any major differences between the different transfection agents or between mock 
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transfected and mGluR2 expressing cells (Figure 2.25 B). Also, the comparison between the 
non-transfected control and the different transfection reagents did not reveal any changes in 
the metabolism of the labeled (sphingo-)lipids. However, the distribution between the 
different sphingolipid species was shifted towards the ceramide after 6 h of metabolic labeling 
with the Hek293 cells. This was in contrast to the findings with the [
3
H]-D-erythro-photo-
sphingosine ([
3
H]-photoSph) (78). For [
3
H]-photoSph, the sphingomyeline fraction peaked 
after 6 h according to the original published data. A similar distribution as in the published 
data was earlier measured for the Hek293 cells (data not shown). Eventually the metabolism 
of the tritiated sphingosine species was different from the analogue with a diazirine group, but 
no direct comparison has been made between the species. 
From the results was concluded that the cellular metabolism of tritiated sphingosine appeared 
to be independent of the transfection agent and the ectopic expression of mGluR2-MycFlag. 
The experimental setup with FuGENE HD as transfection agent and pCMV6 vector 
constructs appeared to be valid as transient expression system for [
3
H]-sphingosine labeling 
experiments. 
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Figure 2.25 | Effect of transfection agents on [
3
H]-sphingosine metabolism in Hek293 cells. The cells were 
transiently transfected with pCMV6 vector control (pCMV6) or GRM2-MycFlag construct and labeled for 6 h 
with 2 µCi (Spec.Activity 20 Ci/mmol) [
3
H]-sphingosine. After 48 h, the cells were harvested and extracted 
with methanol (details see Section 4.12.4). (A) A total activity of 0.075 µCi methanol extract were loaded per 
lane on a TLC plate. The TLC was developed with a choloroform/MeOH/water mixture (65:25:4). The 
developed plate was subjected to autoradiography (representative picture). With the exception of the [
3
H]-
sphingosine standard, the pattern of the autoradiography was assigned by comparison to literature (Haberkant, 
Schmitt (78), marked with an asterisk). (B) The pattern was pixeled in ImageJ 1.51n. The data are shown as bar 
plot in GraphPad Prism (n=2, mean+SEM). 
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The activatable and clickable analog of sphingosine (pacSph), similar in its chemical structure 
to [
3
H]-sphingosine, had shown to be prone to phosphorylation and subsequent degradation by 
sphingosine-1-lysase (S1PL) (80). This phenomenon was related to the fact that sphingosine 
is a degradation and recycling product within the sphingolipid metabolism and can enter both 
anabolic and catabolic pathways. The degradation products, specifically the hexadecanal, can 
be incorporated into other lipids, such as phosphatidylcholines. To avoid loss of signal to 
phosphatidylcholines and the resulting artifacts, the gene encoding sphingosine-1-lysase 
(SGPL1) was knocked out by CRISPR-Cas9 (178) (Figure 1.5). The wild type Hek293 cells 
were compared to the SGPL1 knock out cells to see if [
3
H]-sphingosine metabolisation 
differed between parental and knockout cells (Figure 2.26). 
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Figure 2.26 | Metabolism of [
3
H]-sphingosine in Hek293 wild type and ΔSPGL1 knock-out cells. Wild type 
and ΔSPGL1 knock-out cells were incubated with 2 µCi (Spec.Activity 20 Ci/mmol) tritiated sphingosine for 
6 h. After incubation, the cells were extracted with methanol (details see Section 4.12.4). (A) A total activity of 
0.075 µCi methanol extract were loaded per lane on a TLC plate. The extract was separated in a 
choloroform/methanol/water mixture (65:25:4). The developed plate was subjected to digital autoradiography 
(representative picture). With the exception of [
3
H]-sphingosine standard, the pattern of the autoradiography was 
assigned by comparison to literature (Haberkant, Schmitt (78), marked with an asterisk). (B) The pattern was 
pixeled in ImageJ 1.51n. The data are shown as bar plot in GraphPad Prism (n=3 in parallel, mean+SEM). 
Apart from a faint band, which could not be assigned, there were no differences in the 
metabolism of [
3
H]-sphingosine in Hek293ΔSGPL1 knock out and the wild type cells (Figure 
2.26 A, unknown). As in the previous labeling, ceramide was the most prominent metabolite 
after 6 h incubation with a fraction of ~55% both in wild type and knock out cells (Figure 
2.26 B). The other metabolites were sphingomyelin with around 17-19% of the total activity, 
followed by hexosylceramide with ~8% in both cell lines and gangliosides with a share of 6-
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8%. Notably, the [
3
H]-sphingosine purchased from American Radiolabeled Chemicals 
(St.Louis, USA) appeared to contain different impurities which could not be assigned to the 
published pattern and eventually represent degradation or site products of the synthesis 
(Figure 2.26 A). 
As wild type and Hek293ΔSGPL1 knock out cells had not shown any differences in the 
metabolism of the [
3
H]-sphingosine precursor lipid, the wild type cells were chosen for all 
further experiments with tritiated sphingosine. In the next experiments, mGluR2-Flag and its 
variants were subjected to cellular labelings with the photoaffinity probe [
3
H]-photoSph (78). 
For the cellular photoaffinity labelings, also the influence of the different transfection levels 
in the transient expression system was accounted for: a plasmid DNA titration for 
pCMV6_GRM2_Flag was carried out as done earlier for the surface arrival (Figure 2.12). In 
the current titration, a DNA range from 125 ng to 500 ng was taken into consideration as this 
range had shown the most stable results in the previous experiments. The constructs were 
expressed for 48 h and the labeling with [
3
H]-photoSph started 6 h before UV-crosslinking the 
functionalized sphingolipids. The Flag-tagged proteins were immunoprecipitated and the 
labeling measured by digital autoradiography signal which was then compared to the αFlag 
immunolabeling (details see Section 4.12.3).  
The smear obtained for the input samples in the autoradiography indicated that both labeling 
and incorporation of [
3
H]-photoSph as well as crosslinking of functionalized (sphingo-)lipids 
to cellular proteins had occurred (Figure 2.27 A). For the mock labeled cells, in the absence of 
[
3
H]-photoSph, no signal was visible on the autoradiography. After the immunoprecipitation 
of the Flag-tagged proteins, a visually well distinguishable signal above background was only 
visible between 250 ng and 500 ng plasmid DNA (Figure 2.27 A). In this range, the 
transfection level allowed to measure a stable and reproducible labeling efficiency (Figure 
2.27 B). At the lowest DNA concentration of 125 ng, the labeling was close to the background 
– both on the autoradiography and the immunoblot (Figure 2.27 A). For this reason it cannot 
be excluded that the extraordinary high averaged labeling efficiency, 6.1-fold increased as 
compared to the efficiency at 500 ng, originated from quantification artifacts (Figure 2.27 B). 
Also, the labeling efficiency at 125 ng showed a way higher variation as compared to the 
higher DNA concentrations. Apart from that, the signal for the ASGPR1-MycFlag 
background control, which had been chosen based on the earlier publications, was also 
quantifiable but labeled weaker compared to mGluR2-Flag (65, 68) (Figure 2.27 B). Here, the 
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labeling efficiency was around 23% compared to the labeling efficiency of mGluR2-Flag at 
the same DNA concentration. 
A 
 
 
B 
 
Figure 2.27 | Plasmid DNA titration of 
mGluR2 constructs in Hek293 cells. For the 
titration, Flag-tagged mGluR2 was transiently 
expressed in Hek293 cells, which were then 
labeled with 7.5 µCi (Spec.Activity 
20 Ci/mmol) [
3
H]-photoSph or solvent control 
for 6 h. After incubation, cells were UV-
irradiated and subjected to immuno-
precipitation (details see Section 4.12.3). (A) 
Input (In), flow through (Fl) and 
immunoprecipitated (IP) protein samples 
were separated by SDS-PAGE. The IP signals 
in the autoradiography and the αFlag (Mouse, 
F1804) immunoblot were quantified as 
indicated (black arrow heads: mGluR2, grey 
arrow heads: ASGPRI). αGAPDH signal was 
used as loading control. (B) Quotient of the 
autoradiography and immunoblot signal at 
DNA concentration x was normalized to the 
quotient at 500 ng. The data are shown as 
mean±SEM (n=4) in GraphPad Prism. 
A stable labeling signal for [
3
H]-photoSph was obtained for a concentration range between 
250 ng and 500 ng plasmid DNA per well (Figure 2.27 B). However, to avoid quantification 
artifacts in cellular photocrosslinking assays with weakly expressed mGluR2-Flag variants, 
the highest DNA concentration (500 ng plasmid DNA/well) was chosen for the further 
labeling experiments with the mGluR2-Flag proteins. Here, the labeling of the proteins in the 
assay appeared in absolute terms more stable and quantifiable. 
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As in the previous experiments, the input lanes in the autoradiography showed that the 
cellular photocrosslinking with [
3
H]-photoSph was successful. The radioactive photo-
sphingosine had been taken up into the cells, incorporated into sphingolipids and UV-
crosslinked to proteins (Figure 2.28 A). Free [
3
H]-photoSph would not have been visible on 
the western blot as it was separated from the crosslinked activity during the SDS-PAGE. The 
autoradiography of the immunoprecipitated samples showed a labeling signal for all samples 
but the pCMV6 vector control. Among the different mGluR2-Flag variants, especially for 
mGluR2
Y734A
-Flag a strong radioactive labeling was visible. For others, such as Y607A and 
W773A, the measured signal was close to background. These two variants appeared also to be 
rather weakly expressed, as can be seen on the immunoblot (Figure 2.28 B). This correlated 
with earlier observations in the transient expression system (Figure 2.13). Eventually the 
exchange for alanine slightly lowered the expression level here. Interestingly, β2AR-Flag – 
which had been intended mainly as positive control for the later [
3
H]-cholesterol labelings – 
showed a very pronounced tritium signal (Figure 2.28 A). Contrary, ASGPRI-MycFlag 
labeling suggested a low affinity to sphingolipids in the steady state. 
The quantification of the autoradiography and immunoblot signals showed that for most of the 
mGluR2-Flag W→A and Y→A variants a labeling efficiency comparable to that of the wild 
type receptor had been obtained (Figure 2.28 C). A significantly higher labeling efficiency 
was observed for mGluR2
W697A
-Flag and mGluR2
Y734A
-Flag (1way ANOVA, Dunnetts’ post 
test in GraphPad Prism versus mGluR2-Flag, α=0.05). Here, the labeling efficiency was on 
average increased 2.7- and 2.6-fold, even though the variation between the replicates was 
rather high. However, the increased affinity was surprising as the different variants had been 
designed as loss-of-function. Notably, these two residues were in close proximity to each 
other, located in the exoplasmic leaflet of the transmembrane helices IV and V. Thus it cannot 
be excluded that the observations were interconnected and for example a gap in the surface 
had been created that now was occupied by sphingolipids. For the mGluR2-Flag variants 
Y767A, W773A and Y781A in helix VI – where the original p24-like sphingolipid interaction 
motif had been found – no significant increase or decrease in sphingolipid crosslinking was 
observed (68). The highest affinity in the assay was apparently to β2AR-Flag, which was on 
average 6.5-fold increased as compared to mGluR2-Flag.  
Due to the low crosslinking efficiency of [
3
H]-photoSph and the absence of sphingolipid 
binding defects in the selected mGluR2 variants, no further experiments with the 
mGluR2
C121A
-Flag double mutants were conducted. 
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Figure 2.28 | [
3
H]-photoSph labeling of 
mGluR2 variants in Hek293 cells. Flag-
tagged W→A and Y→A mGluR2 variants 
were transiently expressed in Hek293 cells 
along with the negative control ASGPRI-
MycFlag and the postive control β2AR-Flag. 
The cells were labeled with 7.5 µCi (Spec. 
Activity 20 Ci/mmol) [
3
H]-photoSph 6 h 
prior to UV-crosslinking (details see Section 
4.12.3). (A+B) Input (In), flow through (Fl) 
and immunoprecipitated (IP) protein samples 
were separated by SDS-PAGE. The IP signal 
in the (A) autoradiography and the (B) αFlag 
(Mouse, F1804) immunoblot were quantified 
as indicated (black arrow heads: mGluR2, 
grey arrow heads: ASGPRI, β2AR). 
αGAPDH signal was used as loading 
control. (C) Quotient of the autoradiography 
and immunoblot signal of protein or variant 
P was normalized to signal of mGluR2-Flag. 
The data are shown as dot plot with 
mean±SEM (n=3) in GraphPad Prism. 
Statistics with 1way ANOVA (*=P<0.05). 
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2.5.2 Altered [3H]-photo-cholesterol binding of mGluR2 variants 
Next, interactions of the different GPCRS with cholesterol were investigated. For cholesterol 
a bifunctional analogue originally synthesized by Christoph Thiele was used (77). The [
3
H]-
photo-cholesterol was tritiated and carried a diazirine group – thus had the same 
functionalities as [
3
H]-photoSph. As for the sphingolipid photocrosslinking experiments, the 
aim was to investigate if any of the W→A or Y→A variants would show a loss-of-function. 
For the [
3
H]-photo-cholesterol, no such broad diversity of metabolic products was expected as 
for the [
3
H]-photoSph (77). To test that assumption, the different [
3
H]-photo-cholesterol 
stocks and commercially available [1,2-
3
H(N)]-cholesterol were used for labeling in 
transiently transfected cells. After the transfection, labeling and extraction of labeled lipids, 
the metabolites of [
3
H]-(photo-)cholesterol were separated by TLC. On the TLC, the tritiated 
lipids were compared to their respective stocks and commercially [1,2-
3
H(N)]-cholesterol to 
monitor if there were any major side products formed within cells (Figure 2.29). 
The autoradiography of the TLC showed that only one of the two [
3
H]-photo-cholesterol 
stocks was usable (Figure 2.29, marked with #). The [
3
H]-photo-cholesterol of the respective 
stock ran at the same height as the [1,2-
3
H(N)]-cholesterol. Only one other faint band was 
visible. This pattern remained largely unchanged after 17 h labeling of Hek293T cells and 
even after UV-crosslinking in vivo. The pattern indicated that tritiated cholesterol was not 
subjected to such as complex metabolism as the one observed for [
3
H]-sphingosine (Figure 
2.26). Also, the diazirine group did not appear to have caused any larger changes in the 
running pattern as compared to the commercial [1,2-
3
H(N)]-cholesterol. In contrast to that, the 
other stock (Figure 2.29, marked with *) showed presence of byproducts that were already 
visible in the stocks and were still present after cellular incubation. The fact that they had not 
even been metabolized by the cells indicated that they were either side products of the original 
synthesis that had not been removed successfully or were degradation products. For all further 
experiments only the first (#) stock was used. 
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Figure 2.29 | Metabolism of different 
tritiated cholesterol stocks in 
Hek293T cells. Hek293T cells were 
transiently transfected with 
pCMV6_ADRB2_Flag. 17 h prior to 
harvest the cells were labeled with 
15 µCi of the inidicated [
3
H]-
cholesterol batches (details see Section 
4.12.2). Control cells were left 
untreated (-), compared to cells 
subjected to UV-crosslinking (+). After 
labeling, cells were extracted with 
methanol. 0.075 µCi extract per lane 
was separated in a 
choloroform/methanol/water mixture 
(65:25:4) on a TLC plate. The 
developed plate was subjected to digital 
autoradiography. The batches were 
loaded on the TLC plate as standard 
(-/-). [
3
H]-cholesterol is marked with a 
black arrow head, major side products 
with a grey arrow head. 
In contrast to sphingolipids, there have been numerous studies which investigated the 
interaction between GPCRs and cholesterol (57, 69). For an initial cellular photocrosslinking 
assay with [
3
H]-photo-cholesterol, one adrenergic and one serotonin receptor were included in 
addition to mGluR2. The adrenergic receptor β2AR has been investigated in several 
experimental and computational studies resulting in a set of established cholesterol interaction 
sites (20, 45, 47). The established concept of cholesterol interaction with this receptor made it 
a suitable control to validate the technical performance of the labeling and UV-crosslinking 
with [
3
H]-photo-cholesterol. Moreover, the serotonin receptor 5-HT-2A was included because 
it has been shown to interact with mGluR2 and thus should, at least in part, face a similar 
membrane environment (154). The labeling efficiency of 5-HT-2A-Flag and β2AR (including 
both a N-terminally and a C-terminally Flag-tagged version) was compared to mGluR2-Flag. 
As in the biochemical characterization described in Section 2.3, the cells were transfected 
with a high amount of DNA to ensure sufficient expression of the serotonin receptor. 
The input lane showed that for all receptors [
3
H]-photo-cholesterol had been taken up by cells 
and were successfully UV-crosslinked to adjacent proteins (Figure 2.30 A). Unbound [
3
H]-
photo-cholesterol was separated from the proteins during the SDS-PAGE. For all 
immunoprecipitated GPCRs a labeling with crosslinked activity was visible in the 
autoradiography which corresponded to the respective αFlag signal on the immunoblot. Here, 
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the quantification of the signals showed that both the N- and C-terminally Flag-tagged β2AR 
variant showed a highly efficient labeling which was on average about 6.9- and 5.2-fold 
stronger and significantly increased as compared to the labeling of mGluR2-Flag (1way 
ANOVA, Dunnetts’ post test in GraphPad Prism versus mGluR2-Flag, α=0.05) (Figure 
2.30 B). In contrast to that, 5-HT-2A-Flag labeling with [
3
H]-photo-cholesterol was on 
average reduced by 45 percentage points compared to mGluR2-Flag. The designated negative 
control ASGPRI-MycFlag was expressed, as seen on the αFlag immunoblot, but gave only a 
barely visible signal in the labeling (Figure 2.30 A). Hence, only a weak labeling, which 
corresponded to about 0.5% of mGluR2-Flag, was measured here (Figure 2.30 B). 
Similar to the cellular sphingolipid crosslinking assay with [
3
H]-photo-sphingosine, the 
current experiment showed that Flag-tagged β2AR labeled very efficient with [3H]-photo-
cholesterol (Figure 2.28 C, Figure 2.30 B). No major differences were observed between the 
N- and C-terminally tagged β2AR variants, even though the banding pattern in the αFlag 
immunoblot appeared to be different (Figure 2.30 A). While for the C-terminally tagged 
protein multiple bands were seen between 37 kDa and 100 kDa, only one broad band was 
visible between 37 kDa and 50 kDa for NFlag-β2AR. In contrast to that, the radiolabeling 
showed a similar pattern for both variants: One defined band between 37 kDa and 50 kDa 
which indicted the monomer, and a broader smear between 50 kDa and 75 kDa (and even 
higher apparent molecular weights) which probably corresponded to oligomers. The 
comparison between the autoradiography and the αFlag immunoblot suggested that for the N-
terminally tagged version not all proteins on the blot had been equally well-detected by the 
Flag antibody. For that reason the C-terminally tagged version was chosen as positive control 
for further experiments. Interestingly the other family A receptor, 5-HT-2A, labeled much 
weaker which indicated that (strong) cholesterol photocrosslinking was not an intrinsic 
property of GPCRs in the given setup. 
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Figure 2.30 | Quantification of [
3
H]-photo-
cholesterol labeling controls. Different 
Flag-tagged GPCRs were transiently 
expressed in Hek293 cells and labeled for 
17 h with 15 µCi [
3
H]-photo-cholesterol per 
well which was then UV-crosslinked to 
neighbouring proteins. (details see Section 
4.12.1). (A) Input (In) and 
immunoprecipitated (IP) protein samples 
were separated by SDS-PAGE. The 
autoradiography and the αFlag (Mouse, 
F1804) signals on the immunoblot, scanned 
at 1.5, were quantified as indicated (black 
arrow heads: mGluR2, grey arrow heads: 
ASGPRI, β2AR, 5-HT-2A). αGAPDH signal 
was used as loading control. (B) Quotient of 
the autoradiography and immunoblot signal 
of protein P was normalized to signal of 
mGluR2-Flag. The data are shown as dot plot 
with mean±SEM (n=3) in GraphPad Prism. 
Statistics with 1way ANOVA (*=P<0.05). 
Next, the amount of plasmid DNA coding for mGluR2-Flag and mGluR2
C121A
-Flag was 
titrated to estimate the influence of the transfection level on the labeling efficiency with [
3
H]-
photo-cholesterol. The goal was to establish a transfection level which would allow a 
reproducible labeling of the Flag-tagged mGluR2 variants. Now in the titration experiment, 
the labeling efficiency of the receptors was measured at four different DNA concentrations, 
125 ng, 250 ng, 375 ng, and 500 ng, labeled with a constant amount of tritiated photo-
cholesterol (Figure 2.31). An even lower concentration of 50 ng was skipped after the first 
experiment. 
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Consistent with the previous labeling experiments, UV-crosslinking of [
3
H]-photo-cholesterol 
to cellular protein was identified as strong signals in the input lanes as analyzed by digital 
autoradiography (Figure 2.31 A). Here, probable protein precipitates were visible above the 
lanes, at the positions of the pockets of the SDS-gel. However, these signals did not correlate 
with αFlag signal on the immunoblot which indicated that the protein precipitates did not 
result from the mGluR2 proteins. For the immunoprecipitated samples, a clearly visible signal 
for the photocrosslink was obtained between 125 ng and 500 ng plasmid DNA. No 
background was visible in the immunoprecipitated fraction at 0 ng. For the Flag-tagged 
mGluR2 protein, the signal ratios were stable over the whole range of the tested transfection 
levels when normalized to the labeling efficiency at 500 ng (Figure 2.31 C). In contrast to 
that, mGluR2
C121A
-Flag labeled on average twofold stronger at 125 ng plasmid DNA per well 
and showed a stable labeling efficiency only at between 250 ng and 500 ng. This observation 
was consistent with the cell surface arrival assay for mGluR2
C121A
-Flag in which the lower 
DNA concentration had also shown a stronger phenotype (compare Figure 2.12). This 
observation left two possibilities: either the surface arrival was indeed higher at 125 ng DNA 
per well which allowed more interaction with cholesterol resident in the plasma membrane. 
Or, as previously suggested, the measured effects resulted from quantification artifacts in both 
cases because the signal on the autoradiography and on the immunoblot were too close to the 
background level to allow a reliable quantification. Since the latter case could not be ruled 
out, the lowest concentration at 125 ng was not considered for the further experiments. 
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Figure 2.31 | cDNA titration of mGluR2 
constructs in Hek293 cells. mGluR2-Flag 
and mGluR2
C121A
-Flag were transiently 
expressed in Hek293 cells and labeled for 
17 h with 15 µCi [
3
H]-photo-cholesterol per 
well which was then UV-crosslinked to 
neighbouring proteins. (details see Section 
4.12.1). (A+B) Input (In), flow through (Fl) 
and immunoprecipitated (IP) samples were 
separated by SDS-PAGE. The IP signal in 
the (A) autoradiography and the (B) αFlag 
(Mouse, F1804) signal on the immunoblot 
were quantified as indicated (black arrow 
heads: mGluR2, grey arrow heads: 
ASGPRI). αGAPDH signal was used as 
loading control. (C) Quotient of the 
autoradiography and immunoblot signal at 
DNA concentration x was normalized to the 
quotient at 500 ng. The data are shown as dot 
plot with mean±SEM (n=3) in GraphPad 
Prism. 
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From the titration experiment with was concluded that reproducible measurements for cellular 
photocrosslinking with [
3
H]-photo-cholesterol would be obtained between 125 ng and 500 ng 
for mGluR2-Flag, and 250 ng and 500 ng for mGluR2
C121A
-Flag. Accordingly, the DNA 
concentration was set to 250 ng for the W→A and Y→A mGluR2-Flag variants and 375 ng 
for the mGluR2
C121A
-Flag variants. Thus, for both set of variants the transfection level was 
kept in the middle of the established range. The labeling efficiency was always compared to 
the positive control β2AR-Flag and the negative control ASPGR1-MycFlag. 
For the W→A and Y→A mGluR2-Flag variants the input and the immunoprecipitated 
samples were blotted on separate membranes to get a better signal-to-noise ratio for each of 
them. For the input samples, all protein lanes showed a comparable banding pattern in the 
autoradiography (Figure 2.32 A). After immunoprecipitation, all Flag-tagged proteins showed 
a clearly visible crosslinking signal. For the mGluR2-Flag variants both dimer and monomer 
were labeled with [
3
H]-photo-cholesterol. The strongest signal cholesterol labeling was 
obtained for the positive control β2AR-Flag. The adrenergic receptor labeled 4.1 times 
stronger as compared to mGluR2-Flag wild type (Figure 2.32 C). Among the mGluR2-Flag 
variants, two were significantly decreased in their labeling efficiency: mGluR2
Y745A
-Flag and 
mGluR2
Y781A
-Flag (1Way ANOVA, Dunnetts’ post test, α=0.05). The former one was 
reduced by 30% and the later one by 55% as compared to the wild type. The two mutation 
sites were positioned at the end of helices five and six: Y745A was positioned at the 
cytoplasmic end of helix five and Y781A at the exoplasmic side of helix six (Figure 2.9).  
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Figure 2.32 | Metabolic labeling of mGluR2 
variants with [
3
H]-photo-cholesterol. Different 
mGluR2-Flag variants and controls were 
transiently expressed for 48 h in Hek293 cells. 
The cells were labeled for 17 h with 15 µCi 
[
3
H]-photo-cholesterol, UV-irradiated and Flag-
tagged proteins subjected to 
immunoprecipitation. (details see Section 
4.12.1). (A+B) Input (In), flow through (Fl) and 
immunoprecipitated (IP) protein samples were 
separated by SDS-PAGE. The IP signal in the 
(A) autoradiography and (B) the αFlag (Mouse, 
F1804) signal on the immunoblot were 
quantified as indicated (black arrow heads: 
mGluR2, grey arrow heads: ASGPRI, β2AR). 
αGAPDH signal was used as loading control. 
(C) Quotient of the autoradiography and 
immunoblot signal of protein or variant P was 
normalized to the signal of mGluR2-Flag. The 
data are shown as dot plot with mean±SEM 
(n=5) in GraphPad Prism. Statistics with 1way 
ANOVA (*=P<0.05). 
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The [
3
H]-photo-cholesterol labeling experiment was also performed with the mGluR2
C121A
 
double mutants (Figure 2.33). The mGluR2
C121A
-Flag double mutants were tested with the 
same experimental setup up as the W/Y→A single mutants: The variants were transiently 
expressed for 48 h in Hek293 cells and labeled for 17 h with tritiated photo-cholesterol before 
UV-irradiation and immunoprecipitation of the tagged proteins. 
The input samples showed the same signal pattern in the autoradiography as observed in the 
previous UV-crosslinking experiment with the W→A and Y→A mGluR2-Flag variants 
(compare Figure 2.32 A and Figure 2.33 A). Again, the distinct pattern indicated UV-
crosslinking of functionalized cholesterol with a wide spectrum of cellular proteins. In the 
immunoprecipitation, the labeling controls ASGPRI-MycFlag and β2AR-Flag showed the 
same labeling efficiencies as measured in the first assays (compare Figure 2.32 C and Figure 
2.33 C). The negative control ASGPRI-MycFlag exhibited a normalized labeling efficiency of 
about 3% as compared to 2.6% in the previous experiments. The positive control β2AR-Flag 
was on average 4.1-fold increased in comparison to mGluR
C121A
-Flag, while it had been 4.3-
relatively to mGluR2-Flag. Concerning the immunoprecipitated mGluR2
C121A
-Flag W→A 
and Y→A variants, the labeling of the monomer appeared to be more efficient than for dimers 
(Figure 2.33 A+B). This can be explained by more efficient separation of dimers in the 
absence of the covalent intermolecular disulfide bridge (compare to Figure 2.16); the 
immunoblot showed that monomers were the prevalent signal on the blot. However, the 
average labeling efficiency was only reduced significantly for variant mGluR2
C121A/Y781A
-Flag 
(1Way ANOVA, Dunnetts’ post test, α=0.05) (Figure 2.33 C). As in the previous experiment, 
the efficiency was reduced by more than 55 percentage points. In contrast to that, no 
significant reduction was measured for mGluR2
C121A/Y745A
-Flag. 
In the [
3
H]-photo-cholesterol photocrosslinking assays, both single mGluR2-Flag and double 
mGluR2
C121A
-Flag W→A and Y→A variants showed a similar labeling efficiency in nine 
independent experiments (compare Figure 2.32 and Figure 2.33). The strongest reduction in 
the cholesterol photolabeling was observed for the mutation sites Y745A and Y781A in 
helices five and six, respectively, which had been earlier suggested to be involved in 
activation and dimerization of mGluR2 (121). Interestingly, position Y745A coincided with 
the CRAC motif which had been found for the mGluR family (56). 
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Figure 2.33 | Metabolic labeling of 
mGluR2
C121A
 variants with [
3
H]-photo-
cholesterol. Different mGluR2
C121A
-Flag 
variants and controls were transiently expressed 
for 48 h in Hek293 cells. The cells were labeled 
for 17 h with 15 µCi [
3
H]-photo-cholesterol, 
UV-irradiated and Flag-tagged proteins 
subjected to immunoprecipitation. (details see 
Section 4.12.1). (A+B) Input (In), flow through 
(Fl) and immunoprecipitated (IP) protein 
samples were separated by SDS-PAGE. The IP 
signal in the (A) autoradiography and (B) the 
αFlag (Mouse, F1804) signal on the immunoblot 
were quantified as indicated (black arrow heads: 
mGluR2, grey arrow heads: ASGPRI, β2AR). 
αGAPDH signal was used as loading control. 
(C) Quotient of the autoradiography and 
immunoblot signal of protein or variant P was 
normalized to the signal of mGluR2
C121A
-Flag. 
The data are shown as dot plot with mean±SEM 
(n=4) in GraphPad Prism. Statistics with 1way 
ANOVA (*=P<0.05). 
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2.5.3 Cholesterol binding to TM-mGluR2 in molecular dynamics simulation 
The experimental data suggested that point mutations to alanine are not sufficient to disturb 
the trafficking or dimerization of the mGluR2 variants. On the contrary, cholesterol binding 
appeared to be compromised by the mutation sites in the transmembrane helices V and VI 
(Figure 2.32). However, the molecular determinants governing the binding of cholesterol at 
those particular positions, as well as, whether cholesterol binding might be correlated with 
other processes of the receptor (such as conformational changes in the transmembrane 
domain) remained unknown. To tackle this issue, lipid binding to the transmembrane domain 
of mGluR2 was investigated by molecular dynamics (MD) simulation. The MD simulations 
were carried out with the software package GROMACS 2016.x (179-181). They were 
performed in collaboration with the Max Planck tandem group in Computational Biophysics 
at the University of Los Andes in Bogotá (Colombia), directed by Dr. Camilo Aponte-
Santamaría. Within this collaboration, we performed atomistic and coarse-grained simulations 
of the transmembrane domain of mGluR2 (TM-mGluR2) embedded in a fully solvated lipid 
bilayer of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC). The structural 
dynamics of the bilayer and the protein were quantified in the presence and in the absence of 
cholesterol. 
In total, four atomistic and two coarse-grained simulations systems were considered (Section 
2.1.2.2). In the atomistic systems, simulations were performed for TM-mGluR2 embedded in 
a pure POPC bilayer. In addition, the mutants TM-mGluR2
Y745A
 and TM-mGluR2
Y781A
, 
which displayed experimentally a reduced cholesterol binding, were simulated in a POPC 
bilayer containing 15mol% cholesterol. For the coarse-grained simulations, two wild type 
transmembrane domains were initially separated by 7.5 nm while embedded into either a 
POPC or POPC/CHOL15mol% bilayer system for further simulations. 
2.5.3.1 Atomistic molecular dynamics simulations of TM-mGluR2 
Initial positions of the protein were taken from the homology model of TM-mGluR2, after 
adding the neutral caps at the N- and C-terminal ends (Section 2.1.2.2). The TM-mGluR2 
domain was placed in a POPC bilayer with ~145 POPC molecules in each layer (or ~130 
POPC molecules and ~20 cholesterol molecules in each leaflet which corresponded to 
15mol% cholesterol) by using the web-based CHARMM-GUI (85, 86, 182). The bilayer was 
fully solvated by around 25.500 explicit water molecules and sodium chloride to neutralize 
the charge of the protein and to achieve a physiological salt concentration of 0.15 M. The 
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resulting rectangular simulation box had a size of approximately (10x10x11.5) nm (Section 
4.13.2). The CHARMM36 atomistic force field was used for the protein, the TIP3 water 
model for the water molecules, and the default CHARMM parameters for the ions (83). 
Bonded interactions between atoms were considered by harmonic bonds, constraining those 
involving hydrogen atoms with the LINCS algorithms (183). Short-range non-bonded 
interactions were included via a Lennard-Jones potential, which was set to a switching 
distances of 1.0 nm and truncated at 1.2 nm. Electrostatic interactions were treated by using 
the particle mesh Ewald summation technique (184). Neighboring atoms were considered 
though the Verlet Buffer particle-particle scheme (185, 186). The pressure was maintained 
constant by coupling the system to a Berendsen barostat during solvent-equilibration steps 
and Parrinello-Rahman during the production run (187, 188). Used coupling constant for the 
barostat in the equilibration and production run was 5 ps (Table 4.16). For the equilibration, 
temperature coupling was controlled by Berendsen, while for the production temperature was 
kept constant by coupling the system to a Nose-Hoover thermostat (189-191). Used coupling 
constant for the Berendsen and Nose-Hoover thermostat was 1 ps. Accordingly, the 
temperature of the system was fixed to 310 K and the pressure to 1 bar. For the run, 
GROMACS 2016.x was used. Simulations were performed in the BwForCluster MLS&WISO 
of the state of Baden-Württemberg. 
For each of the four atomistic setups (wild type TM-mGluR2 in POPC and wild type TM-
mGluR2, TM-mGluR2
Y745A
 and mGluR2
Y781A
 in POPC/CHOL15mol% ), four independent 
simulations of 500 ns were run in parallel, yielding 2 µs of cumulative simulation time per 
case (8 µs in total). From the first set of simulations in a pure POPC bilayer conformational 
states were extracted that were then used for the next set of simulations in POPC/CHOL15mol%. 
Each production run was preceded by a set of equilibration steps in which the protein and the 
phosphorous atoms of the lipids were position-restrained. The strength of the position-
restrains was gradually decreased during these steps (Table 4.16). 
2.5.3.2 Coarse-grained molecular dynamics simulations 
The coarse-grained simulation were performed by the MARTINI (Ver.2.2) model of TM-
mGluR2 (details see Section 4.13.1). While the atomistic simulations considered every atom 
of the system, each MARTINI bead represented four heavy atoms (=non-hydrogen) classified 
as polar, nonpolar, apolar or charged bead (84). The protein, the lipids, the water molecules, 
and ions were treated by considering such mapping. The coarse-grained model of the TM-
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mGluR2 was obtained by martinize.py script (192, 193). In addition, an elastic network was 
imposed on all the protein beads to maintain its secondary and tertiary structure. The elastic 
network was imposed to all beads separated by at least 2 beads and within a distance of 
0.9 nm (Rubber force constant of 500 kJ/mol*nm). The adjacent beads were connected by 
bonds and angels of the force field Martini22 (non-polarized water) (193). Two TM-mGluR2 
monomers were placed in a rectangular box of (15x15x12) nm with their center of masses 
placed 7.5 nm apart. The two monomers were embedded in a fully solvated POPC or 
POPC/CHOL15mol% bilayer using the INSANE command (87) (Section 4.13.3). Sodium 
chloride at a concentration of 0.15 M was added to the system and an excess of 24 chloride 
ions compensated the net charge of the protein. 10% of anti-freezing beads was added to the 
solvent to prevent its crystallization. Short-range interactions were treated by a Lennard-Jones 
potential with a cutoff of 1.1 nm and shifted to zero within 0.9 and 1.1 nm. Electrostatic 
interactions were considered via a reaction-field scheme with the Coulomb potential truncated 
at a distance of 1.1 nm, shifted to zero between 0 and 1.1 nm, and with a dielectric constant of 
15 beyond 1.1 nm. Neighbor beads were updated through the Verlet Buffer particle-particle 
scheme (186). An energy minimization and a 10 ns solvent relaxation step preceded the 
production runs (Table 4.17). During the relaxation the protein was kept fixed with position-
restraints (Position restrain force constant 1000 kJ/mol*nm) and the equations of motion were 
integrated at discrete time steps of 10 fs. The position-restraints were removed and 99 
production runs, of 5 µs each, were generated for the POPC system and 100 for the 
POPC/CHOL15mol%  system. In the production runs, equations of motion were integrated at a 
time step of 20 fs. All production runs accounted for 0.95 ms of cumulative simulation time. 
2.5.3.3 Basic physical parameters of the Molecular dynamics simulation  
Four global observables have been computed from the simulations to get insight into the 
stability of the simulation system. These observables are pressure, temperature, simulation 
box volume and density (details of the calculation of these parameters see Section 4.13.4).  
Despite of the use a semiisotropic Parrinello-Rahman barostat, the pressure displayed high 
fluctuations over the course of the simulations (Figure 2.34 A). This is a common behavior of 
MD simulations. In any case, and despite of these high fluctuations, the mean value 
approached the reference pressure of 1 bar. In the coarse-grained systems the average pressure 
was 1.018 bar and 1.012 bar for the POPC and POPC/CHOL systems, respectively (Figure 
2.34 A). In the all atom simulation, the POPC bilayer systems exhibited an average of 
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1.018 bar. In the systems with 15 mol% cholesterol, the pressure had an average of 1.056 bar 
for the wild type, 0.900 bar for TM-mGluR2
Y45A
 and 1.170 bar for TM-mGluR2
Y781A
. The 
high fluctuations in the pressure are related to the rapid changes in the position of the atoms 
due to thermal collisions. Accordingly, the pressure oscillations were larger in the atomistic 
systems than in the coarse-grained systems. 
The temperature was also controlled by coupling the system to a thermostat. This in practice 
implied a rescaling of the velocities of the atoms (beads in the coarse-grained simulations) to 
attain a reference temperature (here 310 K or 37°C). In all systems the 25th to 75th 
percentiles of the temperature were rather narrow and covered the reference temperature: 
Around (308-311) K for the coarse-grained and (309-310) K for the atomistic simulations 
(Figure 2.34 B). In contrast to the pressure, the fluctuation in the temperature was higher for 
the coarse-grained systems than for the atomistic systems. 
The other parameters, density and volume, showed only small changes within a narrow inter-
quartile distance (Figure 2.34 C+D). The densities for the atomistic systems were in all 
simulation approaches quantified with a mean of 1017 kg/m
3
 with half of the values 
distributed between 1016 kg/m
3
 and 1019 kg/m
3
 (Figure 2.34 C). In the coarse-grained 
systems, the intervals between the first and third quartile around the mean densities of 
1059 kg/m
3
 were comparably narrow. Thus, the density showed differences between the force 
fields but within the atomistic and coarse-grained sets the values were stable. For the volume, 
the box sizes of the coarse-grained systems were larger as compared to the all atom systems 
because they harbored two instead of one TM-GluR2 domain. The former had a box size of 
approximately (15x15x12) nm in x,y,z-direction, and the averaged volume was 2537.4 nm
3
 
for the POPC system and 2483.8 nm
3
 for the boxes with cholesterol. Compared to the starting 
volume of 2700 nm
3
 both systems were shrunken in the equilibration. The same was observed 
for the atomistic systems, which had an initial box size of (10x10x11.5) nm or 1150 nm
3
. For 
the POPC systems, 1144.3 nm
3
 were measured as averaged volume, while for TM-mGluR2 
and the mutants the values were fluctuating in a narrow range around 1125 nm
3
 (Figure 
2.34 D). 
Hence, from these four observables we can be certain that the simulated systems were overall 
stable, with the size and density maintained relatively constant, while controlling the pressure 
and temperature. 
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Figure 2.34 | Global observables of the indicated systems recovered from MD simulations. The box-whisker 
plots represent the physical properties of the simulation box during the production run of the simulation. Both 
coarse-grained and all atom systems were controlled by semiisotropic pressure coupling (Parrinello-Rahman 
barostat). The values were retrieved from the systems by GROMACS ‘gmx energy’ for (A) pressure, (B) 
temperature, (C) density and (D) volume (details see Section 4.13.4). The values are presented as box-whisker 
plots for n=4 (all atom) or n=99/100 (coarse-grained) independent simulations considering the whole trajectory. 
The values were plotted as Tukey box plot in RStudio with ggplot2. The boxes indicate the 25th and 75th 
percentiles, the whiskers 1.5 times the inter-quartile distance. The bar in the middle shows the median value. 
2.5.3.4 Lipid density and deuterium order parameters 
The characteristics of the membrane were quantified with GROMACS 2016.x to find out 
about the stability of the bilayer system and the behavior of the lipids in the simulation box. 
The lipid membranes in the atomistic simulation systems showed a stable distribution for the 
membrane and soluble components (Figure 2.35 A+C). The water penetrated into the 
membrane approximately to the spatial extent of the POPC headgroups. The density of the 
POPC acyl chains peaked not at the center of the membrane in z-axis, but at a distance of 
1 nm from the membrane core. In the simulation including cholesterol, these molecules were 
found to be embedded within the acyl chains and showed a similar distribution (Figure 
2.35 C). Notably, the Deuterium order parameter in the simulations with cholesterol peaked 
around a value of 0.263±0.001 for SN1 at carbon index 5, while at the same position an 
averaged value of 0.221±0.001 was measured in the POPC simulations (Figure 2.35 B, Figure 
2.35 D). However, the inclusion of cholesterol did not substantially modify the trend observed 
for the order parameters of SN1 and SN2. In the core of the membrane the Deuterium order 
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parameter for the SN2 acyl-chain was in both systems somewhat lower as compared to that of 
the SN1 acyl chain; at carbon index 7 an averaged value of 0.121±0.001 was measured for 
SN2 as compared to 0.257±0.001 for SN1 in the POPC/CHOL bilayer (Figure 2.35 B+D). 
This reduction in the order for SN2 may be attributed to the difference in saturation between 
these two chains. While the palmitoyl moiety is saturated, the oleoyl at SN2 contains a cis-9 
double bond which is most likely the reason for the low Deuterium order parameter here. 
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Figure 2.35 | Lipid distribution in the simulation box and Deuterium order parameter of acyl chains. The 
parameters were calcualted for the atomistic simulations of TM-mGluR2 in a POPC bilayer in the (A+B) 
absence and (C+D) presence of 15mol% cholesterol. (A+C)The density distribution as as a function of the 
coordinate normal to the membrane (Z-axis) is presented for the indicated lipid moieties and water. The values 
were calculated with GROMACS ‘gmx denisty’ (details see Section 4.13.6.1). The mean density was plotted as 
line and the SEM as ribbon (n=4). (B+D) The deuterium order parameter (-SCD) as function of the acyl chain 
carbon index is presented. It was calculated separately for the SN1 and SN2 acyl chains of POPC with 
GROMACS ‘gmx order’ (details see Section 4.13.6.2). Here, the -SCD is presented as mean±SEM connected by 
lines (n=4). The double bond of the unsaturated oleoyl chain is located between the 9
th
 and the 10
th
 carbons, 
which is here carbon index 7 and 9. 
Similar observations were made for the coarse-grained simulations of TM-mGluR2 (Figure 
2.36). The density profile for the membrane components showed an even distribution of the 
water phase at either site of the membrane with the same bimodal distribution for the acyl 
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chains as observed for the atomistic simulations. In contrast to the atomistic simulations, the 
acyl chains peaked at ~1000 kg/m
3
 and thus at the same density as the water phase. Also, the 
water appeared to penetrate slightly less into the headgroups of POPC as compared to the all 
atom systems: the density curve declined earlier than the one of the POPC headgroups. As 
observed before for the Deuterium order, the palmitoyl chain at position SN1 showed a higher 
order than the oleoyl at position SN2 (Figure 2.36 B+D). Compared to the atomistic 
simulation, the difference between the two acyl chains was less well resolved due to the 
coarse-graining (Figure 2.35 B+D, Figure 2.36 B+D). 
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Figure 2.36 | Lipid distribution in the simulation box and Deuterium order parameter of acyl chains. The 
parameters were calcualted for the coarse-grained simulations of TM-mGluR2 in a POPC bilayer in the (A+B) 
absence and (C+D) presence of 15mol% cholesterol. (A+C)The density distribution as as a function of the 
coordinate normal to the membrane (Z-axis) is presented for the indicated lipid moieties and water. The values 
were calculated with GROMACS ‘gmx denisty’ (details see Section 4.13.6.1). The mean density was plotted as 
line and the SEM as ribbon (n=99/100) (B+D) The deuterium order parameter (-SCD) as function of the acyl 
chain beads is presented. It was calculated separately for the SN1 and SN2 acyl chains of POPC with do-order-
gmx5.py (details see Section 4.13.6.2). Here, the -SCD is presented as mean±SEM connected by lines (n=99/100). 
The double bond of the unsaturated oleoyl chain is located between the 9
th
 and the 10
th
 carbons, which is here 
represented by bead D2. 
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In the coarse-grained system, the presence of cholesterol appeared to influence the palmitoyl 
moiety stronger than the oleoyl (Figure 2.36 B+D). For oleoyl at SN2, the first two beads did 
not show major differences in the order parameters with averages of ~0.52 and ~0.42-0.44 in 
both systems. Only the beads in the core of the membrane showed a higher order parameter in 
the presence of cholesterol, which sifted the averaged values from 0.228 to 0.275 and 0.180 to 
0.224 for the third and fourth bead in the chain, respectively. In contrast to that, the 
Deuterium order parameter for palmitoyl increased for all beads when cholesterol was 
present. 
Finally, the lateral diffusion constant of the POPC lipids was calculated by a linear fit through 
the mean square displacement (MSD) over time for the phosphate groups (Figure 2.37). For 
the system containing only POPC, the diffusion constant estimated for the coarse-grained 
system was about tenfold higher than the one measured in the atomistic system: the mean 
values calculated here were 0.0550x10
5
 cm
2
/s and 0.0068x10
5
 cm
2
/s, respectively. Because 
the diffusion estimate depends on the size the simulation system, comparisons between 
estimates of different systems or from experiments is difficult (194). However, relative 
differences due to the presence of cholesterol can still be assessed. For both systems the 
diffusion constant was reduced in the presence of cholesterol, by about 25% to on average 
0.0416x10
5
 cm
2
/s and 0.0049x10
5
 cm
2
/s for coarse-grained and atomistic systems, 
respectively (Figure 2.37). This result was expected, as it is known that cholesterol rigidifies 
lipid membranes, thereby reducing the overall lateral diffusion in the system (195, 196). 
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Figure 2.37 | Lateral diffusion constant of POPC lipids recovered from MD simulations. The lateral 
diffusion constant was calculated by least squares fitting the linear relationship (D*t+c) through the mean square 
displacement of POPCs’ phosphate groups with GROMACS ‘gmx msd’ (details see Section 4.13.6.3). (A) The 
diffusion constant is presented for the four indicated systems, simulated atomistically: TM-mGluR2 in POPC 
bilayer (Wt POPC), TM-mGluR2 in POPC/CHOL15mol% bilayer (Wt POPC/CHOL), TM-mGluR2
Y745A
 in 
POPC/CHOL15mol% bilayer (Y745A POPC/CHOL), and TM-mGluR2
Y781A
 in POPC/CHOL15mol% bilayer (Y781A 
POPC/CHOL). The bar plots in R represent mean±SEM from n=4 independent simulations. (B) For the coarse-
grained simulation, the diffusion constant is presented for a pure POPC and a mixed POPC/CHOL15mol% bilayer. 
The bar plots in R represent mean±SEM from n=99 (POPC) and n=100 (POPC/CHOL) independent simulations. 
2.5.3.5 Protein dynamics during the MD simulations 
We next investigated the stability and movement of the protein during the simulation. The 
stability could be assessed by computing the root mean square deviation (RMSD) from the 
initial conformation, the root mean square fluctuation (RMSF) for each amino acid residue of 
TM-mGluR2 and the radius of gyration of the protein. 
The radius of gyration (gyration) for the TM-mGluR2 was found to be approximately 2 nm 
(Figure 2.38 A). Interestingly, only small differences were observed between the atomistic 
and the coarse-grained simulations. Thus in both systems the protein kept a steady value for 
the gyration over time which argued for their compactness and integrity throughout the 
simulation. 
The RMSD was calculated for all given conformation compared to the reference structure at 
tS=0 ps. In the atomistic simulations, the RMSD was on average 0.38 nm in the first 
simulation in POPC and reduced by about 20% in the later simulation in POPC/CHOL15mol% 
(Figure 2.38 B). That observation can be explained by the fact that the structures for the run in 
POPC/CHOL15mol% were extracted from the most occupied structures in the POPC system. 
Thus the structures in the second set were already equilibrated 500 ns. The RMSD was of the 
order of 0.25 nm in the coarse-grained simulations and showed a very small error (Figure 
2.38 B). This can be explained by the fixation of the secondary and tertiary structure by the 
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elastic network (197) (Section 2.5.3.2). Both estimates are reasonable given that they come 
from a homology model. 
A B 
  
 
Figure 2.38 | Quality estimates for the TM-nGluR2 homology model in the MD simulations. The radius of 
gyration and the root mean square deviation (RMSD) were calculated with GROMACS ‘gmx gyration’ and 
‘gmx rms’ (details see Section 4.13.5). (A) Radius of gyration and (B) RMSD of TM-mGluR2. The values for 
the radius of gyration and the RMSD were averaged over n=4 trajectories for the atomistic simulations and 
n=99/100 simulation for the coarse-grained simulations. The values for the two protomers in the coarse-grained 
simulations were calculated and plotted seperately. The results are shown as mean±SEM. 
While the RMSD is a measure for the overall movement of the protein, the Root mean square 
fluctuation (RMSF) is a measure for the movement of single amino acid residues. The 
comparison between the atomistic simulation of TM-mGluR2 in a POPC bilayer in the 
presence and absence of cholesterol showed that the movement was slightly more restricted in 
the presence of cholesterol, as seen already for the RMSD (Figure 2.39 A). Here, the RMSF 
analysis revealed that the motion of the protein was not equally pronounced for all the 
residues but was especially strong for the intra- and extracellular loops between the helices; 
for the second intracellular loop between helices III and IV, as well as the for the second 
extracellular loop between the helices IV and V a strong fluctuation was observed (Figure 
2.39 A). Interestingly, also transmembrane helix VI showed a higher flexibility at the 
extracellular site which propagated into the third extracellular loop. 
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Figure 2.39 | Root mean square fluctuation analysis of TM-mGluR2 in atomistic systems. The graphics 
show the Root mean square fluctuation (RMSF) analysis for TM-GluR2 as calculated with GROMACS ‘gmx 
rmsf’ (details see Section 4.13.5). (A) For the first analysis, the RMSF values per amino acid residue were 
compared between TM-GluR2 in a POPC bilayer in the presence and absence of cholesterol. (B) For the second 
analysis, the RMSF was calculated for TM-mGluR2 variants in a POPC bilayer with 15mol% cholesterol. The 
plots represent the RMSF per amino acid residue for TM-GluR2 and its two mutants Y745A and Y781A. 
(A+B) The RMSF were calculated for each trajectory separatly and averaged over the whole set of simulations. 
The helices are indicated on top of the chart. The mean was plotted as line and the SEM as ribbon. 
Next, a comparison was made between the RMSF measured for the protein in a POPC bilayer 
with 15mol% cholesterol. Here, the atomistic simulations of the wild type and the two 
designated cholesterol binding mutants TM-mGluR
Y745A
 and TM-mGluR
Y781A
 were compared 
(Figure 2.39 B). The comparison of the RMSF values showed that flexibility of the single 
residues had a similar pattern similar for the wild type TM-mGluR2 and its Y781A mutants. 
Differences between the simulations were seen for the upper end of transmembrane helix VI 
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where Y781A appeared to be slightly more flexible. Larger differences were seen for TM-
mGluR2
Y745A
 which was less flexible as compared to the wild type and TM-mGluR2
Y781A
. 
The RMSF for the second and third extracellular loop was lower which indicated a slightly 
lower flexibility of the transmembrane domain in these parts after introducing the mutation. 
The RMSD analysis had suggested that the protein structure in the coarse-grained simulations 
was more stable because of the artificially fixed secondary and tertiary structure. A similar 
picture showed for the comparison of the RMSF between the atomistic and coarse-grained 
simulations in POPC (Figure 2.40). The RMSF for the coarse-grained simulations was with 
values below 0.3 nm for most structural components on average lower than for the atomistic 
simulation. However, one striking similarity between the two structures was the flexibility in 
the 2
nd
 intracellular loop (between helices III and IV). Both the atomistic and the coarse-
grained structure showed flexibility in this region. In contrast to that, the flexibility in the 2
nd
 
extracellular loop was not well resembled in the coarse-grained model. Also the upper half of 
helix 6 and the 3
rd
 extracellular loop did not exhibit the flexibility of the all atom simulation. 
The RMSF calculated here might be underestimated it was calculated not calculated from a 
concatenated trajectory, but separately for each and averaged of the set of simulations. 
 
Figure 2.40 | Comparison of TM-mGluR2 in atomistic and coarse-grained simulations. The graphics show 
the analysis for TM-GluR2 in a POPC bilayer. The data for the RMSF analysis were sampled with GROMACS 
‘gmx rmsf’ for each trajectory separatly and averaged over the whole set of simulation (details see Section 
4.13.5). The averaged RMSF are shown as line for the TM-mGluR2 in the all atom (blue, n=4) and coarse-
grained (orange, n=99) simulation setup with the SEM as grey ribbon. The helices are indicated on top of the 
chart. 
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The different parameters here suggested that the transmembrane model of mGluR2 had 
remained stable throughout the simulations. In the next step the interaction between the 
membrane resident cholesterol and the surface of the protein would be calculated. 
2.5.3.6 Cholesterol binding to the protein surface 
Finally, the localization of cholesterol around TM-mGluR2 was monitored. The time-average 
density map of cholesterol was computed to determine regions frequently occupied by these 
molecules. This map was calculated with the GROmaps toolset (198). The density was 
contoured at different confidence levels (Figure 2.41). This calculation revealed a large 
cholesterol density around transmembrane helices I and VII. Because of its size, this density 
region was indicative of unspecific positioning of cholesterol at these sites. The size of this 
density region remained visible throughout several density levels, further ensuring the 
unspecific nature of this region. The interaction site correlated well with the observations 
which had been made in the crystal structure of the transmembrane domain of mGluR1 (71): 
in the crystal structure six cholesterol molecules had been between the dimer interface around 
mirrored interface between helices I. In addition to that, this very large density region, four 
smaller density patches were observed: on at the cytosolic end in the cleft between helices I 
and IV, one at the extracellular half of helix IV, one at the intracellular patch of helix V and 
finally one in the extracellular leaflet around helix VI. The first two cholesterol density sites 
at the cytosolic cleft between helices I and IV, as well as the one on helix VI were still visible 
at 4σ. The density at the intracellular end of helix V was still visible at 3σ but then shrank at 
4σ. Furthermore, the shape of densities approximately resembled the size of a single-
cholesterol molecule as the confidence level increased. Thus we conclude from this 
calculation that single cholesterol molecules accommodated specifically at least three places 
on the surface of TM-mGluR2. 
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 Figure 2.41 | Time-averaged density map 
of cholesterol TM-mGluR2. The cholesterol 
density was calculated with the GROmaps 
toolset (198). With GROmaps a cholesterol 
density map was built for a proximity of 
0.8 nm around the surface of the protein 
(details see Section 4.13.7.2). The density is 
contoured as the white surface at different 
density levels (in standard deviation, sigma 
units). The background average density has 
been set to zero. The protein is depicted in 
cartoon representation, coloring the helices 
according to the labels at the top. Two 
orientations are shown for each density level. 
We next investigated the change on the accommodation of cholesterol due to mutation of the 
tyrosines 745 and 781 by alanine (Figure 2.42). The large unspecific density around the 
helices I and VII and the density on the cytosolic site between helices I and IV were still 
visible for all variants even though the shape seemed to vary between the wild type and the 
mutants. In contrast to that, the density near helix IV, V, and VI altered for TM-mGluR2
Y745A
 
and TM-mGluR2
Y781A
, as described as follows. For TM-mGluR2
Y745A
, the density on front of 
helix IV got smaller and the one at the lower end of helix V disappeared. The density at the 
exoplasmic side of helix VI got more smeared out. For Y781A, both regions of localized 
density around helices IV and V were lost. The density around helix VI split in two distinct 
density regions, presumably corresponding to two positions occupied by cholesterol in the 
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course of the simulations. The alterations in the localization of cholesterol due to the mutants 
observed in the simulations is consistent with the experimental of the in vivo labeling with 
[
3
H]-photo-cholesterol in which the labeling efficiency for the two variants in the full length 
protein had decreased (compare Figure 2.42 and Figure 2.32). Interestingly, the exchange of 
one of the residues in helices five and six also appeared to change the density at other sites of 
the protein suggesting an allosteric mode of alteration for this particular mutant. 
 
 Figure 2.42 | Time-averaged density map 
of cholesterol density at the surface of 
wild type TM-mGluR2 and its two 
mutants Y745A and Y781A. The 
cholesterol density was calculated with the 
GROmaps toolset (198). With GROmaps a 
cholesterol density map was built for a 
proximity of 0.8 nm around the surface of 
the protein (details see Section 4.13.7.2). 
The density is contoured as the white 
surface at a density level of 2σ (in standard 
deviations). The background average 
density has been set to zero. The protein is 
depicted in cartoon representation, coloring 
the helices according to the labels at the top. 
The approximated mutations sites for 
Y745A and Y781A are indicated with a red 
star in helices V and VI respectively. Two 
orientations are shown for variant level. 
We next monitored the localization of cholesterol in coarse-grained simulations (Figure 2.43). 
As the sampling increased, new features on the localization of cholesterol emerged. The large 
density region, previously observed in the atomistic simulations, in front of helices I and VII 
was less pronounced in the coarse-grained simulations (compare Figure 2.43 and Figure 2.41). 
In contrast to that, the density around helices II, III and IV had fused into one big batch and 
unspecific density region. 
Most importantly, the region identified to specifically interact with cholesterol near helices V 
and VI also displayed a well-defined portion of density in the coarse-grained simulations, 
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which could be related to one or at the most two cholesterol molecules sitting at that region. 
Notably, the density at helix V was shifted into the middle of the membrane and the helix as 
compared to the atomistic simulations (Figure 2.43, Figure 2.41). Moreover, in the coarse-
grained simulations two TM-mGluR2 protomers were considered and they often dimerized. 
Of note, dimerization did not affect the density around V and VI. Smaller changes were seen 
around helix I, which had shown to be at the dimerization interface in the mGluR1 X-ray 
structure (71). Overall, our coarse-grained simulations were consistent with the existence of 
this specific binding site for cholesterol near V and VI. 
 
 Figure 2.43 | Cholesterol density 
(99.9%) for the mGluR2 wild type 
transmembrane domain in coarse-
grained simulation. The cholesterol 
density was calculated with the 
GROmaps toolset (198) With 
GROmaps a cholesterol density map 
was built for a proximity of 0.8 nm 
around the surface of the protein 
(details see Section 4.13.7.2). The 
density is contoured as the white 
surface at a density level of 4σ (in 
standard deviations). The background 
average density has been set to zero. 
The protein is depicted in cartoon 
representation, coloring the helices 
according to the labels at the top. Two 
orientations are shown for each 
variant. 
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3 Discussion 
In this work the lipid environment of the G-protein coupled receptor (GPCR) mGluR2 was 
probed for covalent lipid modifications and the non-covalent lipid interactions. In the current 
experimental setup, there was no indication for S-palmitoylation of mGluR2. To study the 
non-covalent lipid interactions of mGluR2 a site-directed mutagenesis approach was chosen. 
It was shown that mutations at position Y745A in transmembrane helix V and Y781A in 
transmembrane helix VI of mGluR2 caused a significant reduction in the steady-state 
interaction with [
3
H]-photo-cholesterol in a photocrosslinking assay in Hek293 cells. At the 
same time, these protein variants did not show alternations in intracellular trafficking or 
dimerization as compared to the wild type. Thus the loss of cholesterol binding most likely 
originated from a direct binding defect. Interaction of the mGluR2 transmembrane domains 
with cholesterol was further probed in a molecular dynamics (MD) simulation both in an 
atomistic and coarse-grained force field. The analysis of the cholesterol interaction showed 
that for the mGluR2 transmembrane domain (TM-mGluR2) cholesterol density was sampled 
next to the tyrosine residues at position 745 and 781. A simulation of the mutated 
transmembrane domains TM-mGluR
Y745A
 and TM-mGluR2
Y781A
 showed that the cholesterol 
density blurred out at the adjacent but also around distal sites. In contrast to the cholesterol 
binding experiments, a similar setup with [
3
H]-photo-sphingosine ([
3
H]-photoSph) did not 
deliver any conclusive results. The data showed that in contrast to the working hypothesis 
sphingolipid binding to the receptor was overall rather weak, and in some cases even 
increased when introducing the point mutations W697A or Y734A in helices IV or V of the 
transmembrane domain of mGluR2. 
3.1 Experimental system 
The basis of the experimental studies was the wild type Hek293 cell line – human embryonic 
cell line immortalized with adenovirus fragments (199). For the mGluRs the Hek293 system 
has been utilized many times, for other GPCRs –such as adrenergic and serotonin receptors – 
Hek293 cells are just one among other expression systems. While the mGluRs showed a 
robust detection in the immunoblot and correct shuttling to the cell surface in Hek293 cells, 
this was not the case for family A GPCRs. The results of this work suggested that 
improvements might be possible both on the side of the expression system, for example by 
including a second cell line as comparison, and on the side of the plasmid constructs of family 
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A GPCRs, for example by introducing artificial signal peptides for a more efficient ectopic 
expression. 
3.1.1 Metabotropic glutamate receptors in Hek293 cells 
First characterizations of the mGluR family as well as the isolation of the first mRNA 
sequences was conducted in a neuronal context (200). The sequence of the first receptors was 
cloned from neuronal rat tissue (201, 202). Likewise, many studies concerning the physiology 
of mGluRs have mainly addressed the function of the mGluRs in neurons. However, many 
studies concerned with the biochemistry of the receptors were conducted in ectopic 
expression systems. For example early studies on the homodimerization of mGluR1 and 
mGluR5 were performed in the context of Hek293 cells (132, 203). Also later studies 
concerned with heterodimerization within the mGluR family and intramembranous 
dimerization of mGluR2 were conducted in the cell line (121, 131). Furthermore, the Hek293 
cells were used for protein-lipid interaction, such as for mGluR1α, or even pharmacological 
studies (56, 204). For that reason the cell line had been chosen as expression system. 
Hek293 cells originate from human embryonic kidney tissue (199, 205). Hek293 cells express 
Homer proteins which have been investigated in a neuronal context, however, their function 
in kidney derived cell is not completely understood (206). Different Homer proteins were 
shown to bind to the extreme C-terminal end of group I mGluRs, namely isoforms mGluR1α 
and mGluR5a, which contain a proline-rich PPxxFR motif (207). Binding of one specific 
isoform, Homer1b, let to retention of receptors in the endoplasmic reticulum (208). It was 
shown in the thesis that all mGluRs were expressed at the surface of the Hek293 cells, but the 
cell surface arrival of mGluR1α was quantified with an average of 30%, about 15 percentage 
points lower compared to mGluR2 (Figure 2.20). Here, the presence of Homer proteins, such 
as Homer1b, could explain a depressed surface arrival. On the contrary, the surface 
expression for mGluR4 was on average 27%, but the receptor does not contain any known 
Homer binding sequence and no definite explanation can be given for that difference. 
However, there many more proteins that can interact with mGluRs (116). This includes 
kinases and ubiquitin ligases among others. The quantification of the surface arrival in the 
steady state might be especially dependent on the former one. For group III mGluRs it was 
shown that phosphorylation by Protein kinase A inhibits the function of the receptors by 
suppressing the coupling with GTP binding proteins (142). In contrast to that, in studies with 
GABABR2 it was found that phosphorylation of the receptor by Protein kinase A results in a 
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reduced desensitization and a stabilization of cell surface expression (209). How cell surface 
expression of other family C GPCRs is affected by phosphorylation is only poorly understood 
but might contribute to the observed differences in cell surface localization of mGluRs. Also 
other post-translational modifications in Hek293 cells could influence the surface expression 
of mGluRs: The expression level of mGluR1α was shown to depend on the presence of a 
ubiquitin ligase, the RING-finger-containing E3 ubiquitin ligase Siah3 (144). Notably, the 
effect of the overexpression was also dependent on the cell type: At the same transfection 
level, the receptor appeared to more prone to degradation in COS-7 and BHK-21 cells than in 
Hek293 cells. In Hek293 cells again only group I mGluRs were targeted by Siah3 for 
degradation (144). Thus, it might worth to consider conducting the biochemical experiment in 
two unrelated cell lines to account for cell type specific effects, which might depend on the 
expression pattern of interacting proteins. 
For mGluR2 not only the surface arrival for one given plasmid DNA concentration was 
investigated, but a titration of DNA amounts used for transient transfection was performed to 
exclude artifacts originating from the transfection level. The transfection level was dependent 
on the DNA concentration as shown by flow cytometry (Figure 2.11). The flow cytometry 
experiment showed a decrease in transfection efficiency with decreasing DNA concentration. 
Thus at low DNA concentration only few cells expressed the construct. However, it was 
shown that cell surface expression of Flag-tagged mGluR2 and mGluR2
C121A
 was surprisingly 
stable at different transfection levels (Figure 2.12). This also held true for the different W→A 
or Y→A variants (Figure 2.13). From that data it was concluded that the transfection level 
was comparable for different mGluR2 variants. The DNA amounts used for transient 
transfection had only a minor influence on the cell surface expression and came only into 
effect at very low plasmid amounts. 
The problem of the transfection efficiency has not seen much discussion in the literature. A 
comparison of different non-viral transfection reagents showed that FuGENE HD was suitable 
for a wide range of cell lines, even though Hek293 cells were not among them (210). Here, 
the transfection efficiency was studied only in terms of enzyme activity of luciferase which 
did not return any information about the percentage of transfected cells. The supplier of 
FuGENE HD, Promega, suggested in a recent electronic article on its website by Hook and 
Landreman (211) that FuGENE HD might very suitable for HeLa cells but not recommended 
for Hek293 cells. With this information future experiments might designed more rational. 
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3.1.2 Other GPCRs in Hek293 cells 
The adrenergic and serotonin receptors investigated in this work were also expressed in 
Hek293 cells. As reviewed for the mGluR receptors in the previous section, these two 
receptor families were biochemically characterized in many cases using ectopic expression 
systems. For the adrenergic receptors, Saunders and Limbird (212) have reviewed several 
studies in COS-7, MDCKII and Hek293 cells among others. Comparison of different studies 
revealed that some effects were dependent on the cell type, including agonist triggered 
receptor internalization in CHO and Hek293 cells. However, even though Hek293 cells might 
not be the most common cell type used to study adrenergic receptors, several investigations, 
such as receptor S-palmitoylation or activation mechanism, have been partly conducted in this 
cell line (213-215). Many investigations on the function of adrenergic receptors were also 
performed in the insect cell line Sf9, including studies on ER targeting and pharmacological 
assays (25, 153, 215). Furthermore, the insect cells were also used for the investigation of S-
palmitoylation of the serotonin receptors 5-HT-1A and -4A (176, 216). Later also mammalian 
cell lines were included, such as mouse N1E-115 neuroblastoma cells, to study receptor 
oligomerization, agonist response and raft localization (26, 217). Overall, as for the 
adrenergic receptors, Hek293 cells are one of several ectopic expression systems used for 
serotonin receptors (218). 
The adrenergic and serotonin receptors were expressed from pCMV6 vector, which had been 
already used for the cloning of the mGluRs. In the thesis two different version of the Flag-
tagged β2AR were used: one with a C-terminal Flag-tag which corresponded to the C-
terminally Flag-tagged mGluR versions and one N-terminally Flag-tagged variant (Figure 
2.4). The N-terminally tagged variant contained an artificial signal peptide in front of the 
Flag-tag which was not present in the wild type (compare UniProt P07550, (104)). For most 
experiments the C-terminally tagged version was used to detect only fully translated proteins. 
Just in one experiment the two variants were directly compared to evaluate if there were 
differences in the cellular photocrosslinking assay with [
3
H]-photo-cholesterol (Figure 2.30). 
The C-terminally tagged variant was detected on the immunoblot as smear between 37-
50 kDa and 75-100 kDa, suggesting the presence of different oligomeric states of the receptor 
(Figure 2.20). For the N-terminally tagged version the signal of the αFlag immunoblot was 
more distinct and only one broad signal between 37-50 kDa was clearly visible (Figure 
2.30 A). In the input samples, only two bands were visible for the N-terminally tagged version 
while for the C-terminally tagged protein additional bands with lower apparent molecular 
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weight were detected. Thus, N-terminal tagging might have allowed for the detection of C-
terminal degradation products. Indeed such an observation was made for an N- and C-
terminally tagged human beta1-Adrenergic receptor (219). Here, C-terminal tagging allowed 
for the detection of various degradation products which originated from N-terminal 
degradation by metalloproteinase (219). [
3
H]-photo-cholesterol labeling showed a similar 
patterns for the N- and C-Flag tagged variants: A presumably monomeric band around 45 kDa 
and a broad smear between 50 kDa and 75 kDa (Figure 2.30 A). Thus the different banding 
pattern visible on the immunoblot might simply result from different reactivity of the αFlag 
antibody due to the presence or absence of the terminal tags. 
For the C-terminal Flag-tagged variant, various bands had been detected for the monomeric 
β2AR (Figure 2.30). An enzymatic deglycosylation experiment showed that the diffuse band 
pattern observed in the immunoblot was mainly due to different glycosylation stages (Figure 
2.21). Both the digestion with EndoH and PNGaseF resulted in a shift of the smear into two 
bands: one at an apparent molecular weight of 40 kDa and one at 80 kDa. This EndoH 
sensitivity argued for poor modification with complex N-glycans. The cell surface 
biotinylation assay pointed into a similar direction, as relatively few receptors were found 
localized to the cell surface (Figure 2.20). Of the cell surface localized pool of the receptor 
only the slower migrating bands were visible. What was the reason for the observed pattern? 
The absence of a cleavable signal peptide might result in an inefficient translocation into the 
endoplasmic reticulum (ER). It was shown that ectopic expressed β2AR can be stabilized by 
introduction of an artificial signal peptide (153). Without artificial signal peptide the pattern 
for the β2AR looked similar for the monomer as in the current thesis (153). This is in contrast 
to the findings that only a long and/or rapid folded N-terminal ends as well as charged amino 
acid residues require the presence of a signal peptide (220, 221). This suggests that there are 
also other factors involved in efficient translational and trafficking eventually not present or 
insufficiently in ectopic expression systems, such as Hek293 cells (112). 
The serotonin receptors used in the thesis, especially the 5-HT-1A variants, were detected 
only as weak αFlag signal on the immunoblot with only a small difference as compared to the 
vector control (Figure 2.20). When comparing 5-HT-1A-Flag and its two cysteine-to-alanine 
mutants, the mutants were detected with a slightly better signal on the immunoblot (176) 
(Figure 2.20, Figure 2.22). In contrast to the faint signals on the immunoblot for the 5-HT-1A-
Flag variants, the autoradiography of the [
3
H]-palmitic acid labeling clearly indicated a signal 
between 37 kDa and 75 kDa for the wild type and single mutant (Figure 2.22 A). The [
3
H] 
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signal indicated a successful expression of the receptors which appeared to be difficult to 
detect by the C-terminal Flag epitope. Thus, most likely, it was not the low expression of this 
mouse protein in a human cell line but the immunodetection that resulted in a poor signal. The 
main reason for poor binding of the αFlag antibody was eventually partial refolding of the 
protein on the blot and subsequently difficult accessibility of the epitope. Also, the slightly 
better detection of the 5-HT-1A
C417A/C420A
-Flag and 5-HT-1A
C417A
-Flag indicated that the S-
palmitoylation sites, situated in close proximity to the tag, might have shielded the Flag 
epitope. The initial observations for the other serotonin receptor, human 5-HT-2A, were 
similar (Figure 2.20, Figure 2.22 A). However, the later experiments with [
3
H]-photo-
cholesterol showed a better detection on the immunoblot (Figure 2.30). Here, the Flag tag in 
the C-terminal tail was separated by more than 70 amino acid residues from the designated S-
palmitoylation site and not only by 9 residues as for 5-HT-1A. Nevertheless, the observations 
would argue for problems with the antibody binding at the C-terminal tail and for a longer 
linker region between tag and tail or a double Flag tag. 
3.2 Post-translational modifications of GPCRs 
As mentioned earlier, N-glycosylation, S-palmitoylation and disulfide bridges as post-
translational modification of GPCRs contribute to the quality control of the receptors (116). In 
the current work, the presence of N-glycosylation and S-palmitoylation sites were probed 
experimentally, while the intramolecular disulfide bridges were not investigated. In addition 
to the intramolecular disulfide bridges, cystine bonds connect the two protomers of the 
mGluR homodimers covalently (132, 134, 203). For some experiments; the intermolecular 
disulfide bond in the mGluR2 homodimer was ruptured by exchange for alanine. 
For the MD simulation only the transmembrane domain of mGluR2 was included in the setup. 
Thus, N-glycosylation sites and most of the disulfide bridges did not have to be considered as 
they are located in the extracellular domain (116). However, for the disulfide bridges, there 
was one exception: a cystine bond connected the second extracellular loop to the 
transmembrane helix III in the atomistic simulations based on the homology model which had 
been built earlier. The unstructured C-terminal end was truncated because according to the 
experimental data no S-palmitoyl modification had to be attached (Figure 2.22). 
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3.2.1 Disulfide bridges as source of stability and experimental artifacts 
A conserved cystine bond in the structure of mGluRs is the bond that tethers the second 
extracellular loop to the transmembrane domain and thus restricts the access to the helix 
bundle (71). The tether was found both in family A and family C receptors (20, 71, 222). The 
presence – or the correct formation – of this intramolecular cystine bond was not explicitly 
checked in the experimental setups but was included in the simulation of the mGluR2 
transmembrane domain (Section 4.13.2). For the atomistic simulations, the residue C721 
(model: C159) in the second extracellular loop was connected with C632 (model: C70) in the 
transmembrane helix III. The connection in the mGluR2 model was estimated from the X-ray 
structures of the mGluR1 transmembrane domain (71, 91). 
While the loss of the tether has not been investigated experimentally for mGluRs, the 
intramolecular disulfide bond that connects the mGluR homodimers has been studied 
intensively. It was found early on that the covalent connection is a hallmark of the mGluR 
family (96, 120, 203). Notably, the cysteine bridge between the protomers is of stabilizing 
nature but not mandatory for the formation of dimers (121). For that reason the cysteine 
residues C121 connecting the mGluR2 protomers were targeted by exchange to alanine, and 
the mutant named mGluR2
C121A
. The idea was to enhance the effect of an eventual loss-of-
lipid interaction in the alanine screening in the background of non-covalently linked dimers. 
Non-reducing SDS-PAGE confirmed the loss of the disulfide linking bridge in the mGluR2 
homodimer. The relative abundance of the monomers after separation by SDS-PAGE 
increased from about around 5% for the wild type variants to 40-50% in the absence of the 
C121-C121 cystine bond (Figure 2.16). Similar experiments had been conducted for mGluR1 
and mGluR5 respectively (132, 203). Notably, the absence of the disulfide bond was not 
sufficient to shift the mGluR2 dimer signal completely towards the monomer, which argues 
for strong non-covalent interactions in the dimer – both in vivo and in the sample preparation. 
It was also found that mGluR2
C121A
-Flag proteins were still expressed at the surface of 
Hek293 cells, as demonstrated in the cell surface biotinylation assay, and were still dimerizing 
in vivo, as seen in the cysteine crosslinking assay (Figure 2.12, Figure 2.15). However, in 
comparison to the Flag-tagged wild type the results were often not as stable – an observation 
which especially made for the Co-immunoprecipitation (Co-IP) assay. Here, the initial Co-IP 
experiments had shown that in the absence of the covalent bond the efficiency of the (Co-)IP 
was much more dependent on the experimental conditions (Figure 2.17). In the following Co-
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IP of the C121A/W,Y→A double mutants it had not been possible to obtain reproducible 
results (data not shown). Here, the loss of the covalent linkage was a source of experimental 
variation. Also in the final [
3
H]-photo-cholesterol labeling the experimental variation for the 
W→A or Y→A mutants on the background of mGluR2C121A was higher compared to the 
single mutants (Figure 2.32, Figure 2.33). Despite that, the overall pattern of the labeling 
remained unchanged between the two sets of variants. Only mGluR2
C121A/Y745A
-Flag dropped 
under the level of significance (Figure 2.33 C). From those findings was concluded that even 
in a presumably less stable dimer the absence of the disulfide bridge did not alter the binding 
of cholesterol to the transmembrane domain. Thus, the mGluR2
C121A
 variants were not a 
suitable tool in the current setup to generate a stronger phenotype in the cellular photo-
crosslinking assay with bifunctional lipids. 
Data from the literature indicate that despite the fact that the intermolecular cystine bond is 
found in all mGluR dimers, the receptor appears to be still functional in the absence of the 
covalent linkage: dimerization, surface expression and signaling take still place (96, 120, 121, 
132, 135). So what then is the physiological relevance of this intermolecular disulfide bridge? 
For mGluR1α, for example, it was shown that the dimerized receptor in the absence of this 
intermolecular disulfide bridge had a lower affinity for the orthosteric agonist (223, 224). The 
intermolecular disulfide bond stabilizes the dimerization interface of the extracellular domain 
which also allows to control cooperativity and activation of the homodimers (120, 224). 
However, Ray and Hauschild (132) showed that the position of the disulfide bridge in the 
mGluR1 homodimer might be subject to small changes. This eventually has then also 
implication on the preferences for the formation of heterodimers with other mGluR family 
members. For the mGluR heterodimers it was shown that only certain pairings are functional 
(131). 
The disulfide bridges contributes to the structure and function of mGluR proteins, but they 
can also be the source of experimental artifacts, such as higher oligomers (trimer, tetramer 
etc.), when separating the proteins by SDS-PAGE under reducing conditions (225) (for 
example see Figure 2.12). Here, the disulfide bridges initially opened by the reductive agent 
DTT, were most likely randomly formed from new during the sample treatment or separation 
which then resulted in distinct higher oligomers (225). Under non-reducing conditions, mostly 
monomer and dimer were visible and few higher oligomers in a smear indicated also random 
aggregation by presumably hydrophobic interaction in SDS micelles (Figure 2.16). However, 
all oligomers greater than the dimer are most likely artifacts which formed post-lysis during 
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sample preparation or SDS-PAGE. In vivo experiments have shown that the physiological 
active forms of mGluRs are dimers (reviewed by Pin and Bettler (122)). In this work, the 
random disulfide-induced oligomerization was partly suppressed by blocking free cysteine 
residues with N-ethylmaleimide in vivo, such as demonstrated by intramembranous 
crosslinking and the Co-IP experiments (Figure 2.15, Figure 2.19). But even here some 
formation of higher oligomers, caused probably by unblocked cysteines exposed during 
denaturation or by random hydrophobic interactions, was observed. Thus, artifacts in the 
SDS-PAGE can just be suppressed but not completely abolished. 
3.2.2 N-glycosylation and surface arrival of GPCRs 
N-glycosylation and the cell surface arrival of the Flag-tagged GPCRs were used as measure 
for the trafficking of the receptors through the secretory pathway. The assays showed that all 
mGluRs were modified with complex N-glycans and shuttled efficiently to the cell surface 
(Figure 2.20, Figure 2.21). In contrast to that, it appeared that the adrenergic receptors, 
especially β2AR, were transported less efficient to the cell surface. For the serotonin receptors 
5-HT-1A from mouse and human 5-HT-2A quantification of trafficking and cell surface 
localization was hampered because of the poor immunodetection of the receptors (Section 
3.1.2).  
For the family C receptors mGluR1α, mGluR2 and mGluR4 there are four, five and five 
annotated N-glycosylation sites according to UniProt entries Q13255, Q14416 and Q14833, 
respectively (104). In the assay, these sites were largely resistant to EndoH after 48 h transient 
expression in He293 cells (Figure 2.21). Only the faster migrating band of the double bands 
proofed to be EndoH sensitive. This pattern was especially well-resolved for the monomer 
signals of mGluR1α and mGluR4, while for mGluR2 the signals were rather one smear than 
double bands. After enzymatic treatment with PNGaseF, the SDS-PAGE separated both the 
monomer and dimer signal of the mGluRs into a corresponding faster migrating band. The 
shift in the electrophoresis suggested that for all mGluRs several N-glycan modifications had 
been present but no definite conclusion can be drawn here. A mutation study performed in 
insect cells on Venus flytrap-only variants of the human mGluR3 suggested that not all 
predicted N-glycosylation sites are modified (118). This raises the question of the connection 
between surface expression and N-glycosylation status. The mGluRs had been shuttled to the 
cell surface at a rate of 30-50% (Figure 2.20). Only for mGluR1α the separation by SDS-
PAGE had worked well enough to show that only the upper (complex N-glycan) band had 
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been pulled down with the surface biotinylation. This suggests that there is a correlation 
between modification with complex N-glycans – or resilience against EndoH – and cell 
surface arrival for mGluRs. In the literature, there has been not much work on N-
glycoslyation in family C receptors, especially for the mGluRs. Inhibition of N-glycosylation 
by tunicamycin in CHO cells showed that the cell surface expression of human mGluR1α was 
not affected by its N-glycosylation status (117). This is contrasted by studies on the family C 
human extracellular Calcium sensing receptor (CaR) in Hek293 cells which showed that 
surface expression and agonist response was sensitive to disruption of N-glycosylation sites 
(165). Bai, Quinn (226) used the N-glycosylation status of CaR as read-out for the maturing 
of variants that carried physiologically relevant mutations at non-N-glycosylation sites. The 
enzymatic deglycosylation of the wild type resulted in a very similar pattern as observed for 
the mGluRs in the current experiments (226): the monomer signals were separated as double 
bands of which the faster migrating one was sensitive to EndoH, while both were shifted after 
PNGaseF treatment. Interestingly, CaRs with severe mutations, like calcium sensing mutant 
CaR
R66C
, were only modified with mannose-rich N-glycans. From these experimental studies 
and the findings presented in the thesis it was reasoned that i) for family C receptors the N-
glycosylation status is a relevant quality criteria for the maturing and shuttling of the 
receptors, and ii) the N-glycosylation pattern along with the cell surface biotinylation assay 
demonstrate a successful shuttling of the mGluRs through the secretory pathway. 
For the mGluR2-Flag W→A and Y→A variants, both the enzymatic deglycosylation and the 
cell surface arrival assay showed that none of the point mutations introduced had a severe 
effect on trafficking of the receptors (Figure 2.13, Figure 2.14). Thus, the strategy to target 
only surface exposed aromatic amino acid side chain had proofed to be successful for the 
transmembrane domain (Section 2.1.2.2). A comparable trafficking of the mGluR2 variants 
was a prerequisite for the cellular studies on protein-lipid interactions. 
Of the adrenergic receptor family, two receptors had been included in the study: Flag-tagged 
Alpha-2A adrenergic receptor (α-2AAR) and β2AR. Both showed a similar running pattern as 
the mGluR receptors: the proteins separated into monomeric and higher oligomeric forms 
upon separation by SDS-PAGE (Figure 2.21). This was probably due to unspecific 
hydrophobic interaction in SDS micelles during the sample preparation even though with urea 
an additional chaotropic substance had been included. Formation of oligomers due to 
formation of unspecific disulfide bonds, as suggested for the mGluRs, was probably less of a 
problem because the adrenergic receptors lack cysteine-rich regions (Section 3.2.1). However, 
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in the cell surface arrival assay, the signal for both receptors after affinity purification was 
surprisingly low (Figure 2.20). The low signal in the affinity purification might have been 
caused by technical issues: both receptors have only two lysine residues in their N-terminal 
domains, while mGluRs have approximately 30. Thus there are few residues available for the 
formation of amide bonds with the Sulfo-NHS-SS-biotin reagent (164) (Section 4.8). The 
sensitivity to EndoH is on the contrary a strong indicator for an altered trafficking through the 
secretory pathway (Figure 2.21). The digestion of α-2AAR with EndoH showed that, similar 
to the mGluRs, only a portion of the receptors was sensitive to the enzyme. This indicates that 
α-2AAR had shuttled successfully through the secretory pathway even though poorly 
detectable in the surface biotinylation assay (Figure 2.20). On the other side, the four signals 
for the presumably monomeric β2AR-Flag receptor were sensitive to EndoH treatment 
(Figure 2.21). Interesting here was also the appearance of four bands in the running pattern 
despite the fact that only two N-glycosylation sites have been reported for β2AR (173). 
Eventually we see a mix of unglycosylated β2AR, receptor modified with one or two 
mannose-rich N-glycans and finally proteins with two more complex N-glycans still sensitive 
to EndoH (169). Apart from the N-glycans, the S-palmitoyl modification at the C-terminal 
end might also explain the fifth band running at the lowest apparent molecular weight (Figure 
2.21); the signal might neither carry the S-fatty acylation, nor the N-glycan modification. 
Taken together, the expression system worked well for α-2AAR, but for the Flag-tagged 
β2AR receptor Hek293 cells might not have been optimal cell line (Section 3.1.2). 
Introduction of an artificial signal peptide in combination with a C-terminal Flag-tag might be 
the optimal combination for ectopic expression of β2AR. 
For the Serotonin receptors, the poor immunodetection hampered a reliable quantification of 
the cell surface arrival (Figure 2.20 and Section 3.1.2). Subsequently the deglycosylation 
assay for the receptors was not carried out. 
3.2.3 S-palmitoylation 
S-palmitoylation of mGluRs was investigated for the set of mGluRs and the adrenergic and 
serotonin receptors containing predicted or described palmitoylation sites and their respective 
non-palmitoylated C→A mutants. In the [3H]-palmitate labeling, all annotated S-fatty 
acylation sites were confirmed for the family A GPCRs. Among the mGluR candidates tested, 
palmitoylation was found only for mGluR1α (Figure 2.22). 
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S-palmitoylation can have different implications on the ‘life’ of a GPCR. For some GPCRs, 
like the adrenergic and serotonin receptors used as positive controls in this work, the S-
palmitoylation has ‘only’ regulatory function. This had the advantage that, despite the loss of 
the S-fatty acylation site in the C-terminal tail, the respective C→A variants were not 
expected to have trafficking defects. Both adrenergic receptors had one S-palmitoylation site. 
α-2AAR contains a S-palmitoylation site at position C442 which seems to have a role in 
internalization after long-term agonist exposure (227). For β2AR residue C341 in the C-
terminal tail has been identified as S-palmitoylation site (76). Here the S-palmitoylation site 
has been associated with the activation-dependent phosphorylation and desensitization (25, 
157). For the serotonin receptors, only the function in mouse 5-HT-1A has been thoroughly 
assessed. The receptor has two established S-palmitoylation sites at positions C417 and C420, 
associated with Gαi protein coupling and raft association (26, 216). For 5-HT-2A the 
homologues site in mouse, C397, was annotated with unknown function (155). In Hek293 
cells, all four receptors but not the variants β2ARC341A and 5-HT-1AC417A/C420A showed a 
positive labeling with [
3
H]-palmitic acid (Figure 2.22). This indicated that the chosen labeling 
time had been long enough to allow for incorporation of [
3
H]-palmitic acid into the GPCRs 
while at the same time avoiding artifacts because of metabolic incorporation of radioactivity 
into amino acid or other molecules (76). It also confirmed the transient nature of S-fatty 
acylation and the suitability of Hek293 cells to test S-palmitoyltransferase activity on GPCRs 
(23, 27). Moreover, the results demonstrated that C-terminal tagging did not have an influence 
on the S-palmitoyltransferase activity. 
For the serotonin receptors, the labeling experiments verified the S-palmitoylation of human 
5-HT-2A in an ectopic expression context. The receptor was also successfully 
depalmitoylated by treatment of samples with beta-mercapoethanol which confirmed the 
nature of the bond (Figure 2.23). The [
3
H]-palmitic acid signal for 5-HT-2A was rather weak 
which might indicate a low expression of the corresponding S-palmitoyltransferase(s) and/or a 
lower turn-over of the modification as compared for example to 5-HT-1A (23, 176) (Figure 
2.22). Among the three mGluR candidates, mGluR2 showed a negative result in the labeling. 
For the protein, no palmitoylation sites has been experimentally identified or predicted so far. 
In contrast to a previous publication, also no modification of mGluR4 was detected (125). 
mGluR1α was the only member of tested mGluRs to be palmitoylated under the chosen 
experimental conditions, however, it was efficiently depalmitoylated with beta-
mercapoethanol only in one out of three experiments, which might have been due to technical 
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problems (Figure 2.24 and Section 2.4). Thus, it cannot be excluded that the labeling was 
false positive for S-palmitoylation and instead represented another post-translational 
modification. N-myristoylation, occurring at the cytoplasmic side of membranes, affects the 
N-terminal end which for mGluR1α is extracellular (228). Isoprenylation occurs at the C-
terminal end of proteins, but mGluR1α is not described to contain a CaaX box (38). Hence, if 
the S-palmitoylation signal for mGluR1α was false positive this more likely represented a 
non-lipid modification. In addition, only the mGluR1α dimer was clearly labeled with [3H]-
palmitic acid, a phenomenon that has also been observed for other receptors, such as the 
beta1-adrenergic receptor (214). For mGluR1α, the missing labeling of the monomer might 
have been due to technical reasons, since in the digital autoradiography a strong background 
was observed in the range of the monomer and thus requires further investigation (Figure 
2.22 A+B). Palmitoylation was not described for mGluR1α in a study focusing on mGluR4 in 
baby hamster kidney cells, however, in this case overall labeling efficiencies and resolution 
were rather low (125). Later on, also a different group reported a negative result for mGluR1α 
in a [
3
H]-palmitic acid labeling performed in insect Sf9 cells (229). For long, the topic of 
mGluR S-palmitoylation remained untouched until availability of enhanced proteomic 
approaches (116). A recent publication using acyl-biotin exchange to monitor S-
palmitoylation in mouse forebrain samples suggested two modification sites in mGluR1 
(155). With C565 and C578 two residues close to the extracellular cysteine-rich linker region 
were identified raising doubts about the specificity of the measured signal as no such 
extracellular S-palmitoylation sites have been described for GPCRs so far. 
Thus, the current experiments can confirm the S-palmitoylation of (human) 5-HT-2A 
identified in the screening by Collins, Woodley (155) but do not allow for a definite 
conclusion on mGluR1α. To address this question, further experiments will have to be 
performed, including for example C-terminal truncation and mutation to localize the site of 
modification. 
3.3 Dimerization of mGluR2 and its alanine mutants 
Oligomerization of GPCRs is a general phenomenon among GPCRs and has been extensively 
studied, in particular for family C receptors (122). mGluRs can form homo- and heterodimers, 
which then trigger miscellaneous intracellular responses (reviewed by Borroto-Escuela, 
Tarakanov (230)). In this work a focus is set on the ‘heterodimerization’ of the mGluR2-Flag 
receptor and the selected mGluR2 W→A or Y→A variants. No defects in the pairing of 
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mGluR2-Flag and its mutants were observed in Co-IP experiments. Moreover, a disulfide 
crosslinking experiment on the intramembranous dimerization interface of mGluR2, 
analogous to what had been described previously, was performed (121). The experiment 
suggested the existence of an intramembranous dimerization interface for mGluR2 between 
transmembrane helices IV, V and VI in addition to the interfaces described for the 
extracellular domain. 
3.3.1 The intramembranous dimerization interface of mGluR2 
The dimerization for mGluRs is best understood at the level of the Venus flytrap domain. 
Here biochemical and structural evidence have shown the existence of a dimerization 
interface stabilized by a intermolecular disulfide bridge (96, 132, 135, 203). In addition to that 
the group of Jean-Philippe Pin also reported a potential dimerization interface within the 
cysteine-rich linker as well as in the transmembrane domain of mGluR2 (120, 121). Notably, 
the later dimerization interfaces were established by cysteine-crosslinking experiments. 
The membrane dimerization interface for mGluR2 was reported for the transmembrane 
helices IV, V and VI in a cysteine-crosslinking assay, which was in contrast to the earlier 
published crystal structure of a mGluR1 homodimer which showed an interface between 
transmembrane helices I (71, 121). The mGluR1 interface was described in a transmembrane 
domain-only construct stabilized with a soluble cytochrome b562 domain. For that reason it 
was speculated that it was a crystallization artifact (121). When the ectopic cysteine residues 
were introduced on the background of MycFlag-tagged mGluR2
C121A
 variants for this work, 
intermolecular crosslinking between the protomers was indeed observed (121) (Figure 2.15). 
Upon receptor activation a shift of the interface from helix IV and V to VI was described in 
the literature (121). If the dimerization interface in the current expression system is dependent 
on receptor activity as suggested still remains to be addressed. Notably, no model for the 
movement of the complete mGluR2 receptor upon activation exists but there are predictions 
based on the experiments with single domains (120, 121). In the future, single-particle 
electron microscopy studies, as done for the human insulin receptor, might reveal how all 
domains simultaneously change their interfaces upon receptor activation (231). For the insulin 
receptor, it was shown that upon activation by insulin the transmembrane domains got in 
closer proximity. In the case of mGluRs, such studies would eventually help to resolve the 
contradicting biochemical and structural findings on the dimerization interface (71, 121). For 
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the current project, it will be also of interest to investigate if intramembranous dimerization 
interface is influenced by the alanine exchange. 
The 5-HT-2A receptor was shown to interact with the transmembrane helix IV of mGluR2, 
which is one of the helices suggested to be involved in mGluR2 homodimerization (121, 154, 
232). It was also shown that the extracellular domain of mGluR2 was not involved in the 
interaction with 5-HT-2A, which would have been also remarkable as serotonin receptors in 
general display a comparably small extracellular domain – in the case of 5-HT-2A ~75 amino 
acids (154). Thus, there would be at least partly a competition for the transmembrane 
dimerization interface between the heteroreceptor mGluR2-5HT2A and the mGluR2 
homodimer. The question if such competition takes place or the receptors form a trimeric 
complex has not been addressed yet. Only for mGluR heterodimers it has been demonstrated 
that when expressed in the same cell, the mGluRs indeed start to compete for dimerization 
interfaces (131). 
3.3.2 Heterodimerization between mGluR2 wild type and its mutants 
The aim of the Co-IP assay was to characterize the heterodimerization between the mGluR2-
Flag and the W→A or Y→A variants. The question was if the alanine exchange would 
prevent the dimerization between the variants and the wild type. For the Co-IP assay, the 
same Flag-tagged constructs were used which had been previously used in the 
characterization of the trafficking. The conditions for the Co-IP were adjusted as suggested by 
Milligan and Bouvier (171) (Section 2.2.2.3). 
The initial experiment showed that Flag-tagged mGluR2 dimers linked by a disulfide bridge 
were tolerable to different lysis and Co-IP conditions (Figure 2.17). In contrast to that, 
mGluR2
C121A
 homodimer was sensitive to the presence of ionic detergents, such as sodium-
deoxycholate and sodium-dodecylsulfate (SDS) (Figure 2.17). This was not surprising as the 
mGluR2
C121A
 homodimer was only stabilized by non-covalent interactions. The ionic 
detergents most likely disturbed the intramembranous as well as the extracellular dimerization 
interface and ruptured ionic and in concert with Triton X-100 also hydrophobic interactions. 
On the contrary, the covalent disulfide bridge between in the wild type dimer prevented the 
detergent-mediated dissociation seen for mGluR2
C121A
. Thus, the presence of the 
intermolecular disulfide bond in the homodimer would not allow discriminating between 
different assay conditions. From this observation was concluded that mGluR2
C121A
 is a more 
suitable tool to establish a robust Co-IP assay.  
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For the dimerization studies conditions were chosen resulting in complete solubilization of 
receptors. In addition, N-ethylmaleimide treatment was used to block free cysteine residues 
along with high salt conditions for washing in order to minimize assay artifacts caused by 
unspecific covalent and non-covalent interactions (171) (Figure 2.18). With this stringent 
assay conditions, the results indicated that even subtle changes at the dimerization interface 
can lead to impaired receptor dimerization: the pull-down of mGluR2-Myc with 
mGluR2
C121A
-Flag as bait resulted in a poor recovery of the prey protein (Figure 2.18). 
Unfortunately, no study mGluR dimerization has reported on the affinity of between receptors 
with and without a specific mutation site. In a study on the dimerization of mGluR1α the 
exchange of amino acid residues for cysteine in close proximity to the ‘original’ C140 
residues was described (132). The results suggested that the position of the cysteine residue 
for the intermolecular disulfide bond was somewhat flexible, but it was not investigated if the 
mutants would still pair with the wild type. Also non-cysteine amino acid residues in the 
mGluR2 Venus flytrap dimerization interface can perturb the formation of homodimers, as 
shown in in vitro experiments in Xenopus oocytes (224). Taken together, disulfide bridge 
formation between cysteines in mGluRs’ extracellular domain is to some extent flexible 
concerning the positioning in homo- and heterodimers. However, also other perturbations at 
the dimerization interface can lead to a reduction in dimerization. 
Based on the assumption, that also small changes at the dimerization interface can interfere 
with formation of mGluR dimers, the different Myc-tagged W→A or Y→A variants of 
mGluR2 and mGluR2
C121A
 were probed for dimerization with the Flag-tagged wild type or 
C121A mutant, respectively. For the mGluR2-Myc variants, no significant perturbation of 
dimerization with the wild type was observed (Figure 2.19). In the absence of the disulfide 
bond in double mutants on the background of a C121A mutation the receptors would still 
dimerize but no stable results were obtained for the recovery of the Myc-tagged preys (data 
not shown). From these results was concluded that the W/Y→A point mutations in the 
transmembrane domain did not cause major receptor dimerization defects but it cannot 
exclude the possibility that the intramembranous dimerization interface was disturbed. 
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3.4 Non-covalent protein-lipid interaction in vivo and in 
silico 
For the non-covalent protein-lipid interactions of mGluR2 both sphingolipids and cholesterol 
interactions were probed in an alanine screening of the mGluR2 transmembrane domain. 
Cellular photo crosslinking assays showed that in two mGluR2-Flag Y→A variants 
cholesterol binding was significantly reduced. Subsequently performed MD simulations of the 
transmembrane domains of the wild type and the two Y→A variants mGluR2Y745A and 
mGluR2
Y781A
 confirmed the reduction of cholesterol binding. In contrast to that, [
3
H]-photo-
sphingosine ([
3
H]-photoSph) labeling of mGluR2 wild type and variants showed rather weak 
interactions. Here, two other mGluR2 variants displayed even an increased efficiency in the 
[
3
H]-photoSph labeling, not the expected reduction. 
3.4.1 Sphingolipid interaction with the mGluR2 receptor in vivo 
The bioinformatics screening for new protein-sphingolipid interaction sites with a p24-like 
N-VX2-TL-X2IY-C sphingolipid binding motif uncovered several GPCRs with three mGluRs 
among them (68). In mGluR2, 7 and 8, the motif was found in helix VI of the transmembrane 
domain suggesting a functional link between sphingolipid interaction and activation of the 
receptors (68, 90, 233). In this work, one residue of the identified N-TX2-TT-X2IW-C motif in 
mGluR2 was tackled by changing the tryptophan residue W773 to alanine. This amino acid 
exchange should have disrupted the interaction between sphingomyelins’ choline moiety and 
the motif in mGluR2 (65). However, the [
3
H]-photoSph labeling of transiently expressed 
Flag-tagged mGluR2
W773A
 proteins indicated that the sphingolipid interaction with the protein 
had even slightly increased (Figure 2.28). For mGluR2
W697A
 and mGluR2
Y734A
 – located in 
transmembrane helices IV and V – sphingolipid photocrosslinking was significantly 
increased. 
The finding that – in contrast to the experiments with p24 – single amino acid exchanges 
within the sphingolipid interaction motif did not result in a loss of sphingolipid binding, can 
be for several reasons (65). First, sphingolipid binding to α-helical domains of a given protein 
depends on several amino acid residues or, as for theV3 loop-like sphingolipid binding 
domain (SBD), also on structural determinants (64, 65). In a MD simulation, it was found that 
the affinity of ganglioside GM1 to 5-HT-1A might dependent on V3 loop-like structures in 
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the receptor (63). Here, it was suggested that the binding of the sphingolipid was dependent 
on the extracellular loops of 5-HT-1A. Such determinants have not been investigated in the 
current project, but structural motifs would be difficult to intercept with point mutations. It 
should be noted that especially in the atomistic simulations of the mGluR2 transmembrane 
domain the loops were found to be flexible (Figure 2.40). If that flexibility would rather 
support or hamper interaction with the glycan moiety of gangliosides remains to be addressed. 
Second, some of the amino acids of the putative sphingolipid binding motif, like T769, were 
according to the mGluR2 transmembrane model buried inside the helix bundle, and thus, 
might not be accessible for sphingolipid binding (Figure 2.8). The linear sphingolipid 
interaction motif found in p24 might be difficult to project on a more complex heptahelical 
structure, as seen for the differences between the linear CRAC/CARC motifs and the three-
dimensional CCM (45). Third, changes in the receptor structure caused by the point 
mutations, be it by conformational changes of the transmembrane domain or by local gaps on 
the surface of the protein, could influence sphingolipid binding within the transmembrane 
domain. Like that, mutation sites like W697A or Y734A might have been the source of 
ectopic sphingolipid interaction sites. In summary, the motifs obtained from the bioinformatic 
screening may need further refinement by determining for example if the C-terminal tyrosine 
residue within the p24 interaction motif is indeed interchangeable with any other aromatic 
amino acid (68). 
An effect that was not considered in this work was the interaction of sphingolipids, or more 
precisely gangliosides, with the receptor by interaction with basic lysine residues. Such 
interactions have been shown for the human epidermal growth factor receptor (EGFR) and the 
human insulin receptor (234, 235). Whether lysine residues might be also contributing to 
glycosphingolipid binding of GPCRs represents an interesting subject for future research, 
especially since basic residues can also be found in cholesterol interaction motifs (54). 
3.4.2 Cellular and in silico interaction of the mGluR2 receptor with 
cholesterol 
[
3
H]-photo-cholesterol labeling in Hek293 cells showed a significant decreased cholesterol 
interaction of the Flag-tagged variants mGluR2
Y745A
 and mGluR2
Y781A 
as compared to wild 
type, while on the background of a mGluR2
C121A
 mutation this was the case only for 
mGluR2
C121A/Y781A
 (Figure 2.32, Figure 2.33). Preceding experiments demonstrated that the 
labeling efficiency was independent on the cellular expression level of the mGluR2 variants 
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(Figure 2.31). Moreover, cellular trafficking and cell surface arrival did not differ 
significantly between Flag-tagged W/Y→A variants and wild type so that all mGluR2 
variants should be found a similar membrane environment (Figure 2.14, Figure 2.13). Taken 
together, the experimental data suggested a loss of cholesterol binding due to the amino acid 
exchange at the respective sites. To get further insight into the molecular interactions 
contributing to cholesterol binding to the transmembrane domain of mGluR2 MD simulations 
were performed. Atomistic simulations showed that the transmembrane domains had well-
defined regions with cholesterol density near transmembrane helices V and VI in proximity to 
the Y→A mutation sites Y745A and Y781A, supporting the results obtained with the cellular 
assay (Figure 2.41). These regions are very likely to correspond to single cholesterol 
molecules, which remained most of the time bound to the protein at those helices. Thus, our 
simulations suggest the possibility of specific cholesterol interaction sites around helices V 
and VI. In silico mutations and coarse-grained simulations also support this hypothesis by 
displaying a distorted density for the earlier and similar cholesterol density for the latter set of 
controls (Figure 2.42, Figure 2.43). The simulations also showed cholesterol density near 
other helices of mGluR2, for example around the cleft between helices I and IV on the 
cytoplasmic side of transmembrane domain (Figure 2.41). The density in this cleft appeared to 
be less specific then the one around the mutation sites introduced into the helices V and VI. 
Here, the coarse-grained simulations did not show any specific binding around the same area 
(Figure 2.43). For the other parts, such the binding site around helices I and VII, the density 
was more spread out, thus implying unspecific interaction at those places (Figure 2.41, Figure 
2.43). 
A well-described cholesterol binding site in GPCRs is the cholesterol consensus motif (CCM, 
[4.39-4.43(R,K)]-[4.50(W,Y)]-[4.46(I,V,L)]-[2.41(F,Y)]) present between helices I and IV of 
the β2AR transmembrane domain (see for example Figure 1.2) (20, 45, 236). In the X-ray 
structures 3D4S and 3NY8 of β2AR, the CCM on the intracellular side between helices I and 
IV was occupied by identically positioned cholesterol molecules: the first cholesterol 
molecule interacted with the CCM via its ‘rough’ β surface while contact to the second 
cholesterol molecule in the cleft was established via the ‘smooth’ α side (45, 236). In contrast 
to that, in the 2RH1 X-ray structure cholesterol packed against the CCM with its α side (20). 
The CCM was later confirmed in MD simulations of this other protein embedded in a DOPC 
(1,2-dioleoyl-sn-glycero-3-phosphocholine) bilayer with different cholesterol concentrations 
(47). In the current MD simulations of the mGluR2 transmembrane domain, the cleft between 
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transmembrane helices I and IV was occupied by cholesterol on the intracellular side, as well 
(Figure 2.41). From the density map it could not be concluded if the cholesterol was bound 
with its ‘rough’ β surface, as suggested for the CCM, or with its ‘smooth’ α side (45).The 
density map only indicated that cholesterol seemed to be more aligned to transmembrane 
helix II than IV. In these helices, the residues of the CCM are not present (UniProt Q14416) 
(14). For example, the tryptophan residue at position W
4.50
 of β2AR conserved in family A 
GPCRs is not present at the corresponding position in family C receptors (14, 16). Of all 
residues of the CCM, only isoleucine I
4.46
 is conserved in transmembrane helix IV of mGluR2 
as I682 (Figure 2.41). Even though the cleft between helices I and IV was also occupied by 
cholesterol in the MD simulation of mGluR2, the experimental alanine screening had not 
shown any loss of binding here (Figure 2.32). The mutation site mGluR2
Y607A
, positioned at 
the cytosolic end of helix II, had remained without effect in the [
3
H]-photo-cholesterol 
labeling. Thus if a CCM-like motif is present in family C the sequence is different, or as for 
the V3 loop-like sphingolipid binding domain, eventually more of a three-dimensional than a 
linear motif. Because the motif might be structurally imprinted, it might also be more difficult 
to disturb the motif by an exchange of single amino acids. It is also remarkable that the 
conserved CCM in family A receptors was not always occupied by cholesterol. For example, 
the human A2A adenosine receptor possesses a CCM positioned at the same spot as β2AR but 
none of the three cholesterol molecules co-crystallized with the adenosine receptor occupied 
the site in the crystal structure (45, 237). Many serotonin receptors are supposed to have a 
conserved CCM – the 5-HT-2A receptor is one of them (45). The homologue 5-HT-2B was 
co-crystallized with cholesterol bound to transmembrane helix I and an α-helical region in the 
C-terminal tail while no cholesterol was found at its CCM (238). From the different examples 
it can be concluded that either the experimental setup inferred with the detection of the CCM 
or that the nature of the cholesterol binding sites in GPCRs has not been completely 
understood. Eventually, the CCM in β2AR just ‘by accident’ correlated with a set of 
conserved residues and was rather part of a structural then a sequential motif. 
In case of mGluR2, there was another distinct cholesterol binding spots observed in the 
simulation that clustered around helix V and VI (Figure 2.41). The sites coincident with the 
two amino acid residues Y745 and Y781 in helix V and helix VI that were identified in the 
alanine screening and subsequent cholesterol labeling of the Flag-tagged mGluR2 variants 
(Figure 2.32). The mutation site Y745A one coincided with the CRAC motif N-L741-X3-
Y745-X2-K748-C at the cytoplasmic end of transmembrane helix V (56, 59). The density here 
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was not as pronounced as at the extracellular end of transmembrane helix VI, but appeared as 
distinct spot. Upon mutation to alanine the cholesterol density at around Y745A disappeared 
(Figure 2.42). Interestingly, a CRAC motif in transmembrane helix V was also described in 
other mGluRs (56). For mGluR1, alanine exchange at single site within the CRAC motif 
showed that only the wild type receptor, but not the point mutants, shifted into detergent 
resistant membranes upon activation (56). The surface arrival of the point mutants was not 
affected –as also observed for mGluR2Y745A (Figure 2.13). In further tests the authors found 
that the mGluR1 CRAC mutants retained their basal activity but were not efficiently activated 
by the agonist. Thus, subtle changes at cholesterol interaction sites can have a strong 
influence on the receptor. The finding are in line with the data obtained for the mGluR2 
receptor in insect Sf9 cells, which showed that association with cholesterol was correlated 
with activation of the receptor (55). On the side of structural biology, less is known about 
putative cholesterol binding sites. In the X-ray structure of mGluR1 transmembrane domain, 
no cholesterol density was found at the CRAC motif. Only in the crystal structure 4NTJ of the 
Purinergic receptors cholesterol was bound to a similar position as found in the current 
simulations and in the biochemical experiments on mGluR1, but no CRAC motif was 
involved here (56, 57, 239) (Figure 2.32, Figure 2.42). 
Interestingly, loss of cholesterol binding at helix V was also seen for the other mutation site 
Y781A despite being located at the extracellular site of helix VI (Figure 2.42). In the MD 
simulations, the density around helix VI got smaller and changed its shape for the Y781A 
mutant, while also other cholesterol interaction sites lost density. An increased flexibility of 
the transmembrane domain around helix VI, induced by the mutations itself or loss of 
cholesterol binding, may be responsible for the alterations of the density at other sites on the 
protein surface (Figure 2.39). Here further analysis of the simulations is needed to find out 
about a possible connection between cholesterol binding and conformational changes in 
mGluR2. However, helix VI is thought to be involved in the activation of GPCRs and 
contains conserved motifs, that keep the receptors in their basal state (71, 90, 233). Studies on 
β2AR have provided insight into a potential mechanism of activation control by cholesterol 
binding to helix VI. In the MD simulations of β2AR, cholesterol binding both around 
transmembrane helices V and VI on the intracellular and extracellular side was reported (47). 
The interaction of cholesterol with β2AR in silico suggested a mechanism in which 
cholesterol restricts the conformational flexibility of the receptor. This supported by 
experimental findings that cholesterol thermostabilized β2AR in vitro (45). By binding to the 
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transmembrane helix VI, the conformational change towards the active state by tilting the 
helix was probably restricted (47). At the same time, the active conformation was stabilized 
by cholesterol which acted as ‘spacer’ between helices V and VI and thus prevented 
spontaneous relapse into the inactive conformation (47). These in silico observations might 
explain the contradicting findings that on the one hand cholesterol bound specifically to 
β2AR, while at the same time cholesterol depletion activated β2AR mediated cellular 
signaling (45, 51). In addition to the findings for β2AR, also other experimental data have 
shown specific interaction between cholesterol and transmembrane helix VI of GPCRs. In the 
crystal structure for the human A2A adenosine receptor two cholesterols packed sideward 
against the exoplasmic end of helix VI at the interfaces with helices V and VII (237). 
Likewise a cholesterol density was shown in the structural model next to transmembrane helix 
VI in the outer leaflet for the µ-opioid receptor structure 4DKL (240). In both cases, aromatic 
amino acid residues –tyrosine and phenylalanine – were involved in the binding of cholesterol 
molecules at the respective sites, but also β-branched residues, leucine and the protein 
backbone (57). A sequence alignment with clustalo between the helix VI of mGluR2, A2A 
adenosine receptor, µ-opioid receptor, and β2AR as annotated in UniProt showed only an 
identity of 3.6% between the receptors for that region. Only the central tryptophan residue 
W
6.50
 (for mGluR2 W773) was conserved but apparently not decisively involved in 
cholesterol binding: Both for the A2A adenosine receptor and µ-opioid receptor the residue 
pointed into the helix bundle (237, 240). The poor sequence conservation suggests that 
besides the linear amino acid sequence additional parameters contribute to cholesterol binding 
(57). Nevertheless, the cholesterol binding at these sites seems to depend also on specific 
interaction with aromatic amino acid residues, as observed in the different crystal structures 
and here in this work for the [
3
H]-photo-cholesterol labeling of the mGluR2 variants and the 
corresponding MD simulations. 
In addition to the specific cholesterol interaction sites, a broad cholesterol density was 
observed around transmembrane I and VII. The density was especially pronounced in the 
atomistic simulations but also in the coarse-grained system (Figure 2.41, Figure 2.43). The 
density was observed at a position where also in the published crystal structure of mGluR1 
4OR2 cholesterol mediated homodimerization (71). Notably, the authors of the mGluR1 
crystal structure study did not claim a specific binding site. In the crystal structure, the 
cholesterol molecules packed against the transmembrane helices I and II on the extracellular 
side whereas in the atomistic simulation of mGluR2 cholesterol density was spread out on the 
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intra- and the extracellular side (Figure 2.41). Also in the coarse-grained simulations the 
cholesterol density was spread out around helices I and VII with no major differences in the 
cholesterol binding was between dimer and monomer (Figure 2.43). For the particular site 
around helix I, another group has simulated the interaction of cholesterol and mGluR1 at the 
homodimer interface (241). It was suggested that cholesterol was held in place by van-der-
Waals and hydrogen bonding, contacting the residue W588 at the upper end of helix I. The 
respective mutation in mGluR2
W567A
 did not show altered cholesterol binding when 
investigated using the cellular photocrosslinking approach with [
3
H]-photo-cholesterol 
(Figure 2.32). From these observations was reasoned that the density around transmembrane 
helices I and VII was unspecific but eventually not strictly dependent on receptor 
dimerization. However, the possibilities of ‘cholesterol cavities’ at the transmembrane 
dimerization interface, which were observed in MD simulation of the chemokine receptor 
type 4, cannot be excluded (89). Including the extracellular domain of mGluR2 in future 
simulations might help to narrow down the physiological dimer interface, which is most likely 
affected in its positioning of the extracellular domains (121). 
Two more GPCRs were labeled with [
3
H]-photo-cholesterol: the β2AR and the 5-HT-2A 
receptor (Figure 2.30). As discussed before, trafficking of the two GPCRs could not be 
studied in detail due to technical problems, precluding a comparison with the mGluR2 protein 
(Figure 2.20, Figure 2.21). However, looking at each receptor separately it is remarkable that 
especially β2AR labeled very well both with cholesterol as well as with sphingolipids (Figure 
2.28, Figure 2.30). Despite the fact that β2AR has specific cholesterol interaction sites, it was 
usually assumed that the receptor in its basal state resides in disordered membrane phase (51). 
However, the problems with the trafficking recognized in the enzymatic deglycosylation 
assay as well as in the cell surface biotinylation caution to make any general conclusion here. 
To further investigate the intracellular localization and lipid binding of β2AR and variants, 
steady state localizations of the receptors and additional lipid labeling, targeting also 
glycerolipids, will have to be performed in future experiments. Nevertheless, the β2AR was 
found to be a reliable positive control for both [
3
H]-photoSph and [
3
H]-photo-cholesterol 
labelings experiments and in so far had fulfilled its purpose. On the other side, 5-HT-2A 
labeled rather weak with [
3
H]-photo-cholesterol (Figure 2.30). The weak labeling is 
remarkable for two reasons. First, the receptor is supposed to interact with mGluR2 (232). 
Thus, the receptors should share a similar membrane environment, but mGluR2 showed a 
stronger affinity to cholesterol in the current setup (Figure 2.30). Second, the S-palmitoylation 
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found also in 5-HT-2A is for other 5-HT-Rs, like 5-HT-1A, associated with raft localization 
(26). At least in the basal state, the photo-induced labeling suggested no strong association 
with cholesterol-rich membrane phase for 5-HT-2A. Moreover, a CCM is predicted for 5-HT-
1A even though that is no measure for the overall affinity for cholesterol (45). Unfortunately, 
the literature on 5-HT-2A is not as comprehensive as for 5-HT-1A, for example, and also no 
X-ray structure has been resolved, yet (242). Nevertheless, the labeling showed that 
interaction with [
3
H]-photo-cholesterol is not an intrinsic property of all GPCRs tested in the 
given experimental setup, which again argues for a specificity of the other observations. In 
this way, 5-HT-2A might also make a better negative control in the photo-induced labeling 
experiments than ASGPR I, which has been used regularly in the past for experiments on p24 
but is as single-spanning protein a rather unsuitable control in labelings with the hepathelical 
GPCRs (65, 68). 
3.5 Conclusion 
In the current work, the membrane environment of the GPCR mGluR2 was probed focusing 
on a potential sphingolipids or cholesterol interaction site. Based on the assumption that 
specific non-covalent interaction sites for sphingolipids and cholesterol contain aromatic 
amino acid residues, tryptophan and tyrosine residues in the transmembrane domain were 
targeted in an alanine screening (45, 53, 64, 65) (Section 2.1.2.2). By means of enzymatic 
deglycosylation and cell surface biotinylation assays, it was shown that W→A or Y→A 
amino acid residue exchanges in the mGluR2-Flag transmembrane domain did not 
significantly affect trafficking of the receptors (Figure 2.13, Figure 2.14). Also, the point 
mutations were not sufficient to disturb the dimerization between mGluR2-Flag and the 
corresponding alanine mutants (Figure 2.19). [
3
H]-photo-sphingosine labeling showed that 
mGluR2 had only a limited affinity to sphingolipids, while for [
3
H]-photo-cholesterol a 
stronger binding was observed (Figure 2.27, Figure 2.31). As compared to wild type mGluR2, 
an increase was seen for some variants in the [
3
H]-photo-sphingosine labeling which was 
surprising as the W→A and Y→A variants had been designed to disturb the putative p24-like 
sphingolipid binding motif (68) (Figure 2.28). The results could not be readily explained by 
the existing data. In contrast to that, for two Y→A variants the [3H]-photo-cholesterol 
labeling was significantly decreased (Figure 2.32). The mutation sites Y745A and Y781A are 
located at the intra- and extracellular site of transmembrane helices V and VI, respectively. To 
find out about the molecular mechanism of cholesterol interaction, the transmembrane domain 
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of mGluR2 was investigated in an atomistic MD simulation in a fully solvated POPC bilayer 
with 15mol% cholesterol. Several cholesterol interaction sites were mapped on the surface of 
the mGluR2 transmembrane domain (Figure 2.41). The most distinct spots were found in 
helices V and VI next to the residues Y745 and Y781. In helix V, Y745A is part of a CRAC 
motif which is conserved in the whole mGluR family (56). Helix VI has been associated with 
the activation of GPCR (90, 233). One more site was in the cleft between helix I and IV, at 
the position of the CCM which had been identified in β2AR (45). Even though the site was 
occupied by cholesterol, the residues of the CCM were not conserved at the particular 
positions in helices II and IV. Apart from that spread out cholesterol density was seen around 
helices I and VII, probably driven by unspecific van-der-Waals forces and hydrogen bonds 
(241). In the same setup, also the two mutant transmembrane domain mGluR2
Y745A
 and 
mGluR2
Y781A
 were simulated. Here, the cholesterol density was decreased and blurred out at 
the adjacent mutation sites but also at other cholesterol interaction sites in the protein (Figure 
2.42). The results of the simulation suggested that the loss of the specific interaction sites by 
alanine exchange at one site may also have influence on cholesterol binding at other spots of 
the mGluR2 transmembrane domain. Here, it will be highly interesting to further investigate a 
possible connection between cholesterol interaction and conformational changes of the 
receptor. 
For the future, a detailed investigation on the effects of pharmacological substances on lipid 
binding will help to further understand roles of lipids in modulating receptor activities. Also 
the effects S-palmitoylation on mGluRs should be further investigated: While mGluR2 and 
mGluR4 were negative in the [
3
H]-palmitic acid labelings, a signal was measured for 
mGluR1α. Even though the nature of the modification could not be confirmed with certainty, 
a more detailed investigation may open a new perspective on lipid modifications in mGluRs 
here. 
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4  Materials and Methods 
4.1 Chemicals and consumables 
4.1.1 List of chemicals 
The following table contains the list of chemicals which had been necessary to conduct the 
experimental work described in the following chapter (Table 4.1). All chemicals were stored 
according to manufacturers’ instructions. 
Table 4.1 | List of chemicals. The chemicals were sorted according to the name. The CAS registry numbers 
were assigned according to the labels of the manufacturers. 
Name 
CAS 
Registry 
Number 
Manufacturer 
Purity/ 
Concentration 
Storage 
1,4-Dithio-D,L-threitol 3483-12-3 Gerbu, Heidelberg, Germany ≥99% 4°C 
2-Amino-2-
(hydroxymethyl)propane-1,3-
diol 
77-86-1 Roth, Karsruhe, Germany ≥99.9% RT 
2-Mercaptoethanol 60-24-2 
MerckMillipore, Darmstadt, 
Germany 
≥99.0% 4°C 
4-Morpholinepropanesulfonic 
acid  
1132-61-2 Serva, Heidelberg, Germany n.A. RT 
Acetic acid 64-19-7 
MerckMillipore, Darmstadt, 
Germany 
≥99.8% RT 
Ampicillin sodium salt 69-52-3  
SigmaAldrich, Munich, 
Germany 
n.A. 4°C 
Bromophenol blue 115-39-9 Waldeck, Muenster, Germany n.A. RT 
Calcium chloride dihydrate 10035-04-8 
SigmaAldrich, Munich, 
Germany 
≥99% RT 
Dichloro(1,10-
phenanthroline)copper(II) 
14783-09-6 
SigmaAldrich, Munich, 
Germany 
98% RT 
Dimethyl sulfoxide 67-68-5  
SigmaAldrich, Munich, 
Germany 
≥99.7% RT 
Dodecylsulfate-Na-salt (in 
pellets) 
151-21-3 Serva, Heidelberg, Germany n.A. RT 
Ethylenediaminetetraacetic 
acid dihydrate 
6381-92-6 
AppliChem, Darmstadt, 
Germany 
≥99% RT 
Glycerol 56-81-5 
SigmaAldrich, Munich, 
Germany 
≥99.5% RT 
Glycine 56-40-6 Labochem international n.A. RT 
HEPES 7365-45-9 Roth, Karsruhe, Germany ≥99.5% RT 
Hydrochloric acid 7647-01-0 Honeywell, Morristown, USA 24.5-26.0% RT 
Magnesium chloride 
hexahydrate 
7791-18-6 
MerckMillipore, Darmstadt, 
Germany 
99.0-101.0% RT 
Manganese(II)chloride 
tetrahydrate 
13446-34-9 
SigmaAldrich, Munich, 
Germany 
≥99% RT 
Methanol 67-56-1 VWR Chemicals 99.9% RT 
N-Ethylmaleimide 128-53-0 
SigmaAldrich, Munich, 
Germany 
≥99.0% 4°C 
Polyethylenimine, Linear, 
MW 25000 
9002-98-6 Polysciences, Warrington, USA n.A. RT 
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Name 
CAS 
Registry 
Number 
Manufacturer 
Purity/ 
Concentration 
Storage 
Potassium acetate 127-08-2 
SigmaAldrich, Munich, 
Germany 
99%-101% RT 
Rubidium chloride 7791-11-9 AlfaAesar, Karlsruhe, Germany n.A. RT 
Sodium chloride 7647-14-5 
Fisher Chemicals, 
Loughborough, UK 
99.5% RT 
Sodium Deoxycholate 302-95-4 
SigmaAldrich, Munich, 
Germany 
≥98% RT 
Sodium hydroxide 1310-73-2 
SigmaAldrich, Munich, 
Germany 
≥98% RT 
Sodium phosphate dibasic 
dihydrate 
10028-24-7 Honeywell, Morristown, USA 98.5-101% RT 
Spectinomycin 
Dihydrochloride 
22189-32-8 
Fisher Bioreagents, Schwerte, 
Germany 
> 603μg/mg 4°C 
Triton X-100 9036-19-5 
MerckMillipore, Darmstadt, 
Germany 
n.A. RT 
Urea  57-13-6 
SigmaAldrich, Munich, 
Germany 
≥99.5% RT 
4.1.2 List of bioreagents 
The following table contains the list of bioreagents (excluding antibodies) (Table 4.2). 
Bioreagents had a well-defined composition but were differentiated from chemicals by the 
absence of a CAS registry number. In addition to that, the exact composition was at times for 
many of bioreagents trade secret of the supplier. All bioreagents were stored according to 
manufacturers’ instructions. 
Table 4.2 | Listof bioreagents. The bioreagents were sorted accodring to their name. 
Name Manufacturer 
Manufacturer 
product number 
(Purchase order 
number) 
Purity/ 
Concentration 
Storage 
0.1 % Collagen 
solution in HCl, 
type I 
Biochrom, Berlin, Germany L7220 1 mg/ml 4°C 
10x Pfu buffer EurX, Gdansk, Poland 
(Supplied with 
PfuPlus Polymerase) 
n.A. -20°C 
Albumine Fraction 
V 
Roth, Karlsruhe, Germany 8076.2 ≥98% 4°C 
Alkaline 
Phosphatase, Calf 
Intestinal (CIP) 
NEB, Ipswich, USA M0290L 10,000 U/ml -20°C 
AsiSI NEB, Ipswich, USA R0630S 10,000 U/ml -20°C 
Bacto Agar 
BD Biosciences, Franklin Lakes, 
USA 
214010 n.A. RT 
Bacto Tryptone 
BD Biosciences, Franklin Lakes, 
USA 
211705 n.A. RT 
Bacto Yeast Extract 
BD Biosciences, Franklin Lakes, 
USA 
212750 n.A. RT 
BamHI-HF NEB, Ipswich, USA R3136L 20,000 U/ml -20°C 
BglII NEB, Ipswich, USA R0144L 10,000 U/ml -20°C 
Buffer EB Qiagen, Hilden, Germany 19086 n.A. RT 
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Name Manufacturer 
Manufacturer 
product number 
(Purchase order 
number) 
Purity/ 
Concentration 
Storage 
Cell Dissociation 
Buffer, Enzyme-
free, PBS-based 
Gibco, Waltham, USA 13151-014 n.A. RT 
Cholesterol, [1,2-
3H(N)]- 
PerkinElmer, Waltham, USA NET139 
1 mCi/ml, 
49.8 Ci/mmol 
-20°C 
cOmplete™, 
EDTA-free Protease 
Inhibitor Cocktail 
Roche, Rotkreuz, Switzerland 11873580001 n.A. 4°C 
CutSmart NEB, Ipswich, USA B7204S n.A. -20°C 
Deoxyguanosine 5'-
[8-3H] triphosphate 
American Radiolabeled 
Chemicals, St.Louis, USA 
ART1557 
1 mCi/ml, 
5-20 Ci/mmol 
-20°C 
DNA Polymerase I, 
Large (Klenow) 
Fragment 
NEB, Ipswich, USA M0210S 5,000 U/ml -20°C 
DpnI NEB, Ipswich, USA R0176L 20,000 U/ml -20°C 
Dulbecco’s 
Modified Eagle’s 
Medium (low 
glucose)  
SigmaAldrich, Munich, Germany D6046 n.A. 4°C 
Dulbecco’s 
Phosphate Buffered 
Saline 
SigmaAldrich, Munich, Germany D8537 n.A. RT 
EcoRI-HF NEB, Ipswich, USA R3101S 20,000 U/ml -20°C 
EcoRV-HF NEB, Ipswich, USA R3195L 20,000 U/ml -20°C 
EZ-Link™ Sulfo-
NHS-SS-Biotin 
Thermo Scientific,, Waltham, 
USA 
21331 n.A. -20°C 
EZview™ Red 
ANTI-FLAG® M2 
Affinity Gel 
SigmaAldrich, Munich, Germany F2426 n.A. -20°C 
Fetal Bovine Serum, 
charcoal stripped 
Gibco, Waltham, USA 12676029 n.A. -20°C 
FuGENE® HD 
Transfection 
Reagent 
Promega, Mannheim, Germany E2312 n.A. 4°C 
Kanamycin sulfate SigmaAldrich, Munich, Germany 60615 
784 μg 
Kanamycin 
base per mg 
(dry basis) 
RT 
Lipofectamine® 
2000 Transfection 
Reagent 
LifeTechnologies, Waltham, 
USA 
11668027 n.A. 4°C 
MluI-HF NEB, Ipswich, USA R3198S 20,000 U/ml -20°C 
NEB, Ipswich, 
USAuffer™ 3.1 
NEB, Ipswich, USA B7203S n.A. -20°C 
Nonidet P-40 
Substitute 
Roche, Rotkreuz, Switzerland 11754599001 n.A. 4°C  
NotI-HF NEB, Ipswich, USA R3189L 20,000 U/ml -20°C 
NuPAGE™ 
Antioxidant 
Invitrogen, Waltham, USA NP0005 n.A. 4°C 
NuPAGE™ LDS 
Sample Buffer (4X) 
Invitrogen, Waltham, USA NP0008 n.A. 4°C 
NuPAGE™ Tris-
Acetate SDS 
Running Buffer 
(20X) 
Invitrogen, Waltham, USA LA0041 n.A. 4°C 
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Name Manufacturer 
Manufacturer 
product number 
(Purchase order 
number) 
Purity/ 
Concentration 
Storage 
Opti-MEM™ 
Reduced Serum 
Medium 
 
Gibco, Waltham, USA 
 
31985070 
 
n.A. 
 
4°C 
Palmitic Acid, 
[9,10-3H(N)]- 
PerkinElmer, Waltham, USA NET043 
5 mCi/ml, 
53.7 Ci/mmol 
-20°C 
Penicillin-
Streptomycin 
SigmaAldrich, Munich, Germany P4333 
10000 U/ml 
Penicillin, 
10 mg/ml 
Streptomycin  
-20°C 
PeqGold dNTP-
Mixe Long Range 
Peqlab, Radnor, USA 20-3111 
dATP, dCTP, 
dGTP and 
dTTP each at 
10 mM  
-20°C 
Pfu DNA 
Polymerase Gold 
EurX, Gdansk, Poland 
n.A. (not supplied 
anymore) 
n.A. -20°C 
PfuPlus! DNA 
Polymerase 
EurX, Gdansk, Poland E1118-02 5 U/µl -20°C 
Photosphingosine, 
D-erythro [3-3H]  
American Radiolabeled 
Chemicals, St.Louis, USA 
ART2048 
1 mCi/ml, 
20 Ci/mmol 
-20°C 
Pierce™ High 
Capacity 
NeutrAvidin™ 
Agarose 
ThermoScientific, Waltham, 
USA 
29202 n.A. 4°C 
PmeI NEB, Ipswich, USA R0560S 10,000 U/ml -20°C 
Powdered milk Roth, Karlsruhe, Germany T145.2 
33.0-40% 
protein 
RT 
Precision Plus 
Protein™ All Blue 
Prestained Protein 
Standards 
Bio-Rad, Hercules, USA 1610373 n.A. -20°C 
Q5® High-Fidelity 
DNA Polymerase 
NEB, Ipswich, USA M0491A 2,000 U/ml -20°C 
Q5® Reaction 
Buffer 
NEB, Ipswich, USA B9027S n.A. -20°C 
Roche, Rotkreuz, 
Switzerland X-
treme Gene HP 
Roche, Rotkreuz, Switzerland 6366244001 n.A. 4°C 
SERVA DNA Stain 
Clear G 
Serva, Heidelberg, Germany 39804 n.A. 4°C 
Sphingosine, D-
erythro, [3-3H] 
American Radiolabeled 
Chemicals, St.Louis, USA 
ART0490 
1 mCi/ml, 
20 Ci/mmol 
-20°C 
Standardized Fetal 
Bovine Serum 
Biochrom, Berlin, Germany S0615 n.A. -20°C 
T4 DNA ligase  NEB, Ipswich, USA M0202S 400,000 U/ml -20°C 
T4 DNA Ligase 
Reaction Buffer 
NEB, Ipswich, USA B0202S n.A. -20°C 
Taq DNA 
Polymerase 
Axon, Kaiserslautern, Germany 22466 5 U/µl -20°C 
Trypsin-EDTA 
solution 
SigmaAldrich, Munich, Germany T3924 n.A. 4°C 
Turbofect 
ThermoScientific, Waltham, 
USA 
R0532 n.A. 4°C 
Tween-20 Roth, Karlsruhe, Germany 127.1 n.A. RT 
Ultima Gold™ 
Universal LSC-
Cocktail 
PerkinElmer, Waltham, USA 6013329 n.A. RT 
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4.1.3 List of consumables 
The list of consumables itemizes containers and articles necessary for the preparation of 
samples and realization of experimental procedures (Table 4.3). All consumables were stored 
according to manufacturers’ instructions. 
Table 4.3 | List of consumables. The consumables were sorted accodring to their name. They were stored at 
room temperature if not stated otherwise. 
Name Abbreviation Manufacturer 
Manufacturer 
product number 
(Purchase order 
number) 
Specification 
6-well cell culture 
plate 
6-well plate 
Greiner bio-one, 
Kremsmuenster, 
Austria 
657160 
Polysterol, lid with 
condensation ring 
Cell culture dish 
10cm 
n.A. 
Greiner bio-one, 
Kremsmuenster, 
Austria 
664160 
Polysterol, 100/20 
mm, vents 
Freezing tube CyroS CyroS 
Greiner bio-one, 
Kremsmuenster, 
Austria 
126263 
Polypropylene, screw 
cap 
Micro tube 1.5 ml 1.5 ml micro tube 
Sarstedt, 
Nuembrecht, 
Germany 
72690001 
Polypropylene, 
attached cap 
Microfuge®Tube 
Polyallomer 1.5 mL 
w/Cap 
Ultracentrifuge tube 
BeckmanCoulter, 
Brea, USA 
357448 
Polypropylene, 
9.5x38 mm 
Millex-GS filter 0.22 
µm, 33 mm 
0.22 µm filter 
MerckMillipore, 
Darmstadt, 
Germany 
SLGS033SS Pore size 0.22 µm 
NuPAGE™ 3-8% 
Tris-Acetate Protein 
Gels 
Tris-Acetate gel 
Invitrogen, 
Waltham, USA 
10well: 
EA0375BOX, 
12well: 
EA03752BOX, 
15well:   
EA03755BOX 
SDS-PAGE gel, 1.0 
mm thick, 8x8 cm in 
size,  
stored at 4°C 
Paper for 
chormatography 
n.A. 
Macherey-Nagel, 
Dueren, Germany 
MN827 n.A. 
Pipettor tips Mµlti-
Flex®-tips 
Gel loading tips 
Roth, Karlsruhe, 
Germany 
Y419.1 Polypropylene, round 
Polyvinylidene 
fluoride membrane 
Immobilon®-FL 
PVDF membrane 
MerckMillipore, 
Darmstadt, 
Germany 
IPFL00010 
Polyvinylidene 
fluoride, pore size 
0.45 µm 
QIAGEN Plasmid 
Maxi Kit 
n.A. 
Qiagen, Hilden, 
Germany 
12163 n.A. 
QIAGEN Plasmid 
Midi Kit 
n.A. 
Qiagen, Hilden, 
Germany 
12143 n.A. 
QIAprep Spin 
Miniprep Kit 
n.A. 
Qiagen, Hilden, 
Germany 
27106 n.A. 
QIAquick Gel 
Extraction Kit 
n.A. 
Qiagen, Hilden, 
Germany 
28706 n.A. 
QIAquick PCR 
Purification Kit 
n.A. 
Qiagen, Hilden, 
Germany 
28106 n.A. 
SafeSeal tube 1.5 ml n.A. 
Sarstedt, 
Nuembrecht, 
Germany 
72.706 
Polypropylene, 
attached lid with 
retaining cams 
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Name Abbreviation Manufacturer 
Manufacturer 
product number 
(Purchase order 
number) 
Specification 
TLC Silica gel 60 n.A. 
MerckMillipore, 
Darmstadt, 
Germany 
1.05721.0001 20x20 cm glass plate 
4.2 Cloning and Plasmids 
All reactions and buffers were prepared with autoclaved and demineralized water 
4.2.1 Sequencing reactions and primers 
All sequencing reactions were ordered at Eurofins Genomics/GATC biotech (Luxemburg, 
Luxemburg) as Supremerun Sanger sequencing reaction. The samples were sent as cleaned up 
plasmid DNA prepared with either Qiagen Mini, Midi, or Maxi kit. Sequencing primers were 
ordered directly at Eurofins Genomics/GATC biotech and stored at sight (Table 4.4). 
Table 4.4 | Sequencing primers for Sanger sequencing reactions. All primers without a specific GRM number 
indicate sequencing primers for GRM2 sequencing. All sequences are 5’→3’. 
Primer Sequence 
BGH-Reverse TAGAAGGCACAGTCGAGG 
CMV-F CGCAAATGGGCGGTAGGCGTG 
GATC-GRM1_ORF1500-2042138 TCGCTATGACTATGTGC 
GATC-GRM1_ORF2200-2042141 CCCTTTGGGCTACAATG 
GATC-GRM1_ORF700-2042135 GGAATGGACGCTTTCAAAG 
GATC-grm1400-895721 GCCGCTACAACATCTTCACC 
GATC-grm1500-895721 CCTCTCGCTGCAGTGAGC 
GATC-grm2000-895722 ACGCATCTTCGGTGGGGC 
GATC-GRM4_ORF1350-2024900 TCAACTTCTCAGGCATCGC 
GATC-GRM4_ORF650-2024897 CTATGTGTCCACAGTGG 
GATC-grm650-895720 GACTATGGCGAGACAGGCATTG 
GATC-grm750-895720 TGAGCCGCGCGGCCTTTGAGG 
GATC-pCMV6-PolyARev-1565997 GTCAGACAAAATGATGC 
M13-FP TGTAAAACGACGGCCAGT 
pEGFP-FP TTTAGTGAACCGTCAGATC 
pEGFP-RP AACAGCTCCTCGCCCTTG 
T3 ATTAACCCTCACTAAAGGGA 
T7-981079 TAATACGACTCACTATAG 
SnapGene Viewer 4.1.4 (GSL Biotech LLC, Chicago, USA) and Serial Cloner 2.6.1 
(SerialBasics, France) were used for analyzing the ab1-sequencing files and sequencing 
alignments respectively. 
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4.2.2 List of cloning and mutagenesis primers 
All primers were ordered at biomers.net (Ulm, Germany) as cartridge-purified DNA 
oligomers at scale “XS” (0.02 µmol) without internal or end modifications (Table 4.5). The 
dried oligomers were resolvated in Buffer EB to a final concentration of 100 pmol/µl. To 
generate a PCR primer mix, forward (frwd) and reverse (rev) primers were diluted in Buffer 
EB to a final concentration of 10 pmol/µl and stored at -20°C until further use. 
Table 4.5 | Cloning and mutagenesis primers. The primer names indicated left hand site are identical to the 
names on the orders and tubing. All sequences are 5’→3’. 
Primer Sequence 
Grm2_RBS_BglII_Frwd GGTACCGAGGAGATCTGCCG 
Grm2_Flag_EcoRV_Rev TATAGATATCATTTGCTGCACGCGTAAGCGATGACGTTGTCG 
Grm2_Myc_PmeI_Rev TATAGTTTAAACCAGATCCTCTTCTGAGATGAGTTTCTGCTC 
Grm2_SP_BamHI_Frwd TATAGGATCCGAGGGCCCAGCCAAGAAGG 
Grm2_Myc_PacI_Rev TATATTAATTAAACCAGATCCTCTTCTGAGATGAGTTTCTGCTC 
Grm2_C121A_frwd CACGCCACATCGCCCCCGACGGCTCTTATG 
Grm2_C121A_rev CATAAGAGCCGTCGGGGGCGATGTGGCGTG 
GRM2_C121A_L698C_frwd CATCGTGGTCGCCTGGTGCGTGGTGGAGGC 
GRM2_C121A_L698C_rev GCCTCCACCACGCACCAGGCGACCACGATG 
GRM2_C121A_Y734C_frwd CTCGCTGGCCTGCAATGTGCTCCTCATC 
GRM2_C121A_Y734C_rev GATGAGGAGCACATTGCAGGCCAGCGAG 
GRM2_C121A_V782C_frwd CCATCTTCTATTGCACCTCCAGTGACTACCG 
GRM2_C121A_V782C_rev CGGTAGTCACTGGAGGTGCAATAGAAGATGG 
Grm2C121A*_L698C_frwd CTCATCGTGGTCGCCTGGTGCGTGGTGGAGGC 
Grm2C121A*_L698C_rev GCCTCCACCACGCACCAGGCGACCACGATGAG 
Grm2_W567A_frwd CTGGGGCGATGCCGCGGCTGTGGGAC 
Grm2_W567A_rev GTCCCACAGCCGCGGCATCGCCCCAG 
GRM2_Y607A_frwd CAGGTCGGGAGCTCTGCGCCATCCTGCTGG 
GRM2_Y607A_rev CCAGCAGGATGGCGCAGAGCTCCCGACCTG 
Grm2_W697A_frwd CTCATCGTGGTCGCCGCGCTGGTGGTGGAG 
Grm2_W697A_rev CTCCACCACCAGCGCGGCGACCACGATGAG 
Grm_W697A_frwd(2) CATCGTGGTCGCCGCGCTGGTGGTGG 
Grm_W697A_rev(2) CCACCACCAGCGCGGCGACCACGATG  
GRM2_Y734A_frwd GCTCGCTGGCCGCCAATGTGCTCCTCATC 
GRM2_Y734A_rev GATGAGGAGCACATTGGCGGCCAGCGAGC 
Grm2_Y745A_frwd CTCTGCACGCTTGCTGCCTTCAAGACTCG 
Grm2_Y745A_rev CGAGTCTTGAAGGCAGCAAGCGTGCAGAG 
Grm2_Y767A_frwd GCTTCACCATGGCCACCACCTGCATCATCTG 
Grm2_Y767A_rev CAGATGATGCAGGTGGTGGCCATGGTGAAGC 
Grm2_W773_frwd GTACACCACCTGCATCATCGCGCTGGCATTCC 
Grm2_W773_rev GGAATGCCAGCGCGATGATGCAGGTGGTGTAC 
Grm2_Y781A_frwd CTGCCCATCTTCGCTGTCACCTCCAGTGACTAC 
Grm2_Y781A_rev GTAGTCACTGGAGGTGACAGCGAAGATGGGCAG 
GFP_Frwd TATAGCGGCCGCTCGTGAGCAAGGGCGAGGAG 
GFP_Rev TATAGATATCATTTGCTGCCCTGTACAGCTCG 
GFP_GlySer_Frwd TATAGCGGCCGCAGGGCGGAGGCGGAAGCGTGAGCAAGGGCGAGGAG 
GFP_A207K_frwd GCACCCAGTCCAAGCTGAGCAAAGACCCCAAC 
GFP_A207K_rev GTTGGGGTCTTTGCTCAGCTTGGACTGGGTGC  
ADBR2_frwd TATAGCGATCGCCATGAAGACCATCATCGCC 
ADBR2_rev TATAGTTTAAACCAGCAGTGAGTCATTTGTACTACAATTC 
HTR2A_frwd TATAGCGATCGCCATGGAACAAAAACTTATTTCTGAAGAAGATC 
HTR2A_rev TATAGTTTAAACCACACAGCTCACCTTTTCATTCAC 
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Primer Sequence 
HTR2A_Cmyc_frwd TATAGCGATCGCCATGGATATTCTTTGTGAAGAAAATACTTCTTTG 
HTR2A_Cmyc_rev TATAGCGGCCGCGTGCGTGTCACACAGCTCACCTTTTCATTC 
HTR2A_Cflag_rev TATAACGCGTCACACAGCTCACCTTTTCATTC 
ADRB2_cFlag_frwd TATAGCGATCGCCATGGGGCAACCCGGGAAC 
ADRB2_cFlag_rev TATAACGCGTCAGCAGTGAGTCATTTGTACTACAATTC 
ADRB2_cMyc_rev TATAGCGGCCGCGTGCGTGTCAGCAGTGAGTCATTTGTACTACAATTC 
5HTR1A_CF_frwd TATAGCGATCGCCATGGATATGTTCAGTCTTGGCC 
5HTR1A_CF_rev TATAACGCGTGCGGCAGAACTTGCAC 
ADA2A_CF_frwd TATAGCGATCGCCATGGGCTCCCTGCAG 
ADA2A_CF_rev TATAACGCGTCACGATCCGCTTCCTG 
GRM4_CF_frwd TATAGCGATCGCCATGCCTGGGAAGAGAGG 
GRM4_CF_rev TATAACGCGTGATTGCATGGTTGGTGTAAGTG 
GRM1_CF_frwd TATAGCGATCGCCATGGTCGGGCTCCTTTTG 
GRM1_CF_rev TATAACGCGTCAGGGTGGAAGAGCTTTG 
GRM1_CF_rev2 TATAACGCGTCAGGGTGGAAGAGCTTTGC 
ADRB2_C341A_f CAGGAGCTTCTGGCCCTGCGCAGGTCTTCTTTG 
ADRB2_C341A_r CAAAGAAGACCTGCGCAGGGCCAGAAGCTCCTG 
ADRA2A_C442A_f CTTCAAGAAGATCCTCGCTCGGGGGGACAG 
ADRA2A_C442A_r CTGTCCCCCCGAGCGAGGATCTTCTTGAAG 
HTR1A_C417A_f GAAGATCATCAAGGCCAAGTTCTGCCGCACG 
HTR1A_C417A_r CGTGCGGCAGAACTTGGCCTTGATGATCTTC 
HTR1A_C420A_f GATCATCAAGGCCAAGTTCGCCCGCACGCGTG 
HTR1A_C420A_r CACGCGTGCGGGCGAACTTGGCCTTGATGATC 
4.2.3 Chemocompetent Escherichia coli 
Chemocompetent bacteria were grown in LB medium without selection. All bacterial stocks 
were obtained from Alexia Herrmann (AG Britta Bruegger, Heidelberg University 
Biochemistry Center). For the preculture, 10 ml LB medium (10 g Tryptone, 5 g Yeast 
Extract, 10 g NaCl, fill up to 1 l with ddH2O) were inoculated with Escherichia coli (E.coli) 
bacteria from stock. The bacteria grew overnight at 37°C under constant shaking at 180 rpm. 
The grown preculture was used the next day to inoculate a 400 ml LB culture. The main 
culture was grown to an OD600 = 0.4. 
The cells from the main culture were pelleted (4000 x g, 15 min, 4°C). The cell pellets were 
resuspended on ice in a total volume of 50 ml Resuspension buffer (30 mM CH3COOK-
CH3COOH pH 5.8, 50 mM MnCl2, 100 mM RbCl, 10 mM CaCl2, 15%(V/V) glycerol). The 
bacteria were then pelleted again at 3000 x g for 10 min at 4°C. The final pellets were taken 
up in a total volume of 10 ml Freezing buffer (10 mM MOPS-NaOH pH 7.0, 75 mM CaCl2, 
10 mM RbCl, 15%(V/V) glycerol). The prepared chemocompetent bacteria were aliquoted and 
stored at -80°C until further use. 
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4.2.4 Transformation protocol 
Chemocompetent E.coli cells were allowed to defrost on ice for (10 – 30) min. Then DNA 
(10 ng Plasmid DNA or 10 μl Ligation/ PCR reaction) was added to the defrosted bacteria and 
incubated for another (20 – 30) min on ice. The heat shock was carried out for (30 – 60) sec at 
42°C. The cells settled for another (2 – 5) min on ice afterwards. The transformed E.coli cells 
recovered for (30 – 60) min at 37°C in 1 ml LB medium without antibiotics to allow for the 
expression of resistance genes. After the recovery, the bacteria were pelleted by centrifugation 
(5 min at 300 x g) and resuspended in about (100 – 200) μl of supernatant. The cell 
suspension was plated on a LB-agar (LB medium, 3.75 g agar/250 ml) selection plate with 
accommodated antibiotic. 
4.2.5 pCMV6 vector control 
The empty pCMV6 vector control was generated from the commercially available plasmid 
pCMV6_GRM2_MycFlag sold by OriGene (Rockville, USA) as GRM2 (Myc-DDK-tagged)-
Human glutamate receptor (RC218103). 
The plasmid pCMV6_GRM2_MycFlag was digested with BglII and NotI-HF in NEB3.1 
buffer. The 5’ overhangs of the digested vector were filled up with Klenow Polymerase 
according to manufacturers’ protocol. The blunt ends were ligated with T4 DNA ligase 
overnight at 16°C. The ligation product was transformed into chemocompetent E.coli Stbl3. 
Identity of clones was confirmed by sequencing with CMV-F at Eurofins Genomics/GATC 
biotech. The final construct was pCMV6 vector control. 
4.2.6 Flag-tagged and Myc-tagged GRM2 constructs 
The GRM2 and GRM2
C121A
 constructs carrying either a Myc- or a Flag-Tag at the C-terminal 
end were cloned from the pCMV6_GRM2_MycFlag and the pCMV6_GRM2
C121A
_MycFlag 
vector (for details see Wiedemann (243)) respectively. The GRM2 open reading frames 
(ORFs) were amplified with extensions from double-tagged vectors and were inserted again 
in the corresponding digested pCMV6 vector. 
The ORF was amplified with Q5 DNA Polymerase (NEB) using either the primer pair 
Grm2_RBS_BglII_Frwd/ Grm2_Flag_EcoRV_Rev for the Flag-tagged construct or the 
primer pair Grm2_RBS_BglII_Frwd/ Grm2_Myc_PmeI_Rev for the Myc-tagged construct 
(Table 4.6).  
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Table 4.6 | Q5 PCR protocol for Flag- and Myc-tagged constructs. (A) Pipetting scheme PCR reaction. (B) 
Reaction cycle mPCR 
A Component Volume [µl] B Cycle Temperature [°C] Time 
ddH20 35.5 Activation 98 30 sec 
dNTPs 1 Melting 98 30 sec (30x) 
Template DNA (10 ng/µl) 1 Annealing 65 30 sec (30x) 
Primermix (10 pmol/µl) 2 Extension 72 2 min (30x) 
5x Q5 buffer 10 Final elongation 72 2 min 
Q5 Polymerase 0.5    
The PCR products with a size of 2.67 kb and 2.7 kb were cleaned up from agarose gel 
(stained with Serva DNA Stain Clear G). The PCR product and the backbone was prepared by 
double digestion with BglII/EcoRV-HF in buffer NEB3.1 in the case of the Flag-tagged 
construct, or consecutive digestion with BglII in NEB3.1 and PmeI in CutSmart in the case of 
the Myc-tagged construct. The digested backbones were cleaned up from agarose gel and 
subsequently dephosphorylated with Calf Intestinal Alkaline Phosphatase (CIP). The digested 
PCR products were finalized with the PCR purification kit. The prepared PCR products and 
backbones were ligated using T4 DNA ligase according to manufacturers’ protocol. The 
ligation product was transformed into chemocompetent E.coli Stbl3. The identity of clones 
was confirmed by sequencing with CMV-F, GATC-grm750-895720, GATC-grm1500-89572, 
and GATC-grm2000-895722 at Eurofins Genomics/GATC biotech. The plasmids cloned 
were pCMV6_GRM2
Wt
_Flag, pCMV6_GRM2
Wt
_Myc, pCMV6_GRM2
C121A
_Flag, and 
pCMV6_GRM2
C121A
_Myc. 
4.2.7 GRM2C121A double mutants for crosslinking 
The GRM2
C121A 
double mutants were based on the pCMV6_GRM2
C121A
_MycFlag construct 
and used for Cysteine crosslinking experiments. All mutants were generated using 
mutagenesis PCR (mPCR) according to the Stratagene QuikChange protocol (244) with 
modifications (Table 4.8). The primers were designed with the PrimerX web program, hosted 
by bioinformatics.org (245), based on the complete DNA sequence of the template plasmid. 
The “QuikChange Site-Directed Mutagenesis Kit by Stratagene” primer design protocol was 
used as basis for the calculation of optimal primer properties. To facilitate automatic 
generation of primers on the GC-rich template, adjustments were made in the settings of 
PrimerX (Table 4.7). 
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Table 4.7 | Settings PrimerX DNA-based mutagenesis primer design. The table returns the values of the 
adjusted parameters in the PrimerX web program. 
Parameter Value 
Melting temp 75 to 85°C 
GC content 40 to 65% 
Length 25 to 45 bp 
5' flanking region 11 to 21 bp 
3' flanking region 11 to 21 bp 
Terminates in G or C Yes 
Mutation site at center Not required 
For the mPCR, the template plasmid was obtained as DNA preparation from E.coli Stbl3. The 
plasmids were amplified with the mutagenesis primer pairs GRM2_C121A_L698C_frwd/rev, 
GRM2_C121A_Y734C_frwd/rev, and GRM2_C121A_V782C_frwd/rev. In deviation of 
standard protocol, Pfu Polymerase Gold and corresponding 10x Pfu buffer was used for the 
reaction. 
Table 4.8 | mPCR protocol GRM2
C121A
 double mutants. (A) Pipetting scheme PCR reaction. (B) Reaction 
cycle mPCR 
A Component Volume [µl] B Cycle Temperature [°C] Time 
ddH20 40 Activation 95 5 min 
dNTPs 1 Melting 95 30 sec (18x) 
Plasmid DNA (100 ng/µl) 1 Annealing 65-70 60 sec (18x) 
Primermix (10 pmol/µl) 2 Extension 68 10 min (18x) 
10x EurX Pfu Buffer 5 Final 
elongation 
68 15 min 
EurX Pfu Polymerase Gold 1 
After the mPCR, the DNA was digested for 1 h with DpnI. The enzyme was applied directly 
to the PCR mix. About (5 – 10) µl of the final reaction mix were used for transformation into 
chemocompetent E.coli Stbl3. Identity of clones was confirmed by sequencing with CMV-F, 
GATC-grm750-895720, GATC-grm1500-89572, and GATC-grm2000-895722 at Eurofins 
Genomics/GATC biotech. The final constructs were pCMV6_GRM2
C121A/L698C
_MycFlag, 
pCMV6_GRM2
C121A/Y734C
_MycFlag, and pCMV6_GRM2
C121A/Y734C
_MycFlag. 
4.2.8 eGFP-tagged GRM2 variants 
The eGFP-tagged variants of GRM2 were based on a mutagenized eGFP version which was 
cloned into a pCMV6_GRM2_MycFlag plasmid.  
In the first step, the template plasmid (pEGFP-FLAG-BBS-1) was mutagenized in the eGFP 
ORF at position A207. The primer pair GFP_A207K_frwd/rev was designed in PrimerX web 
program and applied to the template plasmid following the Strategene QuikChange protocol 
(244) with minor changes (Table 4.10). The annealing temperature was adjusted to 60°C. The 
DpnI digested mPCR products were transformed into E.coli DH5α and selected on a 50 µg/ml 
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kanamycin LB-agar selection plate. Positive clones were identified by Sanger sequencing 
with CMV-F primer at Eurofins Genomics/GATC biotech. 
To get the insert, the eGFP
A207K
 ORF of the pEGFP
A207K
-FLAG-BBS-1 plasmid was 
amplified by PCR with the primer pairs GFP_Frwd/Rev or GFP_GlySer_Frwd/GFP_Rev 
(Table 4.9). The later one contained a DNA fragment coding for a glycine-serine linker. 
Table 4.9 | Q5 PCR protocol eGFP
A207K
 constructs. (A) Pipetting scheme PCR reaction. (B) Reaction cycle PCR. 
A Component Volume [µl] B Cycle Temperature [°C] Time 
ddH20 35.5 Activation 98 30 sec 
dNTPs 1 Melting 98 30 sec (30x) 
Template DNA (10 ng/µl) 1 Annealing 58 30 sec (30x) 
Primermix (10 pmol/µl) 2 Extension 72 1 min (30x) 
5x Q5 buffer 10 Final elongation 72 2 min 
Q5 Polymerase 0.5    
To get the backbone, pCMV6_GRM2_MycFlag was double digested with NotI-HF/EcoRV-
HF in CutSmart buffer. Both the PCR product of the eGFP
A207K
 insert and the digested 
pCMV6_GRM2 backbone were cleaned up from agarose gel. The purified eGFP
A207K
 insert 
was subjected to double digest with NotI-HF/EcoRV-HF in CutSmart buffer and isolated with 
Qiagen PCR purification kit. The backbone was dephosphorylated using the CIP protocol and 
cleaned up with Qiagen PCR purification kit afterwards.  
The digested insert and the dephosphorylated backbone were ligated with T4 DNA ligase 
overnight at 4°C, for 6 h at 16°C and 1 h at 24°C. The ligation product was transformed into 
E.coli Stbl3 and selected on a 25 µg/ml kanamycin LB-agar selection plate. Positive clones 
were picked from the selection plate and linearized with EcoRV-HF to find constructs with 
insert. The identity of clones was confirmed by sequencing with CMV-F, GATC-grm750-
895720, GATC-grm1500-89572, GATC-grm2000-895722, pEGFP-FP, and GATC-pCMV6-
PolyARev-1565997 at Eurofins Genomics/GATC biotech. The final constructs were 
pCMV6_GRM2-Gly4Ser-eGFP
A207K
_Flag and pCMV6_GRM2-eGFP
A207K
_Flag. 
4.2.9 GRM2Wt and GRM2C121A W→A and Y→A variants 
For the alanine screening different tryptophan and tyrosine residues in the transmembrane 
domain of GRM2 were targeted and changed to alanine by site-directed mutagenesis. The 
constructs pCMV6_GRM2
Wt
_Flag, pCMV6_GRM2
Wt
_Myc, pCMV6_GRM2
C121A
_Flag, and 
pCMV6_GRM2
C121A
_Myc served as templates for the mPCR reactions yielding in total 32 
different constructs. 
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The mutagenesis primers were designed in PrimerX as described Section 4.2.7. To facilitate 
automatic generation of primers on the GC-rich template, the settings in the primer design 
step had to be adjusted to a melting temperature of up to 85°C and a GC-content of up to 80% 
(Table 4.7). The mPCR was carried out according to the Stratagene QuikChange protocol 
(244) with minor adjustments (Table 4.10). 
Table 4.10 | mPCR protocol GRM2
Wt
 and GRM2
C121A
 W→A and Y→A variants. (A) Pipetting scheme PCR 
reaction. (B) Reaction cycle mPCR. The value x for the cycle step annealing was adjusted to 52°C for W697A 
and Y745A, to 55°C for W567A, Y734A, W773A, and Y781A, and to 60°C for Y607A and Y767A. 
A Component Volume [µl] B Cycle Temperature [°C] Time 
ddH20 40 Activation 95 2 min 
dNTPs 1 Melting 95 1 min (18x) 
Plasmid DNA (100 ng/µl) 1 Annealing x 1-2 min (18x) 
Primermix (10 pmol/µl) 2 Extension 68 11 min (18x) 
10x EurX Pfu Buffer 5 Final 
elongation 
68 15 min 
EurX Pfu Polymerase 1 
The mPCR products were digested and transformed into E.Coli Stbl3 as described earlier. 
Identity of clones was confirmed by sequencing with CMV-F, GATC-grm750-895720, 
GATC-grm1500-89572, and GATC-grm2000-895722 at Eurofins Genomics/GATC biotech. 
The 32 constructs were Flag- or Myc-tagged single or double mutants based on the constructs 
described in Section 4.2.6 with single alanine mutations in the GRM2 ORF at positions 
W567, Y607, W697, Y734, Y745, Y767, W773 or Y781. 
4.2.10 Flag-and Myc-tagged GPCRs 
cDNA clones of ADRB2 and HTR2A were obtained as from Addgene (Cambridge, USA) as 
β₂AR-mCFP (Addgene plasmid #38260, deposited by Robert Lefkowitz (152)) and c-Myc-5-
HT2A (Addgene plasmid #67944, deposited by Javier Gonzalez-Maeso (154)). Further cDNA 
clones for Htr1a (mouse), ADRA2A, GRM1 and GRM4 were purchased from BioCat 
(Heidelberg, Germany) as 5-hydroxytryptamine (serotonin) receptor 1A (BC138681-seq-
TCMS1004-GVO-TRI), alpha-2A Adrenergic receptor (BC035047-seq-TCHS1003-GVO-
TRI), Glutamate receptor metabotropic 1 (BC111844-TOH6003-GVO-TRI) and Glutamate 
receptor, metabotropic 4 (BC130526-TCH1003-GVO-TRI) respectively. 
4.2.10.1 ADRB2 and HTR2A contructs 
The Addgene plasmids with cDNA clones ADRB2 and HTR2A were delivered as agar stab. 
Single colonies were obtained by streaking resuspended bacterial agar on a 100 µg/ml 
ampicillin LB-agar selection plate. Single clones were picked and sequenced at Eurofins 
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Genomics/GATC biotech. ADRB2 was sequenced with CMV-F, BGH-Reverse, and pEGFP-
RP. For HTR2A I used CMV-F and BGH-Reverse. 
10 ng plasmid was used to isolate the ORF sequence and adjacent tags (PCR protocol see 
Table 4.9). For ADRB2, I used the primer pair ADBR2_frwd/rev to isolate the ORF with the 
N-terminal Flag-tag, ADRB2_cFlag_frwd/rev to generate a clone with C-terminal Flag-tag 
and ADRB2_cFlag_frwd/ADRB2_cMyc_rev to tag the ORF C-terminally with a Myc-tag. 
For the N-terminal Flag tag, both the PCR product and pCMV6_GRM2_MycFlag were 
double digested with AsiSI and PmeI in CutSmart. The insert and backbone, 
pCMV6_GRM2_Flag, of the C-terminal Flag-tag construct were double digested with AsiSI 
and MluI-HF in CutSmart. For the Myc-tagged ADRB2 version, the PCR product and the 
pCMV_GRM2_Myc vector were digested with AsiSI and NotI-HF. The digested inserts and 
backbones were ligated as described in Section 4.2.8. The ligation products were transformed 
into E.coli Stbl3 and positive clones selected on 25 µg/ml Kanamycin LB-agar selection 
plates. The clones were tested by linearization with BamHI-HF and subsequently sequenced 
with CMV-F and GATC-pCMV6-PolyARev-1565997 at Eurofins Genomics/GATC biotech. 
The resulting constructs were pCMV6_NFlag_ADRB2, pCMV6_ADRB2_Flag, and 
pCMV6_ADRB2_Myc. 
The HTR2A constructs were clones in a similar manner as described beforehand. The ORF 
was isolated using the PCR setup as described in Table 4.9. The N-terminally Myc-tagged 
contruct was isolated with the primer pair HTR2A_frwd/rev. For the C-terminal Flag-tagged 
construct, the primer pair HTR2A_Cmyc_frwd/HTR2A_Cflag_rev was used. The Myc-
tagged version was prepared with primer pair HTR2A_Cmyc_frwd/rev. N-Myc insert and the 
corresponding backbone were double digested with AsiSI and PmeI in CutSmart. C-Flag 
constructs were digested with AsiSI and MluI-HF in CutSmart, and C-Myc fragments were 
incubated with AsiSI and NotI-HF in CutSmart as well. The ligation, transformation and 
selection of clones were performed as for ADRB2. The final constructs were 
pCMV6_NMyc_HTR2A, pCMV6_HTR2A_Flag and pCMV6_HTR2A_Myc. 
4.2.10.2 HTR1A, ADRA2A, GRM1 and GRM4 constructs 
The cDNA clones of Htr1a (mouse), ADRA2A, GRM1, and GRM4, were cloned as C-
terminally Flag-tagged constructs into the pCMV6 vector. The constructs had been delivered 
as agar stab and were propagated in the corresponding selection medium: the pCR4-TOPO 
constructs HTR1A and GRM4 were cultured in 25 µg/ml kanamycin, the pENTR223-1 vector 
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with GRM1 in 50 ug/ml spectinomycin and pBluescriptR_ADRA2A in 100 µg/ml ampicillin. 
The identity of the clones was confirmed by partial Sanger sequencing of the ORF at Eurofins 
Genomics/GATC biotech. HTR1A and GRM4 constructs were sequenced with sequencing 
primer T3, ADRA2A with T7-981079, and GRM1 with M13-FP. 
The inserts were successfully amplified by PCR for HTR1A (5HTR1A_CF_frwd/rev), GRM1 
(GRM1_CF_frwd/rev2) and GRM4 (GRM4_CF_frwd/rev) by the Q5 DNA polymerase 
standard protocol described in Table 4.9. For ADRA2A (ADA2A_CF_frwd/rev) the PCR 
reaction had to be supplied with GC-enhancer (supplied with Q5 DNA polymerase). All PCR 
products and pCMV6_GRM2_Flag were digested with AsiSI and MluI-HF in CutSmart 
buffer. The digested pCMV6 backbone DNA was cleaned up from agarose gel and 
dephosphorylated with CIP protocol. The prepared insert and backbone DNA were ligated 
and transformed into E.coli Stbl3 as described in section 4.2.8. 
Positive clones were identified by digesting the different clones again with AsiSI and MluI-
HF. For ligated GRM1 constructs, colony PCR was applied to screen larger sets of clones 
(Table 4.11). 
Table 4.11 | Colony PCR protocol. (A) Pipetting scheme for one colony PCR. The reaction was conducted with 
the GRM1_CF_frwd/rev2 primer pair. Reagents marked with an asterisk (*) were supplied with Taq DNA 
Polymerase. (B) Reaction cycle colony PCR. 
A Component Volume [µl] B Cycle Temperature [°C] Time 
ddH20 15.4 Activation/ 
Denaturation 
95 4 min 
dNTPs 0.4 
25 mm MgCl2* 1.6 Melting 95 1 min (35x) 
Bacterial sample - Annealing 60 1 min (35x) 
Primermix (10 pmol/µl) 0.4 Extension 72 3:30 min (35x) 
10x Mg-free buffer B* 2.0 Final elongation 72 5 min 
Taq DNA Polymerase 0.2    
The identity of the positive clones was confirmed by sequencing with CMV-F and PolyARev-
1565997 at Eurofins Genomics/GATC biotech. For larger constructs, GRM1 and GRM4, 
additional sequencing primers were designed: GATC-GRM1_ORF700-2042135, GATC-
GRM1_ORF1500-2042138, GATC-GRM1_ORF2200-2042141 for GRM1, and GATC-
GRM4_ORF650-2024897, GATC-GRM4_ORF1350-2024900 for GRM4. The final 
constructs were pCMV6_Htr1a_Flag, pCMV6_ADRA2A_Flag, pCMV6_GRM1_Flag and 
pCMV6_GRM4_Flag. 
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4.2.11 Cloning of GPCR palmitoylation mutants 
Selected constructs described in section 4.2.10.1 and 4.2.10.2 were used to generate C→A 
mutants. The mutations sites were estimated from literature on loss-of-function of 
palmitoylation at the C-terminal tail of the GPCRs. For Htr1a, the mutation sites were 
estimated from the C417A and C420A single and double mutants described by Papoucheva, 
Dumuis (176). The ADRA2A mutant C442A was published by Kennedy and Limbird (156). 
Finally, for the ADRB2 mutation site C341A biochemical and structural evidence was found 
by Odowd, Hnatowich (76) and Cherezov, Rosenbaum (20). 
The Flag-tagged pCMV6 cDNA clones pCMV6_HTR1A_Flag, pCMV6_ADRA2A, and 
pCMV6_ADRB2_CFlag were used to design mutagenesis primers with PrimerX as described 
earlier (Section 4.2.7). The plasmids were amplified with the mutagenesis primer pairs 
HTR1A_C417A_f/r, HTR1A_C420A_f/r, ADRA2A_C442A_f/r, and ADRB2_C341A_f/r. In 
deviation of the standard protocol, I used Pfu Plus and the corresponding 10x Pfu buffer for 
the mPCR (Table 4.12). 
Table 4.12 | mPCR protocol GPRC C→A mutants. (A) Pipetting scheme mPCR reaction. (B) Reaction cycle 
mPCR. 
A Component Volume [µl] B Cycle Temperature [°C] Time 
ddH20 40.5 Activation 95 1 min 
dNTPs 1 Melting 95 45 sec (18x) 
Plasmid DNA (50 ng/µl) 1 Annealing 65-70 1 min (18x) 
Primermix (10 pmol/µl) 2 Extension 68 7 min (18x) 
10x EurX Pfu Buffer 5 
Final 
elongation 
68 7 min 
EurX Pfu Plus 0.5    
The mPCR products were digested and transformed into E.Coli Stbl3 as described earlier and 
positive clones selected on 25 µg/ml Kanamycin LB-agar selection plates. Identity of clones 
was confirmed by sequencing with CMV-F and GATC-pCMV6-PolyARev-1565997 at 
Eurofins Genomics/GATC biotech. The final constructs obtained were 
pCMV6_Htr1a
C417A
_Flag, pCMV6_Htr1a
C417A/C420A
_Flag, and pCMV6_ADRB2
C341A
_Flag. 
4.3 Cell lines and cell culture 
For cell maintenance and as required for experiments, the human cells lines were kept in CO2-
incubators (Standard laboratory: Forma SteriCycle CO2 incubator, ThermoFisher, Waltham, 
USA; Isotope laboratory: BBD 6220, Hereaus, Hanau, Germany) at 37°C and 5% CO2 in a 
water saturated atmosphere. All bench work with the cells was conducted under sterile 
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conditions in a laminar flow hood (HeraSafe KS12 Safety Cabinet, EN12469:2000, Class II, 
ThermoFisher) with equipment, in so far required, disinfected with 70% ethanol(aq) solution. 
All consumables and chemicals used were either supplemented as cell culture grade from 
suppliers or sterilized by autoclaving or filtration. 
4.3.1 Hek293 
Hek293 cells were obtained from AG Felix Wieland (Heidelberg University Biochemistry 
Center). The cells were cultured in DMEM complete growth medium. To make DMEM 
complete growth medium, Dulbecco’s Modified Eagle’s Medium (DMEM) was supplied with 
final concentration of 100 U/ml penicillin, 0.1 mg/ml streptomycin (PS) and 10% 
Standardized Fetal Bovine Serum (FBS). FBS was supplemented as heat-inactivated stock 
treated at 56°C for 45 min. 
4.3.2 Hek293ΔSGPL1 
The knock-out of Sphingosine-1-phosphate lyase 1 (SGPL1) gene was conducted with the 
genetic scissors of the CRISPR-Cas9 system in Hek293 cells. The CRISPR-Cas9 plasmids for 
the target gene were designed by Per Haberkant (80) and a copy obtained from Mathias Gerl 
(178). The cloning and cell culture work was conducted as part of the master‘s thesis of 
Hannah Olschowski, nee Wiedemann (243). The cells were cultures as described in Section 
4.3.1. 
4.3.3 Hek293T 
Hek293T cells were obtained from ATCC as 293T cell line (ATCC CRL-3216, Order No 
W002940). The cells were cultured in DMEM complete growth medium supplemented with 
heat-inactivated FBS. 
4.3.4 Subculturing procedure 
Hek293 and Hek293T cells grew as adherent cells on Collagen A-coated (0.1 % Collagen 
stock solution in HCl(aq)) 10 cm cell culture dishes. To coat the cell culture dishes, they were 
incubated with a final concentration of 0.01% Collagen A in Dulbecco’s Phosphate Buffered 
Saline (PBS) for at least 30 min at 37°C. Cell culture dishes or well plates for experiments 
were coated with final concentration of 0.02% Collagen A to provide better adherence during 
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the experimental procedures. After incubation with Collagen A solution, the PBS dilution was 
aspirated and the coated surface washed once with room temperature PBS. 
To passage the cells, the cell layer was grown to a confluency of 70-80%. The cell layer was 
then washed once with room temperature PBS and cells were enzymatically detached 
(Trypsin-EDTA solution) for about (1 – 3) min. Detached cells were diluted 1:10 or 1:20 in 
DMEM complete growth medium. The diluted cell suspension was plated on a Collagen A-
coated 10 cm cell culture dish (total of ~1x10
6
 or 5x10
5
 cells per dish). Cells were passaged 
every 3-4 days and not more than 20 times before using a new batch. 
4.3.5 Cyropreservation of cells 
As for subculturing, the cells were grown to a confluency of 70-80% in a 10 cm cell culture 
dish, enzymatically detached and diluted in DMEM complete growth medium. One dilution in 
DMEM complete growth medium contained a total of 5x10
6
 cells making one freezing batch. 
The cells of one freezing batch were spun down for 5 min at 200 x g and 4°C. The cell pellet 
was resuspended in 1 ml DMEM cryopreservation medium. The base of the DMEM 
cryopreservation medium was DMEM complete growth medium which was supplemented 
with 5%(V/V) of dimethyl sulfoxide (DMSO) and 5%(V/V) of heat-inactivated FBS. The cells 
suspension was transferred into a freezing tube (CyroS). The freezing tube was cooled down 
by placing it on ice for about 5 min, then into -20°C freezer for 1h and to -80°C for about 16h 
before transferring it to liquid nitrogen. All human cell lines were kept in liquid nitrogen for 
long-term storage. 
4.3.6 Defrosting of cells 
To defrost and recultivate human cells, freezing tubes were removed from the liquid nitrogen 
tank and placed on dry ice for transport. The freezing tube was then warmed by gentle 
agitation in a 37°C water bath. As soon as the content had thawed, the cell suspension in 
DMEM cryopreservation medium was diluted 1:10 with cold DMEM complete growth 
medium. The cells were then pelleted by centrifugation at 300 x g for 5 min and 4°C. The cell 
pellet was resuspended in 10 ml room temperature DMEM complete growth medium and the 
cell suspension plated on a Collagen-A coated 10 cm cell culture plate. Before starting an 
experiment, the cells were subcultured at least three times. 
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4.3.7 Transfection procedures 
For transient transfection of cells with empty pCMV6 or expression vectors, the cells were 
seeded 16-18h before the transfection into either 6-well cell culture dishes or 10 cm cell 
culture plates. If not stated otherwise, the cell culture medium remained unchanged in the 
course of the transfection. 
For transfection with FuGENE HD transfection reagent (FuGENE HD), the transfection mix 
was prepared according to manufacturers’ instructions (246) in OptiMem medium with 
plasmid DNA solved in Buffer EB. The DNA was usually supplied from a plasmid DNA 
stock with a concentration of (100 ± 1) ng/µl. The ratio between µg of DNA and µl of 
FuGENE HD was 1:3. The transfection mix was incubated (10 ± 2) min at room temperature 
before adding the complete batch to the DMEM complete growth medium. FuGENE HD was 
used as standard transfection reagent with the indicated amounts of DNA if not stated 
otherwise. 
For transfection with Roche X-treme Gene HP, 500 ng plasmid DNA was diluted in 50 µl 
OptiMEM. X-treme Gene HP was added to the mixture in a µg DNA/µl reagent ratio of 1:3. 
The transfection mixture was incubated for 20 min at room temperature and then added to the 
cells. 
For transfection with Lipofectamine2000, 1 µl the transfection reagent was diluted in 25 µl 
OptiMEM. Likewise, 500 ng plasmid DNA was diluted in 25 µl OptiMEM. Then, 25 µl of 
Lipofectamine2000 and DNA dilution were mixed to obtain the transfection mix. The 
transfection mix was incubated 5 min at room temperature and the whole batch was added to 
the cells. 
For the transfection with Turbofect, 500 ng plasmid DNA was diluted in 50 µl OptiMEM. 
1 µl Turbofect, thus in a ratio of 1:2, was added to obtain the transfection mix. The 
transfection mix was incubated for 15 min at room temperature and added completely to the 
cells. 
Polyethyleneimine (PEI) solution was obtained as diluted (1 mg/ml) and HCl(aq) neutralized 
stock from Alexia Herrmann (AG Britta Brugger, Heidelberg University Biochemistry 
Center). For the transfection, 2 µg plasmid DNA was diluted in 31.25 µl OptiMEM. The 
transfection mix was finalized with 3.75 µl PEI stock solution. The transfection mix was 
allowed to incubate for 1h at room temperature before adding the complete batch to the cells. 
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For the calcium-phosphate method I prepared HEPES buffered saline (HBS, HEPES- HCl(aq) 
pH 7, 280 mM NaCl, 1.5 mM Na2HPO4) and a 2M CaCl2(aq) solution according to protocols 
on bioprotcols.org (247). Both solution were filtered sterile with a 0.22 µm filter 
(MerckMillipore), aliquoted and frozen at -20°C until further use. To prepare the transfection 
mix, 10.4 µl 2M CaCl2(aq) solution were mixed with 1.0 µg plasmid DNA. The mix was 
adjusted to a total volume of 85.0 µl with ddH20. The complete dilution was then added 
dropwise to an equal volume of HBS. The finalized transfection mix was incubated at room 
temperature for 1 min before adding the complete preparation to the cells. 
4.4 Flow Cytometry 
All flow cytometry measurements were conducted with the FACSCalibur (BD Biosciences, 
Franklin Lakes, USA; provided and owned by AG Walter Nickel, Heidelberg University 
Biochemistry Center). 
For the experiment, 1.8x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded per well into a 
Collagen-A coated 6-well cell culture plate. The cells were allowed to settle for about 16h 
before transfecting them with FuGENE HD protocol. For the transfection different amounts of 
plasmid DNA, either pCMV6-Entry as vector control or different eGFP expressing vectors, 
were used as indicated. The transfection proceeded for 48h before harvesting the cells. 
To harvest the cells, cell layer was washed once by room temperature PBS. The cells were 
then incubated with enzyme-free Cell Dissociation Buffer (Gibco) at 37°C. The dissociated 
cells were transferred into a 1.5 ml micro tube and pelleted at 500 x g for 5 min at 4°C. The 
cell pellet was resuspended in 500 µl sorting medium (94.5%(V/V) DMEM w/o phenol red, 
5%(V/V) Cell Dissociation Buffer, 0.5%(W/V) BSA) and the cell suspension transferred into a 
fresh, non-autoclaved 1.5 ml micro tube. 
The measurement on FACSCalibur was performed with CellQuest Pro software (BD 
Biosciences). The software was used to adjust laser voltage until signal strength in the FL1 
channel was below threshold (relative intensity 1x10
4
) and in a range of 285 V. For the 
analysis only living cells were accepted as events. The living cells (“R1”) were gated from 
x/y- plot of sideward scatter (SSC) versus forward scatter (FSC). Usually I gated in a SSC 
range of 100-500 and a FSC range of 250-650. The gated events were plotted on a histogram 
with signal strength (counts) plotted against the relative intensity in the FL1 channel 
(530 nm). The cut off was determined for each set of measurements individually based on the 
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pCMV6-Entry vector control. The amount of events above cut off (“M1”) was expressed as 
percentage of R1. The percentages of R1 (called %Gated) were plotted as grouped bars in 
GraphPad Prism 5.04 (GraphPad Software, La Jolla, USA). 
4.5 SDS-PAGE and Western blotting 
Protein samples were separated by sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS-PAGE) and subsequently blotted on a Polyvinylidene fluoride (PVDF) 
membrane (MerckMillipore). The size of proteins was approximated from Prestained protein 
standard. 
To prepare the proteins, samples were incubated with SDS sample buffer (adapated with 
modifications from Laemmli (177): 0.1 M Tris-HCl(aq) pH 8.3, 4 M Urea, 10%(V/V) glycerol, 
12%(W/V) SDS, 0.01%(W/V) bromophenol blue, optional for reducing conditions: 50 mM DTT) 
at 70°C for 15 min and 1000 rpm on Eppendorf ThermoMixer C (Hamburg, Germany). The 
preparation was spun down for 2 min at 4000 x g. The samples were loaded with gel loading 
tips on 3-8% Tris-Acetate gels (Invitrogen) or 7% or 10% self-casted SDS-PAGE gels. The 
samples were separated in 1x Tris-Acetate running buffer (diluted with ddH20) or 1x SDS 
Running buffer (0.0248 mM Tris, 0.1944 mM glycine, 0.00346 mM SDS), respectively. In 
addition to that, NuPAGE Antioxidant (Invitrogen, NP0005) was applied in Tris-Acetate gel 
systems. In Tris-Acetate gel systems, samples were allowed to enter the gel at 75 V(const.), then 
proteins were separated at 150 V(const.). Bio-Rad Mini-PROTEAN Tetra Cel systems 
(Hercules, USA) were run initially at a 100 V(const.), then proteins were separated at 
150 V(const.). 
The gels were blotted on PVDF membrane in a Mini Trans-Blot cell (Bio-Rad). In the cell, 
the gel was fixed in the gel holder cassette by paper for chromatography (Macherey-Nagel). 
The blotting in the cell ran at 100 V(const.) for 70 min at room temperature (cooling element 
included) or for 16 h at 30 V(const.) (8°C cold room). The blotting buffer was diluted from a 
10x stock (0.248 M Tris, 1.92 M glycine) in ddH20 and spiked with 20%(V/V) methanol. 
To measure the membrane in digital autoradiography, the membrane was washed for 1 h in 
ddH20 and dried for 24 h at room temperature. For immunoblotting, the PVDF membrane was 
blocked with 5%(W/V) powdered milk in PBS for 1 h at room temperature. 
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4.5.1 Digital autoradiography of PVDF membranes 
Dried PVDF western blot membranes were fixed with adhesive tape on Tritium samples 
holder cassette (provided by Biospace, Paris, France). On the fixed PVDF membrane, I 
spotted [
3
H]-GTP dissolved in 30% MeOH(aq) besides the prestained protein standard to 
visualize the bands in the autoradiography. 
The membrane was imaged for 24 h by digital autoradiography (b-Imager 2000; Biospace, 
Paris, France). The settings were preset by Biospace. In short, the isotope selection in the 
acquisition control window was set to “3H” and zoom selection to “Full Field 
(200*250 mm)”. The stop condition was fixed to an acquisition time of 24 h. The results were 
quantified with Image Studio Lite Ver 5.2.5 (LI-COR Biosciences, Lincoln, USA). The 
results were plotted with GraphPad Prism 5.04. 
Imaged membranes were reactivated for 5 min in methanol and washed for 30 min in 
Radiolabeling wash buffer (PBS, 20%(V/V) methanol). Residual methanol was removed from 
the membrane by gentle agitation in PBS. The membrane was finally blocked by 5%(W/V) 
powdered milk in PBS for 1 h at room temperature. 
4.5.2 Protein Immunoblotting 
Protein Immunoblotting was used to detect, visualize and quantify proteins blotted on PVDF 
membranes. In brief, the membranes were decorated with an animal-derived primary 
antibodies from rabbit or mouse (Table 4.13). The primary antibody was recognized by a 
secondary antibody coupled to an infrared dye (Table 4.14). 
PVDF membranes blocked with skim milk were washed with Immunoblot wash buffer (PBS, 
0.1%(V/V) Tween-20) under gentle agitation for 3x 5 min. The primary antibody was diluted in 
Immunoblot incubation buffer (PBS, 0.1%(V/V) Tween-20, 2.5%(W/V) BSA) as indicated (Table 
4.13). To remove unspecifically bound primary antibodies, the blot was washed in 
Immunoblot wash buffer. 
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Table 4.13 | List of primary antibodies. All primary antibodies were diluted in Immunoblot incubation buffer 
(PBS, 0.1%(V/V) Tween-20, 2.5%(W/V) BSA). 
Name Supplier 
Manufacturer 
product 
number 
(Purchase 
order number) 
Host 
Epitope (peptide)/ 
Immunogen 
Dilution 
Monoclonal 
ANTI-FLAG® 
M2 
SigmaAldrich F1804 
Mouse 
(monoclonal) 
DYKDDDDK 1:1000 
Anti-DDDDK 
tag 
Abcam ab1162 
Rabbit 
(polyclonal) 
xxxDDDDK 1:5000 
Anti-GAPDH 
[6C5] 
Abcam ab8245 
Mouse 
(polyclonal) 
Rabbit muscle GAPDH 1:5000 
anti-C Myc 
Novus 
Biologicals 
NB600-336 
Rabbit 
(polyclonal) 
Human c-Myc protein 
(385-435) 
1:1000 
anti-Calnexin 
Enzo 
Lifesciences 
ADI-SPA-860-
D 
Rabbit 
(polyclonal) 
C-terminus of dog 
calnexin 
1:1000 
As the primary antibodies, the secondary antibodies were diluted in Immunoblot incubation 
buffer (Table 4.14). The blots were incubated with secondary antibody either for 1 h at room 
temperature or for 16 h at 8°C in cold room. After incubation, the blots were washed under 
gentle agitation for 3x 5 min in Immunoblot wash buffer. All immunoblots were scanned on 
an Odyssey CLx-1014 (LI-COR) controlled with ImageStudio Ver 5.0 (LI-COR). The settings 
were adopted for immunoblots as suggested by manufacturer. In brief, the focus was set to 
0.0 mm at a resolution of 42 µm. The intensity was adjusted as indicated. 
Table 4.14 | List of secondary antibodies. All secondary antibodies were diluted in Immunoblot incubation 
buffer (PBS, 0.1%(V/V) Tween-20, 2.5%(W/V) BSA). 
Name Supplier 
Manufacturer 
product 
number 
(Purchase 
order number) 
Host Label Dilution 
Anti-Mouse 
IgG IRDye 
800CW 
Rockland 610-731-002 Donkey IRDye 800CW 1:10000 
Anti-Mouse 
AlexaFluor 680 
ThermoFisher A-21057 Goat Alexa Fluor 680 1:10000 
Anti-Rabbit IgG 
Alexa Fluor 680 
ThermoFisher A-21076 Goat Alexa Fluor 680 1:10000 
Anti-Rabbit IgG 
IRDye 800CW 
Rockland 611-131-002 Goat IRDye 800CW 1:10000 
Immunoblots were processed and quantified with Image Studio Lite Ver 5.2.5 (LI-COR). The 
software was used to crop and rotate blots as needed. Signals on blot were quantified using 
the build-in analysis tool of Image Studio Lite. In short, bands were bordered by a rectangular 
region of interest with background mode “Median”. The border width of the background 
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mode was set to 3 pixels with segment mode “all”. The output value “Signal” was used for all 
further analysis and plotting in GraphPad Prism 5.04. 
4.6 Thin layer chromatography 
Thin layer chromatography (TLC) was used to separate lipid extracts on a silica glass plate 
support. The protocol was adopted from Haberkant, Schmitt (78). 
For lipid preparation, the cell layer was washed twice with room temperature PBS after 
labeling. The cells were then scraped in PBS and membranes pelleted at 17.000 x g for 5 min 
at 4°C. The pellet was overlaid with 100 µl methanol and vortexed twice for 10 sec (Vortex, 
Bohemia, USA). The vortexed extract was cleared by centrifugation (17.000 x g, 10 min, 
4°C). After centrifugation, 80 µl supernatant were sampled and stored at -20°C until further 
use. 
To quantify β-decay of tritium, the lipid extract was subjected to scintillation counting on LS-
6000TA (Beckmann Coulter, Brea, USA). The counts per minute (CPM) in 2 µl lipid extract 
were measured in 5 ml LSC-Cocktail. The LSC-Cocktail was measured for 1 min returning 
the averaged CPM. The averaged CPM was used to calculate the activity in µCi with the 
formula CPMx45x10
-7
. The formula assumed a counting efficiency of 10% for tritium and a 
conversion factor of 4.5x10
-13
 from decays per minute (DPM) to Ci. 
For the TLC I spotted lipid extract with a total activity of 0.075 µCi per lane on a Silica gel 60 
TLC plate. The plate was developed in cholorform:methanol:water (65:25:4, v/v/v), dried for 
24 h and subjected to digital autoradiography on β-Imager 2000 (Biospace). During the 
autoradiography, the developed Silica gel 60 plate was supported by a 2 mm glass plate in the 
tritium cassette. The β-decay was measured with isotope selection “3H” and zoom selection 
set to “Full Field (200*250 mm)”. The results were quantified with Fiji 1.51n (National 
Institute of Health, USA) or Image Studio Lite Ver 5.2.5 (LI-COR). The results were plotted 
with GraphPad Prism 5.04. 
4.7 Cysteine crosslink assay 
The protocol for cysteine crosslinking was adopted with modifications from Xue, Rovira 
(121). The cysteines were introduced on the background of a C121A mutation in the 
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exoplasmic domain yielding GRM2
C121A/xC
 double mutants expressed from pCMV6-Entry 
vectors (Section 4.2.7). 
For the experiment, 1.8x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded per well into a 
Collagen-A coated 6-well cell culture plate. The cells were allowed to settle for about 16 h 
before transiently transfecting them with FuGENE HD protocol (Section 4.3.7). For the 
transfection, cells were incubated with 250 ng pCMV6_GRM2
C121A/xC
_ MycFlag double 
mutants. 
The transfection was stopped after 48 h and the cell layer washed twice with cold PBS. For 
the in vivo cysteine crosslink, the cells were incubated with freshly prepared Crosslink buffer 
(1.5 mM Dichloro(1,10-phenanthroline)copper(II), 16.7 mM Tris-HCl(aq) pH 8.0, 1 mM 
CaCl2, 5 mM MgCl2, 100 mM NaCl) for 20 min at room temperature under gentle agitation. 
After the incubation, the reaction was stopped by washing the cells once with Crosslink 
quenching buffer (PBS, 10 mM NEM) on ice. The cells were incubated with Crosslink 
quenching buffer another 15 min at 8°C (cold room) under gentle agitation. To harvest the 
cells, the cell layer was washed once with cold PBS and cells were scraped off and 
membranes pelleted for 10 min at 17.000 x g at 4°C. The cell pellet was lysed in 100 µl RIPA 
buffer (50 mM Tris-HCl(aq) pH 7.4, 150 mM NaCl, 1%(V/V) NonIdetP-40, 0.5%(W/V) Sodium 
deoxycholate, 0.1%(W/W) SDS) spiked with Protease inhibitor complete. The lysis was allowed 
to proceed for 1 h at 8°C (cold room) by overhead mixing on rotator at 50 U/min. 
The lysate was cleared for 30 min at 12.000 x g and 4°C. 20 µl supernatant (20%) were 
sampled after centrifugation and incubated with 20 µl LDS sample buffer at 37°C for 10 min. 
20 µl of the incubation mix (= 10% of total lysate) were separated on a 3-8% Tris-Acetate gel 
and subjected to immunoblotting as described in section 4.5. 
4.8 Surface Biotinylation 
Surface biotinylation of cell surface proteins was employed to deteremine the relative surface 
arrival of proteins as compared to the total expression level in the cell. 
For the experiment, 1.8x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded per well into a 
Collagen-A coated 6-well cell culture plate. The cells were allowed to settle for about 16 h 
and then were transiently transfected using the FuGENE HD protocol (Section 4.3.7). For the 
assay, the cells were either transfected with different amounts of pCMV6_GRM2_Flag 
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plasmid DNA or fixed amounts of corresponding alanine variants (Section 4.2.9) as indicated. 
For the set of GPCRs, different C-terminally Flag-tagged pCMV6-Entry constructs 
(Section 4.2.10) were used as indicated at a concentration of 500 ng per well. For all assays 
pCMV6_ASGRI_MycFlag was used as positive and pCMV-Entry as vector control. 
The transfection was stopped after 48 h by washing the cell layer twice with PBS
Mg/Ca
 (PBS, 
1 mM MgCl2, 0.1 mM CaCl2). The cells were then incubated with Biotinylation incubation 
buffer (8.24x10
-4
 M Sulfo-NHS-SS-Biotin, 10 mM triethanolamine pH 9.0, 150 mM NaCl, 
2 mM CaCl2) for 30 min at 8°C (cold room) under gentle agitation. To stop the NHS-
esterification, the cell layer was washed once with Biotinylation quenching buffer (PBS
Mg/Ca
, 
100 mM glycine) and then incubated with the quenching buffer another 20 min at 8°C (cold 
room). The cells were finally washed twice with PBS and lysed in 300 µl HEPES lysis buffer 
(50 mM HEPES NaOH(aq) pH 7.4, 100 mM NaCl, 5 mM EDTA, 1%(V/V) Triton X-100, 
0.5%(W/V) Na-Deoxycholate) spiked with Protease inhibitor complete per well. 
The cells were incubated with HEPES lysis buffer for 10 min at 37°C. After incubation, the 
cells were scraped and lysate transferred into a 1.5 ml micro tube. The lysate was sonicated in 
a Sonorex RK-100 water bath at 80 W/35 kHz (Bandelin, Berlin, Germany) for 3 min at room 
temperature. The lysis was finalized by a 15 min incubation step at 24°C and 1200 rpm 
(Thermomixer C, Eppendorf, Hamburg, Germany). The lysate was cleared by centrifugation 
(18.000 x g, 10 min, 4°C). 200 µl supernatant were sampled and incubated with 50 µl 
Neutravidin bead slurry (prior to incubation washed three time with HEPES lysis buffer) over 
night at 8°C (cold room) by overhead mixing on rotator at 50 U/min. Another 20 µl 
supernatant were samples as “Input” and snap-frozen in liquid nitrogen and stored at -80°C 
until further use. 
The next day, the loaded Neutravidin beads were spun down (3000 x g, 4°C, 1 min). After 
centrifugation, 20 µl “Flow-through” were sampled from the supernatant. The beads were 
washed three times with HEPES lysis buffer and once with Tris wash buffer (0.1 M Tris-
HCl(aq) pH 8.3, 100 mM NaCl, 0.1 %(V/V) Triton X-100, 0.5 %(W/V) Na-Deoxycholate). After 
washing, the bead bed was resuspended with 40 µl reducing SDS sample buffer. 20 µl Input 
and Flow-through sample were mixed with 10 µl reducing SDS sample buffer. The protein 
samples were incubated for 30 min at 50°C and 1000 rpm (Thermomixer C). 
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The protein samples were cleared by centrifugation (4.000 x g, 2 min, room temperature) and 
loaded on a 3-8% Tris acetate gel. The samples were separated and blotted as described in 
section 4.5. 
4.9 Deglycosylation assay 
The deglyosylation was performed with either EndoH or PNGaseF (List of bioreagents, 
Section 4.1.2). The readout of the assay was an electrophoretic shift of the signal on the 
immunoblot. For the assay, 1.8x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded per 
well into a Collagen-A coated 6-well cell culture plate. The cells were allowed to settle for 
about 16 h before transfecting them with FuGENE HD protocol (Section 4.3.7). The cells 
were transiently transfected with 500 ng pCMV6_GRM2_Flag constructs or different GPCR 
constructs per well as indicated. The transfection was allowed to proceed 48 h. 
The transfection was stopped by placing the cell culture plates on ice and washing them twice 
with ice cold PBS. The cells were then scraped into cold PBS and the membranes were 
pelleted at 16.000 x g for 10 min at 4°C. The membrane pellet was resuspended in 100 µl 
HEPES lysis buffer and Protease inhibitor complete. The lysis was allowed to proceed for 2 h 
at 8°C (cold room) by overhead mixing on rotator at 50 U/min. The insoluble debris was 
pellet at 3000 x g for 10 min at 4°C. The supernatant was recovered, snap-frozen and stored at 
-80°C until further use. 
The protein from the lysate were precipitated by Wessel-Fluegge protocol (248). For 100 µl 
cell lysate, subsequently 400 µl methanol, 200 µl chloroform and 300 µl deionized water were 
added. The sample was vortexed after each step. The phases were separated by centrifugation 
at 20.000 x g at room temperature for 2 min. The upper phase was removed. The interphase 
and the lower phase were retained and mixed with 300 µl methanol. The proteins were 
pelleted by centrifugation at 20.000 x g for 5 min at room temperature. The entire supernatant 
was taken off and the protein pellet air-dried for about 10 min in the digester. 
For the PNGaseF protocol, the protein pellet was taken up in 40 µl 1x Glycoprotein 
Denaturing Buffer (provided with the enzyme, diluted with deionized water). The pellet was 
resuspended by shaking at 37°C and 1000 rpm for 10 min (Thermomixer C). Then the 
proteins were denatured by heating to 100°C for 10 min. Afterwards, the sample was chilled 
on ice and then spun down (500 x g, 1 min, 4°C). 10 µl supernatant were recovered and 
prepared for deglycosylation by adding 2 µl GlycoBuffer 2 (10x), 2 µl 10% NP-40 and 6 µl 
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ddH20. The reaction mix was finalized by adding 1µl PNGaseF. The reaction was incubated 
for 1 h at 37°C. For the negative control 1 µl ddH20 was added. For SDS-PAGE, 10 µl 
reducing SDS sample buffer was added and the protein sample incubated and separated as 
described previously (Section 4.5). 
For the incubation with EndoH, the same incubation steps were followed with preparation in 
1x Glycoprotein Denaturing Buffer. 10 µl supernatant were mixed with 2 µl GlycoBuffer 3 
(10x) and 7 µl ddH20. The reaction mix was finalized with 1 µl EndoH. The proteins were 
sampled for SDS-PAGE as described in the previous paragraph. 
4.10  Non-reducing SDS-PAGE 
For the non-reducing SDS-PAGE, 1.8x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded 
per well into a Collagen-A coated 6-well cell culture plate. The cells were allowed to settle for 
about 16 h before transfecting them with FuGENE HD protocol (Section 4.3.7). The cells 
were transiently transfected with 250 ng pCMV6_GRM2_(Myc)Flag or 
pCMV6_GRM2
C121A
_Flag constructs. The transfection was allowed to proceed 48 h. 
The cells were washed, oxidized and crosslinked with NEM, and finally lysed as described in 
Section 4.7. The samples were snap-frozen and stored at -80°C until applied to SDS-PAGE. 
For SDS-PAGE, non-reducing SDS sample buffer was added and the protein samples were 
incubated and separated as described previously (Section 4.5). 
4.11  Co-immunoprecipitation 
For the co-immunoprecipitation of transmembrane-spanning GPCRs, three different protocols 
were applied. At each step, the protocol was refined to minimize unspecific binding of soluble 
and other transmembrane proteins while at the same time maximizing the specific binding of 
mGluR2 homodimers. 
4.11.1 Basic co-immunoprecipitation protocol 
For the basic protocol, 2.6x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded per well into 
a Collagen-A coated 6-well cell culture plate. The cells were allowed to settle for about 16 h 
before transfecting them with FuGENE HD protocol (Section 4.3.7). The cells were 
transiently co-transfected with 250 ng pCMV6_GRM2_Flag and 250 ng 
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pCMV6_GRM2_Myc plasmid DNA (either GRM2 wild type or GRM2
C121A
; see also 
Section 4.2.6). The transfection was allowed to proceed 48 h. 
To stop the transfection, the cells were placed on ice and washed once with cold PBS. Cells 
were then scraped in 500 µl PBS/well and pelleted at 3000 x g for 10 min at 4°C. The cell 
pellets were resuspended in 300 µl lysis buffer on the basis of either Triton X-100 or 
NonIdetP-40 (Table 4.15). 
Table 4.15 | Lysis buffers for co-immunoprecipitation of GPCRs. The buffers were prepared on the basis of a 
50 mM HEPES-NaOH(aq) pH 7.4, 200 mM NaCl, 5 mM EDTA system. All buffers were spiked with Protease 
inhibitor complete before use. 
Buffer 
1.0%(V/V) 
Triton X-100 
1.0%(V/V) 
NonIdetP-40 
0.5%(W/V) 
Na-Deoxycholate 
0.1%(W/V) 
SDS 
TX100 + − − − 
TX100+Dx + − + − 
TX100+Dx+SDS + − + + 
NP40 − + − − 
NP40+Dx − + + − 
NP40+Dx+SDS − + + + 
The lysis of the cells was allowed to proceed for 2 h at 8°C (cold room) by overhead mixing 
on rotator at 50 U/min. The lysate was cleared by centrifugation at 18.000 x g for 30 min at 
4°C. 250 µl supernatant were subjected to immunoprecipitation with 20 µl αFlag bead slurry 
(washed three times with corresponding buffer prior to incubation).The lysate was incubated 
with the beads over night at 8°C (cold room) by overhead mixing on rotator at 50 U/min. 
20 µl supernatant were sampled as “Input”, snap-frozen and stored at -80°C until further use. 
The next day the αFlag beads were pelleted at 800 x g for 1 min at 4°C. After centrifugation, 
20 µl supernatant were sampled as “Flow-through”. The bead bed was washed three times 
with 500 µl of the corresponding lysis buffer (Table 4.15). The complete bead bed was then 
resuspended in 40 µl reducing SDS sample buffer. 10 µl reducing SDS sample buffer was 
added to 20 µl Input and Flow-through sample likewise. All protein samples were incubated 
for 15 min at 70°C and 1000 rpm (Thermomixer C). The protein samples were loaded on a 3-
8% Tris-Acetate gel as indicated. The samples were separated and blotted as described in 
section 4.5. 
4.11.2 Co-immunoprecipitation protocol with alkylation 
For the co-immunoprecipitation protocol including an optional alkylation step, 1.6x10
5
 
Hek293 cells in a volume of ~2.5 ml were seeded per well into a Collagen-A coated 6-well 
cell culture plate. The cells were allowed to settle for about 16 h before transfecting them with 
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FuGENE HD protocol (Section 4.3.7). The cells were transiently co-transfected with 250 ng 
pCMV6_GRM2
C121A
_Flag and 250 ng of Myc-tagged constructs of GRM2
C121A
, or GRM2, or 
ADRB2 (Sections 4.2.6 and 4.2.10.1). For each possible combination, two wells were 
transfected to allow for one alkylated and one untreated batch. 
48 h post-transfection, one set of cells was subjected alkylation as described in section 4.7. In 
brief, cells were incubated with Crosslink buffer for 20 min at room temperature. After the 
incubation, the reaction was stopped by washing the cells once with Crosslink quenching 
buffer. The cells were then incubated with Crosslink quenching buffer another 15 min at 8°C 
(cold room). The previous steps for alkylation were skipped in the case of the negative 
control. To harvest the cells, the cell layer was washed twice with cold PBS and then scraped 
into HEPES Co-IP buffer (50 mM HEPES-NaOH(aq) pH 7.4, 200 mM NaCl, 5 mM EDTA, 
1%(V/V) NonIdetP-40) prepared with Protease inhibitor complete. The lysis at 8°C (cold room) 
was allowed to proceed by overhead mixing on rotator at 50 U/min. After the lysis, the all 
insoluble debris was removed by centrifugation at 100.000 x g for 60 min at 4°C in 1.5 ml 
ultracentrifuge tubes. After centrifugation, 20 µl supernatant were saved as “Input” sample. 
Another 250 µl supernatant were incubated with 20 µl αFlag bead slurry. The αFlag beads 
had been washed twice times with HEPES Co-IP buffer and blocked with 2.5%(W/V) BSA 
prior to usage. The lysate was incubated with the beads over night at 8°C (cold room) by 
overhead mixing on rotator at 50 U/min. 
The next day, the beads were pelleted at 800 x g for 1 min at 4°C. After centrifugation, 20 µl 
supernatant were sampled as “Flow-through”. Subsequently, the beads were washed either 
three times with HEPES Co-IP buffer, or once with HEPES Co-IP buffer, then Co-IP wash 
buffer I (50 mM HEPES-NaOH(aq) pH 7.4, 400 mM NaCl, 5 mM EDTA, 1%(V/V) NonIdetP-
40), and finally with Co-IP wash buffer II (50 mM HEPES-NaOH(aq) pH 7.4, 400 mM NaCl, 
5 mM EDTA, 0.1%(V/V) NonIdetP-40). The bead bed was resuspended in 40 µl reducing SDS 
sample buffer. 20 µl Input and Flow-through samples were prepared with 10 µl reducing SDS 
sample buffer. The protein samples were incubated for 15 min at 70°C and 1000 rpm 
(Thermomixer C). After incubation, insoluble debris was pelleted at 4000 x g for 2 min. The 
supernatant was loaded on a 3-8% Tris-Acetate gel as indicated. The samples were separated 
and blotted as described in section 4.5. 
4 Materials and Methods 
173 
 
4.11.3 Co-immunoprecipitation of mGluR2 variants 
The co-immunoprecipitation of mGluR2 variants was largely carried out as described in 
section 4.11.2 with minor changes.1.6x10
5
 Hek293 cells in a volume of ~2.5 ml were seeded 
per well into a Collagen-A coated 6-well cell culture plate. 16 h after seeding, the cells were 
transiently transfected with using the FuGENE HD protocol (Section 4.3.7). The cells were 
co-transfected with either 250 ng pCMV6_GRM2_Flag or pCMV6_GRM2
C121A
_Flag as bait, 
and 250 ng of corresponding Myc-tagged GRM2
W/Y→A
 variants, or ADRB2 negative control. 
In additional to that, 500 ng Flag- or Myc-tagged GRM2 or GRM2
C121A
 were transfected as 
“Flag vs Flag” or “Myc vs Myc” process controls. 
Having compared the different experimental setups as described section 4.11.2, the 
experimental procedure was fixed to alkylation of all samples. The cells were harvested and 
lysed as described. The soluble supernatant after ultracentrifugation was used for 
immunoprecipitation. For the immunoprecipitation of “Flag vs Flag” and “Myc vs Myc” 
samples, 125 µl of corresponding lysate was mixed with 125 µl HEPES Co-IP buffer. For the 
“Lysate control” 125 µl “Flag vs Flag” and 125 µl “Myc vs Myc” were mixed and co-
incubated with αFlag beads. 
After overnight incubation at 8°C, the αFlag beads were pelleted and washed under stringent 
conditions with HEPES Co-IP buffer, and Co-IP wash buffer I and II. The different Input, 
Flow-through and IP samples were probed and incubated as described in the previous section. 
The samples were separated on a 3-8% Tris-Acetate gel and blotted as described in section 
4.5. 
4.12  Metabolic labeling with tritiated lipids 
All radiolabeling experiments with (precursor) lipids were conducted in Hek293 cells if not 
stated otherwise. The preparation was conducted in the regular cell culture. For the actual 
labeling, the cells were transferred into Isotope laboratory. In the Isotope laboratory, all lysis 
steps, SDS-PAGE and western blotting steps were conducted, as well as the digital 
autoradiography. The final immunoblot was again performed under regular conditions. For 
work with lysates and proteins samples, 1.5 ml Safeseal tubes were used. 
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4.12.1 [3H]-photo-cholesterol (protein labeling) 
The radioactive [
3
H]-photo-cholesterol was obtained as stock synthesized by Xabi Contreras 
with a concentration of 5 µCi/µl. The original synthesis and labeling protocol was published 
by Thiele, Hannah (77). For the labeling experiment, 1.8x10
5
 cells were seeded into a 
Collagen-A coated 6-well cell culture plate. For the DNA titration, the cells were transfected 
with either pCMV6_GRM2_Flag or pCMV6_GRM2
C121A
_Flag in the amounts indicated 
following the FuGENE HD protocol. For later experiments with GRM2 variants, the cells 
were transiently transfected after ~17 h with either 250 ng of pCMV6_GRM2_Flag or 375 ng 
of pCMV6_GRM2
C121A 
_Flag and the corresponding W,Y→A single or double mutant 
constructs. As controls I used corresponding amounts of pCMV6-Entry, 
pCMV6_ADRB2
Wt
_Flag and pCMV6_ASGRI_MycFlag constructs. The transfections were 
allowed to proceed 31 h. 
After the transfection, the cells were labeled for 17 h with [
3
H]-photo-cholesterol. Both the 
GRM2 single mutants and the GRM2
C121A
 double mutants were labeled with 15 µCi/well 
(=3 µl, solvated in ethanol). For the labeling, the transfection medium was exchanged for 
DMEM labeling medium (DMEM, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 10%(V/V) 
delipidated FBS). 
After a total transfection and labeling time of 48 h, the cells were placed on a cooling block 
and washed twice with ice-cold PBS. For UV-irradiation, the cells were overlayed with 1 ml 
PBS and exposed to UV-light (Sylvania R 100 W; UV-Labortechnik, Glashuetten, Germany) 
for 6 min at a distance of 5 cm to the bulb. After the UV-crosslinking, the cells were scraped 
into PBS and membranes were pelleted at 16.000 x g for 5 min at 4°C. The membrane pellet 
was resuspended in 300 µl HEPES lysis buffer (spiked with Protease inhibitor complete) and 
spun on rotator at 50 U/min for 2 h and 6°C (cold room Isotope laboratory). After lysis, the 
debris was spun down (3000 x g, 10 min, 4°C). 20 µl of the supernatant were sampled as 
“Input” and were frozen at -20°C until further use. 270 µl were incubated overnight at 6°C 
(cold room Isotope laboratory) with 25 µl αFlag bead slurry (washed three times with HEPES 
lysis buffer prior to use).  
The next day, the αFlag beads were spun down (800 x g, 1 min, 4°C) and 20 µl supernatant 
were sampled as “Flow-through”. The bead bed was washed three times with HEPES lysis 
buffer and once with Tris wash buffer. The washed αFlag beads were resuspended with 30 µl 
reducing SDS sample buffer. Likewise, 20 µl Input sample and 20 µl Flow-through were 
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prepared with 10 µl reducing SDS sample buffer. All proteins sample were incubated for 
15 min at 70°C and 1000 rpm (Thermomixer Comfort; Eppendorf, Hamburg, Germany). 
After incubation, beads and insoluble debris was removed by centrifugation at 4000 x g for 
2 min at room temperature. The samples were loaded on a 3-8% Tris-Acetate gel, and 
separated and blotted as described in section 4.5. 
The protein labeling with [
3
H]-photo-cholesterol was determined from digital autoradiography 
(Section 4.5.1) and immunoblotting (Section 4.5.2). 
4.12.2 [3H]-(photo-)cholesterol (lipid labeling) 
The comparison of tritiated cholesterol metabolism was largely conducted as described in the 
previous section (Section 4.12.1) with minor changes. In brief, 1.8x10
5
 Hek293T cells were 
seeded in a Collagen-A coated 6-well cell culture plate. The cells were transiently transfected 
with 500 ng pCMV6_ADRB2_Flag constructs per well and labeled with either 15 µCi of the 
old stock of [
3
H]-photo-cholesterol used in section 4.12.1, or a freshly opened vial which 
originated from the same synthesis, or commercially available [
3
H]-cholesterol obtained as 
[1,2-3H(N)]-Cholesterol (PerkinElmer). After 17 h of incubation the cells were either UV-
irradiated or left untreated. 
Both UV-irradiated and control cells were scraped in 1 ml PBS. 800 µl were retained for 
protein analysis and processed as described in the previous section. The remaining 200 µl cell 
suspension were used for lipid extraction as described in Section 4.6. 0.075 µCi activity were 
spotted on each lane and separated on a TLC plate. The β-decay on the developed TLC plate 
was measured by digital autoradiography (β-Imager 2000). 
4.12.3 [3H]-photo-sphingosine (protein labeling) 
[
3
H]-photo-sphingosine was obtained as Photosphingosine, D-erythro [3-3H] from American 
Radiolabeled Chemicals (St. Louis, USA). The original synthesis and labeling protocol was 
the work of Haberkant, Schmitt (78). 
For the labeling experiment, 1.2x10
5
 cells were seeded into a Collagen-A coated 6-well cell 
culture plate. For the DNA titration, the cells were transiently transfected with 
pCMV6_GRM2_Flag in the amounts indicated following the FuGENE HD protocol. For later 
experiments with GRM2 variants, the cells were transfected after ~20 h with 500 ng of 
pCMV6_GRM2_Flag or the corresponding W,Y→A constructs. As controls I used 
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corresponding amounts of pCMV6-Entry, pCMV6_ADRB2_Flag and 
pCMV6_ASGRI_MycFlag constructs. The transfections were allowed to proceed 42 h. 
The cells were labeled with 7.5 µCi [
3
H]-photo-sphingosine 6 h prior to harvest. For the 
labeling, the cells were washed once with PBS and the transfection medium was exchanged 
for 2 ml DMEM labeling medium with tritiated lipids. To stop the [
3
H]-photo-sphingosine 
labeling after 6 h, the cells were placed on a cooling block and washed twice with ice-cold 
PBS. For UV-irradiation, the cells were overlayed with 1 ml PBS and exposed to UV-light for 
6 min at a distance of 5 cm to the bulb (Sylvania R 100 W). After the UV-crosslinking, the 
cells were scraped into PBS and membranes pelleted at 16.000 x g for 5 min at 4°C. The 
membrane pellet was resuspended in 300 µl HEPES lysis buffer (prepared with Protease 
inhibitor complete) and spun on rotator at 50 U/min for 2 h and 6°C (cold room Isotope 
laboratory). After lysis, the debris was spun down (3000 x g, 10 min, 4°C). 20 µl of the 
supernatant were sampled as “Input” and frozen at -20°C until further use. 270 µl were 
incubated overnight at 6°C (cold room Isotope laboratory) with 25 µl αFlag bead slurry 
(washed three times with HEPES lysis buffer prior to use). 
The next day, the αFlag beads were spun down (800 x g, 1 min, 4°C) and 20 µl supernatant 
were sampled as “Flow-through”. The bead bed was washed three times with HEPES lysis 
buffer and once with Tris wash buffer. The washed αFlag beads were resuspended with 30 µl 
reducing SDS sample buffer. Likewise, 20 µl Input sample and 20 µl Flow-through were 
prepared with 10 µl reducing SDS sample buffer. All proteins sample were incubated for 
15 min at 70°C and 1000 rpm (Thermomixer Comfort). After incubation, beads and insoluble 
debris was removed by centrifugation at 4000 x g for 2 min at room temperature. The samples 
were loaded on a 3-8% Tris-Acetate gel, and separated and blotted as described in section 4.5. 
The protein labeling with [
3
H]-photo-cholesterol was determined from digital autoradiography 
(Section 4.5.1) and immunoblotting (Section 4.5.2). 
4.12.4 [3H]-sphingosine labeling (lipid labeling) 
The metabolism of tritiated sphingosine was quantified to compare different protocols for 
transient transfection and metabolism in Hek293 wild type and Hek293ΔSGPL1 cells. For the 
experiment, ~2.6x10
5
 cells were seeded per well in a Collagen-A coated 6-well cell culture 
plate. The cells were allowed to settle for about 16 h before transfection. The protocols for 
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transient transfection were used as described in section 4.3.7 with either pCMV6-Entry or 
pCMV6_GRM2_MycFlag constructs in the amounts indicated.  
The transfection was allowed to continue for 42 h, before exchanging the medium for DMEM 
labeling medium prepared with [
3
H]-sphingosine. Each well was labeled with 2 µCi activity 
diluted in 2 ml DMEM labeling medium. The labeling was allowed to proceed for 6 h before 
harvesting the cells. The cells were scraped into 1 ml PBS. The suspension was splitted into 
two 500 µl fractions: one for protein analysis and one for lipid analysis. 
The protein analysis was conducted as described in section 4.12.3 with minor changes. In 
brief, cell pellets were lysed in 50 µl HEPES lysis buffer. 15 µl lysate were incubated with 
15 µl reducing SDS sample buffer. The samples were separated on a 3-8% Tris acetate gel 
and blotted as described earlier. The blot was analyzed by immunoblotting. The lipid 
extraction and analysis was performed as described in section 4.6. 075 µCi activity were 
spotted on each lane and separated on a TLC plate. The β-decay on the developed TLC plate 
was measured by digital autoradiography (β-imager 2000). 
4.12.5 [3H]-palmitic acid 
[
3
H]-palmitic acid was obtained as [9,10-3H(N)]-Palmitic Acid from Perkin Elmer (Waltham, 
USA). The protocol was adapted with modifications from Paul, Bartenschlager (249). For the 
experiment, 1.8x10
5
 cells were seeded into a Collagen-A coated 6-well cell culture plate. 17 h 
after seeding, the cells were transiently transfected with different C-terminally Flag-tagged 
GPCR constructs using the FuGENE HD protocol. The tagged GPCRs, both wild types and 
cysteine-to-alanine mutants, were expressed from the pCMV6-Entry expression vector 
(Sections 4.2.10 and 4.2.11). 
The transient transfection was stopped after 44 h and the cells were starved for 1 h in 2 ml 
lipid-free DMEM labeling medium per well. After incubation, the medium was changed for 
DMEM labeling medium spiked with 160 µCi/2 ml. The cells were labeled for 3 h. After 3 h, 
the well plates were placed on ice and the cell layer washed twice with ice cold PBS. The 
cells were scraped into 800 µl cold PBS and each well was washed again with 400 µl PBS to 
remove residual cells. The cells were pelleted by centrifugation at 3000 x g for 10 min at 4°C. 
The cell pellet was resuspended in HEPES lysis buffer prepared with Protease inhibitor 
complete. The lysis was allowed to continue for 2 h at 6°C (cold room Isotope laboratory). 
Insoluble debris was spun at 16.000 x g, 5 min, 4°C. 20 µl of the supernatant were sampled as 
4 Materials and Methods 
178 
 
“Input” and frozen at -20°C until further use. 260 µl were incubated overnight at 6°C (cold 
room Isotope laboratory) with 25 µl αFlag bead slurry (washed three times with HEPES lysis 
buffer prior to use) under continuous overhead mixing on rotator at 50 U/min. 
The next day, the loaded αFlag beads were pelleted (800 x g, 1 min, 4°C). After 
centrifugation, 20 µl were sampled as “Flow-through”. The beads were batch washed three 
times with HEPES lysis buffer and once with Tris wash buffer. The bead bed was 
resuspended with 40 µl non-reducing SDS sample buffer. Likewise, 20 µl Input and Flow-
through samples were prepared with 10 µl non-reducing SDS sample buffer. All proteins 
sample were incubated for 15 min at 70°C and 1000 rpm (Thermomixer Comfort). After 
incubation, beads and insoluble debris was removed by centrifugation at 4000 x g for 2 min at 
room temperature. The samples were loaded on a 3-8% Tris-Acetate gel, and separated and 
blotted as described in section 4.5. 
For deacylation of samples, that is the reduction of the thioester bond between fatty acid and 
cysteine residue, the protein samples were incubated with a final concentration of 15% β-
mercaptoethanol under the same conditions as in the previous section. 
4.13 Molecular dynamics simulation in GROMACS 
4.13.1 Building a transmembrane model: Modeling and Martinization 
The transmembrane domain of mGluR2 (TM-mGluR2) was modeled with SWISS-MODEL 
online program (158-161, 250). The SWISS-MODEL template library (SMTL version 2014-
10-01, PDB release 2014-09-26) was searched with Blast (163) and HHBlits (162) for 
evolutionary related structures matching the target sequence. Among the related structures, 
the crystal structure of mGluR1 was chosen to build the model of the transmembrane domain 
(RCSB entry 4or2.1.A, published by Wu, Wang (71)) (Figure 4.1). 
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Figure 4.1 | Sequence alignment between mGluR1 (4or2.1.A) and mGluR2 (Target) transmembrane 
domain using HHBlits. The sequence of the mGluR1 and mGluR2 transmembrane domain had a sequence 
idenity of 50.0% according to HHBlits and 52.9%  according to BLAST. 
For the modelling, SWISS-MODEL copied structure coordinates which were conserved 
between target and template. Insertion and deletions in the sequence were estimated from a 
fragment library. The intra- and extracellular loops were modelled with ProMod-II (250) and 
MODELLER (251). The pdb output was used for the further molecular biological and 
computational simulation work. The results of the search for evolutionary related structures 
are found in detail in Section 2.1.2.2. 
The model of the mGluR2 transmembrane domain was martinized using martinize.py 
command. To prepare the atomistic PDB file as input file for martinize.py, it was converted 
into a GROMACS structural file with ‘gmx pdb2gmx’ with GROMACS 2016.x (179-181). 
The pdb file was used as input to generate the GROMACS structural file gro. In the gro file 
hydrogen atoms were added as well as ionized N- and C-terminal ends. With ‘gmx editconf’ 
the gro file was placed into a (10x10x10) nm box. The structure was relaxed with the steepest 
decent in 10 steps á 0.02 ps. The structural output file of the energy minimization was used as 
input ‘-f’ for the martinize.py command (192). The restraints for the secondary structure were 
defined with the web-based program DSSP (197). DSSP extracted the information about the 
secondary structure based on the 3D structure given in the pdb input file. The output dssp file 
was used as input ‘-ss’ for martinize.py. The position restrains were written to all particle 
positions in the output structure. For the elastic network, the upper distance bound ‘-eu’ was 
set to 1.1 Å (F=0 if rij>1.1 Å) and the the force field to martini22. Finally, the cut-off distance 
for cystine bonds was set to 0.32 nm. 
4.13.2 Assembly all atom simulations 
To assemble the box for the atomistic molecular dynamics simulation, the model of the 
mGluR2 transmembrane domain was embedded in a fully solvated POPC or POPC/CHOL 
bilayer using the CHARMM-GUI online program (85, 86, 252, 253). The program consisted 
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of several steps, starting with import of the PDB file and subsequently leading through the 
assembly of the system. 
In the initial step ‘PDB Info’, the residues C70 and C159 in (TM-mGluR2 model) were 
considered to be connected by a disulfide bridge. The terminal groups were patched as ACE 
and CT2 (neutral). In the orientation option of ‘Step 1’, the system was aligned along the first 
principal axis (z). The molecule was flipped along the z-axis. In ‘Step 2’, basic system size 
determination options were assigned. The leaflets of the lipid bilayer were allowed to have a 
heterogeneous lipid composition. The lipid bilayer was solvated with a water layer of 17.5 Å 
on top and bottom. The length of x and y (lateral axis) were determined by the ratio of the 
lipid components and guessed with 10.5 Å in each direction. The first system was built as 
POPC (16:0, 18:1) system which resulted in a total of ~145 POPC molecules in each layer. In 
‘Step 3’, the protein model was inserted into the bilayer by the replacement method with a 
check of the lipid ring and protein surface penetration. The ion concentration was set to a 
physiological salt concentration of 0.15 M NaCl with Ion placement method ‘Distance’. The 
fourth step returned information about the successful assembly of the protein system. In 
‘Step 5’, the system was assembled with input files for GROMACS and a parameterization in 
the CHARMM36 force field. The temperature was set to 310 K (generated grid information 
for PME fast Fourier transforms automatically). 
The system was minimized and equilibrated with the mdp files generated in CHARMM-GUI 
(Table 4.16). The system was slowly released from its restraints in seven consecutive steps. In 
all steps the Verlet cut-off scheme with a cut-off distance of 1.2 Å was used. In brief, the 
system was minimized with the steepest decent in 5000 steps in the first cycle. The next three 
equilibration cycles were conducted with 25000 steps of 1 ps. The last three cycles were 
conducted 50000 steps of 2 ps. All equilibration steps were processed with the Berendsen 
barostat which was also used for temperature coupling. 
For the production run, four simulation á 500 ns were run in parallel. The production run was 
conducted in 250x10
6
 steps of 0.002 ps. The temperature was controlled by Nose-Hoover 
thermostat and the pressure by semiisotropic pressure coupling with the Parrinello-Rahman 
barostat. 
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Table 4.16 | MDP files provided by CHARMM-GUI for the minimization, equilibration and production 
run. The mdp files provided the information for GROMACS 2016.x preprocessor (‘gmx grompp’). 
 
Minimi-
zation 
Equilibration 
Step 1 
Equilibration 
Step 2 
Equilibration 
Step 3 
Equilibration 
Step 4/5/6 
Production 
define 
DREST_ON 
DSTEP6_0 
DREST_ON 
DSTEP6_1 
DREST_ON 
DSTEP6_2 
DREST_ON 
DSTEP6_3 
DREST_ON 
DSTEP6_4/5/
6 
 
integrator steep md md md md md 
dt  0.001 0.001 0.001 0.002 0.002 
emtol 1000      
nsteps 5000 25000 25000 25000 50000 250000000 
nstlog  1000 1000 1000 1000 1000 
nstxout  1000 1000 1000 1000 10000000 
nstvout  1000 1000 1000 1000 10000000 
nstfout  1000 1000 1000 1000 10000000 
nstcalcenergy  100 100 100 100 100 
nstenergy  1000 1000 1000 1000 1000 
nstxout-
compressed 
     5000 
cutoff-scheme Verlet Verlet Verlet Verlet Verlet Verlet 
nstlist 10 20 20 20 20 20 
rlist 1.2 1.2 1.2 1.2 1.2 1.2 
coulombtype pme pme pme pme pme pme 
rcoulomb 1.2 1.2 1.2 1.2 1.2 1.2 
vdwtype Cut-off Cut-off Cut-off Cut-off Cut-off Cut-off 
vdw-modifier Force-switch Force-switch Force-switch Force-switch Force-switch 
Force-
switch 
rvdw_switch 1 1 1 1 1 1 
rvdw 1.2 1.2 1.2 1.2 1.2 1.2 
tcoupl  berendsen berendsen berendsen berendsen 
Nose-
Hoover 
tc_grps  
PROT MEMB 
SOL_ION 
PROT MEMB 
SOL_ION 
PROT MEMB 
SOL_ION 
PROT MEMB 
SOL_ION 
PROT 
MEMB 
SOL_ION 
tau_t  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
ref_t  310 310 310 310 310 310 310 310 310 310 310 310 310 310 310 
pcoupl    berendsen berendsen 
Parrinello-
Rahman 
pcoupltype    semiisotropic semiisotropic 
semi-
isotropic 
tau_p    5 5 5 
compressibility    
4.50E-05 
4.50E-05 
4.50E-05 
4.50E-05 
4.50E-05 
4.50E-05 
ref_p    1 1 1 1 1 1 
constraints none h-bonds h-bonds h-bonds h-bonds h-bonds 
constraint_ 
algorithm 
LINCS LINCS LINCS LINCS LINCS LINCS 
continuation   yes yes yes yes 
nstcomm  100 100 100 100 100 
comm_mode  linear linear linear linear linear 
comm_grps  
PROT MEMB 
SOL_ION 
PROT MEMB 
SOL_ION 
PROT MEMB 
SOL_ION 
PROT MEMB 
SOL_ION 
PROT 
MEMB 
SOL_ION 
gen-vel  yes     
gen-temp  310     
gen-seed  -1     
refcoord_ 
scaling 
 com com com com com 
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For the run in POPC/CHOL15mol%, the system was generated in CHARMM-GUI for the wild 
type protein as described in the previous paragraph. The initial conformations for the wild 
type transmembrane domain had been extracted from the previous run in the POPC 
membrane. For the mGluR2 mutants Y745A (TM model: Y183A) and Y781A (TM model: 
Y213A) the target residues were mutated in Pymol 1.8.4.0. (Schroedinger, New York, USA). 
The mutated PDB files were inserted into the newly assembled membrane systems in the 
place of the wild type protein. The equilibration and production was conducted as described in 
the previous paragraph. 
4.13.3 Coarse-grained simulations 
The coarse-grained system was setup with the membrane building tool INSANE (87) using 
the standard Martini 2.2 force field simulation settings including the topology files for Amino 
acids 2.2, Lipids 2.0 and Ions 2.0 (84, 192). The martinized model of the mGluR2 
transmembrane domain was inserted into either a pure POPC bilayer or into a 
POPC/CHOL15mol% bilayer. 
In the coarse-grained system two protomers were simulated in one box. In 100 parallel setups, 
the two martinized mGluR2 transmembrane domains were placed in the origin of an empty 
box of (10x10x10) nm. In the box the transmembrane domains were rotated randomly around 
their z-axis by an angle θ between 0° and 360° to randomize the initial starting conformation 
in the box. The center of mass of the second monomer was then translated 7.5 nm in the y-
axis. The two separated monomers were centered in the box and used as input for INSANE. 
INSANE was used to build a simulation box of (15x15x12) nm with the two protomers 
centered in the box and inserted into either a POPC or POPC/CHOL15mol% bilayer. The 
membrane was solvated with CG water (each CG water represented 4 H20 molecules) and 
0.15 M NaCl. The assembled system was relaxed in 10x10
4
 steps (0.01 ps) using the 
Berendsen barostat (Table 4.17, Relaxation). In the Verlet cut-off scheme the Lennard-Jones 
interactions were shifted to zero at a distance of 1.1 nm. The production run for each 
simulation box was 5 μs (25x107 steps á 0.02 ps), totaling a simulated time of 0.5 ms for both 
setups (Table 4.17, Equilibration). The reference pressure was set to 1 bar and controlled with 
semiisotropic pressure coupling by Parrinello-Rahman. The temperature was set to 310 K and 
controlled by velocity scaling. 
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Table 4.17 | Relaxation and equilibration (production) mdp files for the Martini 2.2 force field. The mdp 
files provided the information for GROMACS 2016.x preprocessor (‘gmx grompp’). 
Parameter Relaxation Equilibration 
title Martini Martini 
define -DPOSRES  
integrator md md 
dt 0,01 0,02 
nsteps 100000 250000000 
nstcomm 100 100 
comm-grps n.A. n.A. 
nstxout 0 500000 
nstvout 0 500000 
nstfout 0 500000 
nstlog 100 5000 
nstenergy 100 5000 
nstxtcout 2000 5000 
xtc_precision 100 1000 
xtc-grps n.A. n.A. 
energygrps n.A. PROTEIN1 PROTEIN2 CHOL 
nstlist 10 20 
ns_type grid grid 
pbc xyz xyz 
rlist 1,4 1,4 
coulombtype Reaction_field Reaction_field 
rcoulomb_switch 0 0 
rcoulomb 1,1 1,1 
epsilon_r 15 15  
vdw_type cutoff cutoff 
rvdw_switch 0,9 0,9 
rvdw 1,1 1,1 
cutoff-scheme verlet verlet 
coulomb-modifier Potential-shift Potential-shift 
vdw-modifier Potential-shift Potential-shift 
epsilon_rf 0 0 
verlet-buffer-drift 0,005 0,005 
tcoupl V-rescale v-rescale 
tc-grps Protein_POPC_CHOL W_ION Protein_POPC_CHOL W_ION 
tau_t 1 1 1 1 
ref_t 310 310 310 310 
Pcoupl berendsen Parrinello-Rahman 
Pcoupltype semiisotropic semiisotropic 
tau_p 3 12 
compressibility n.A. 3E-4 3E-4 
ref_p n.A. 1 1 
refcoord-scaling COM COM 
gen_vel yes no 
gen_temp 310 310 
gen_seed 473529 473529 
constraints none none 
constraint_algorithm Lincs Lincs 
continuation no no 
lincs_order 8 8 
lincs-iter 2 2 
lincs_warnangle 30 30 
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4.13.4 Analysis simulation box 
The analysis of the simulation box was conducted with the GROMACS 2016.x energy 
function (‘gmx energy’). To extract the energy components, the *.edr and the *.xtc were of 
the whole trajectory were supplied along with the term for either ‘Pressure’, ‘Temperature’, 
‘Volume’ or ‘Density’. The output files were converted into text files and analyzed by 
concatenating the corresponding values in one numeric vector in RStudio (Ver. 1.0.153). 
From the concatenated numeric vector minimum/maximum value, 25th and 75th percentiles 
(outlines of the box), median (line in the middle of the box), the difference between the 25th 
and 75th percentiles (inter-quartile distance), and whiskers (75th percentile plus 1.5 times 
inter-quartile distance, 25th percentile minus 1.5 times inter-quartile distance) were 
calculated. The values were plotted as Tukey boxplot using the ‘geom_boxplot’ function in 
ggplot2 (Version 3.0.0). 
4.13.5 Analysis protein structures 
The change and stability of the protein structure was quantified with GROMACS 2016.x 
commands ‘gmx rmsf’, ‘gmx rms’ and ‘gmx gyrate’. 
The Root mean square fluctuation (RMSF) of the amino acid residue positions in the protein 
in the course of the trajectory was calculated by fitting it to the reference structure (amino 
acid residue position at t=0 ps, provided as tpr file). The command considered the whole 
trajectory. The output was converted into a text file and imported into RStudio (Ver. 1.0.153). 
The single files were concatenated into one numeric matrix (row: residue number, columns: 
trajectory number). From the rows the mean and standard error of mean (SEM) for each 
amino acid residue was calculated (total of 260 positions). The data were plotted by ggplot2 
(Version 3.0.0) with the mean plotted as ‘geom_line’ and the SEM as ‘geom_ribbon’. 
To calculate the Root mean square deviation (RMSD) each structure from the trajectory was 
compared to its reference structure at t=0 ps (provided as tpr file). This yielded a RMSD for 
each given measurement point in time in the course of the trajectory. The given time points tx 
and the corresponding RMSD were printed as text file. The text files were imported into 
RStudio (Ver. 1.0.153). For any trajectory the mean was calculated and stored in a numeric 
vector. From the vector, the mean of means and SEM was calculated. The mean of means was 
plotted as ‘geom_bar’ with the SEM as ‘geom_errorbar’ in ggplot2 (Version 3.0.0). 
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Radius of gyration (gyration) was calculated as total gyration from the single radii of gyration 
in x,y and z-direction with ‘gmx gyrate’. The radius of gyration in one direction was 
calculated as root-mean-square of the radii components orthogonal to the axis. The gyration 
of the proteins was analyzed the same way as described in the previous paragraph for the 
RMSD. 
4.13.6 Analysis membrane system 
4.13.6.1  Lipid density profile 
The lipid density profile was calculated with the GROMACS 2016.x command ‘gmx density’. 
For the calculation, different index groups were considered. Water and cholesterol index 
groups remained unchanged. The POPC index group was split into ‘head’ (choline and 
glycerol moiety) and ‘tail’ (acyl chains) group. For the atomistic simulations, the atom types 
‘N’ – ‘C3’ were considered as ‘head’, and the types ‘C21’ – ‘C316’ as ‘tails’. In the coarse-
grained simulations, the atom types ‘NC3’ – ‘GL2’ were indexed as ‘head’ group, and 
‘C1A’ – ‘C4B’ as ‘tails’. The density was calculated as normal on the membrane in direction 
of z and relative to the center of the (changing) box. 
The density calculation was stored as text file giving the averaged density for the given index 
group at each measurement point in z-direction. The text files were imported into RStudio 
(Ver. 1.0.153). The single files were concatenated into one numeric matrix (row: z-axis, 
columns: trajectory). From the rows the mean and SEM for each point on the z-axis was 
calculated. The data were plotted by ggplot2 (Version 3.0.0) with the mean plotted as 
‘geom_line’ and the SEM as ‘geom_ribbon’. 
4.13.6.2  Deuterium order parameter 
For the atomistic simulations, the fatty acid moieties of the POPC index group were split into 
the SN1 and SN2 group. The SN1 index group considered 18 atom indices from ‘C21’ - 
‘C218’ and the SN2 index group 16 atom indices from ‘C31’ - ‘C316’. For each index group 
the Deuterium order parameter was calculated separately using the GROMACS 2016.x 
command ‘gmx order’ with direction of the normal on the membrane set to the z-axis. The 
output text file was imported into RStudio (Ver. 1.0.153). The single files were concatenated 
into one numeric matrix (row: acyl chain index, columns: trajectory). From the rows the mean 
and SEM for each atom in the acyl chain was calculated. The data were plotted by ggplot2 
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(Version 3.0.0) with the mean plotted as ‘geom_point’ and the SEM plotted as 
‘geom_errorbar’. The points were connected by ‘geom_line’. 
For the martini simulation, the Deuterium order parameter was analyzed with the do-order-
gmx5.py command. The command was set with an initial time of 5x10
3
 ps and finished at 
5x10
6
 ps with one in ten frames considered. The absolute number of POPC molecules in each 
system was retrieved with the ‘grep’ command from the topology file. The output file 
‘deuter_raw’ was imported into RStudio (Ver. 1.0.153). The single files were concatenated 
into one numeric matrix (row: ‘GL-C1’, ‘C1-C2/D2’, ‘C2/D2-C3’, ‘C3-C4’, columns: 
trajectory). From the rows the mean and SEM for each of the four beads was calculated. The 
data were plotted by ggplot2 (Version 3.0.0) with the mean plotted as ‘geom_point’ and the 
SEM plotted as ‘geom_errorbar’. The points were connected by ‘geom_line’. 
4.13.6.3  Lipid diffusion by mean square displacement 
The lipid diffusion constant was calculated both for the whole POPC molecule as well as for 
the phosphate group only. The later one was indexed for the calculation. 
The diffusion constant D was calculated using the GROMACS 2016.x command ‘gmx msd’. 
The value D is obtained by a least squares fitting of the linear relationship (D*t+c) through 
the mean square displacement (MSD) of time (t) of the indexed group. The lateral diffusion 
was calculated in a plane perpendicular to z-axis. The first frame in the trajectory was at 
5x10
4
 ps with the time between the restarting points in trajectory set to 1x10
3
 ps. The start and 
end time for fitting was set to 1x10
3
 ps and 1x10
5
 ps respectively. The calculated averaged 
diffusion constant was printed by GROMACS 2016.x in an output text file. The output text 
file was imported into RStudio (Ver. 1.0.153). The respective value was retrieved from the 
3rd line of the output file, which had been broken up with the ‘strsplit’ command and 
converted into a numeric. The numerics of the diffusion constant for one set of trajectories 
were collected in a numeric vector from which the mean and SEM were calculated. The mean 
values were plotted as ‘geom_bar’ with SEM as ‘geom_errorbar’ in ggplot2 (Version 3.0.0). 
4.13.7 Cholesterol density analysis 
Both the cholesterol density maps for the atomistic and the coarse-grained simulation were 
calculated using gtide. In all cases the density maps were calculated from concatenated 
trajectory files containing only cholesterol and protein molecules considering only cholesterol 
molecules within a given distance from the protein surface. 
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4.13.7.1  Coarse-grained systems 
To get a density map for cholesterol binding in coarse-grained simulation, the protomers had 
to be separated and the cholesterols next to them along with them. From the cholesterol 
molecules below threshold distance, the density map was calculated. 
With the script ‘get_one-protomer-one-chol-in-sequence.sh’, the protomers were assigned to 
two different index groups. Then the minimum distance between the two protomers was 
calculated with the command ‘gmx mindist’. The protomers in a proximity of <0.5 nm were 
considered to be dimerized at the given time point in the trajectory. Then the cholesterol 
molecules were given seperated indices. From the distance between the cholesterol molecules 
and the protomers it was calculated whether the cholesterol molecules were unbound 
(>0.5 nm), attached to monomeric protomer A or B, or bound to the respective protomers in 
the dimer structure. From that snapshots, the script ‘cat_one-chol_trajs.sh’ concatenated a 
trajectory dimer and nodimer. The third script ‘add_helices.sh’ added the information about 
the exact length of the helices to the reference pdb. With the fourth script 
‘get_cholesterol_density.sh’ the information about cholesterol bound to dimerized or 
monomeric transmembrane domains was extracted with gtide from the corresponding 
concatenated trajectories. The denisty map was plotted as ‘isosurface mesh’ in Pymol 
(Ver. 1.0.153) on the ‘dimer’ and ‘nodimer’ reference pdb. 
4.13.7.2 Atomistic systems 
To run the gtide script, the original trajectories were prepared with GROMACS 2016.x ‘gmx 
trjconv’. For the output trajectories only a common index group of the protein and the 
cholesterol molecules was considered skipping the first 5x10
4
 ps of the original file. In the 
second step, the output trajectories were concatenated. The concatenated trajectories were 
then fitted (rotation and translation) against the starting structure of the original trajectory. 
The starting time ‘t0’ and the time step between input frames ‘timestep’ were set to 1 ps. 
The concatenated and fitted trajectories with the protein and cholesterol molecules were used 
as input for gtide. The program considered the starting structure of the respective trajectory as 
reference to build a cholesterol density map in a proximity of 0.8 nm and at a resolution of 
0.1 nm around the surface of the protein. The density maps were plotted as ‘isosurface mesh’ 
in Pymol (Ver. 1.0.153) with confidence interval σ set to the indicated values. 
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